This is a Validated Antibody Database (VAD) review about mouse Ifng, based on 627 published articles (read how Labome selects the articles), using Ifng antibody in all methods. It is aimed to help Labome visitors find the most suited Ifng antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Ifng synonym: IFN-g; Ifg

others
Ifng antibody (BioLegend, XMG1.2) was used . Nat Commun (2018) ncbi
Ifng antibody (Biolegend, XMG1.2) was used . EMBO J (2019) ncbi
Ifng antibody (BioLegend, 505827) was used . Immunity (2018) ncbi
Ifng antibody (BioLegend, XMG1.2) was used . J Clin Invest (2018) ncbi
Ifng antibody (Biolegend, XMG1.2) was used . Front Immunol (2018) ncbi
Ifng antibody (BioLegend, XMG1.2) was used . PLoS ONE (2018) ncbi
Ifng antibody (BioLegend, XMG1.2) was used . J Clin Invest (2018) ncbi
Ifng antibody (Biolegend, XMG1.2) was used . Nature (2017) ncbi
Ifng antibody (Biolegend, XMG1.2) was used . J Virol (2017) ncbi
Ifng antibody (Biolegend, XMG1.2) was used . Nat Commun (2017) ncbi
Ifng antibody (BioLegend, XMG1.2) was used . J Exp Med (2017) ncbi
Ifng antibody (BioLegend, XMG1.2) was used . J Exp Med (2017) ncbi
Ifng antibody (BioLegend, XMG1.2) was used . J Exp Med (2017) ncbi
Ifng antibody (BioLegend, XMG1.2) was used . J Clin Invest (2017) ncbi
In order to characterize mitochondrial changes in T cells due to PD-1 blockade therapy, Ifng antibody (BioLegend, XMG1.2) was used . Proc Natl Acad Sci U S A (2017) ncbi
Invitrogen
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; loading ...; fig 7d
Invitrogen Ifng antibody (eBioscience, 12-7311-81) was used in flow cytometry on mouse samples at 1:100 (fig 7d). Nat Commun (2022) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:400; fig 3d
Invitrogen Ifng antibody (Thermo Fisher Scientific, 12-7311-82) was used in flow cytometry on mouse samples at 1:400 (fig 3d). Heliyon (2022) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3h
Invitrogen Ifng antibody (eBioscience, 25-7311-82) was used in flow cytometry on mouse samples (fig 3h). PLoS Pathog (2022) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; loading ...; fig 1e, 3e
Invitrogen Ifng antibody (Invitrogen, XMG1.2) was used in flow cytometry on mouse samples at 1:100 (fig 1e, 3e). J Neuroinflammation (2022) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:1000; loading ...; fig 1e
Invitrogen Ifng antibody (eBioscence, Thermo Fisher, XMG1.2) was used in flow cytometry on mouse samples at 1:1000 (fig 1e). PLoS Pathog (2022) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 3b
Invitrogen Ifng antibody (eBioscience, 25-7311-82) was used in flow cytometry on mouse samples (fig 3b). Theranostics (2021) ncbi
rat monoclonal (XMG1.2)
  • western blot; mouse; loading ...; fig 2a
Invitrogen Ifng antibody (Thermo Fisher, MM700) was used in western blot on mouse samples (fig 2a). Int J Mol Sci (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:200; loading ...; fig 5b, 5d
Invitrogen Ifng antibody (Thermo Fisher, XMG1.2) was used in flow cytometry on mouse samples at 1:200 (fig 5b, 5d). Nat Commun (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5e
Invitrogen Ifng antibody (eBioscience, 11-7311-81) was used in flow cytometry on mouse samples (fig 5e). Adv Sci (Weinh) (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:500; loading ...; fig s4b, s4c
Invitrogen Ifng antibody (Invitrogen, 48-7311-80) was used in flow cytometry on mouse samples at 1:500 (fig s4b, s4c). Clin Exp Metastasis (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...
Invitrogen Ifng antibody (eBioscience, 25-7311-82) was used in flow cytometry on mouse samples . Int J Mol Sci (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; human; 1:40; fig 5e
Invitrogen Ifng antibody (ThermoFisher Scientific, 25-7311-41) was used in flow cytometry on human samples at 1:40 (fig 5e). elife (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; fig 6g
Invitrogen Ifng antibody (eBioscience, 17-7311-81) was used in flow cytometry on mouse samples at 1:100 (fig 6g). Nat Commun (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4d
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 4d). Proc Natl Acad Sci U S A (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...
Invitrogen Ifng antibody (Invitrogen, XMG1.2) was used in flow cytometry on mouse samples . Front Immunol (2021) ncbi
rat monoclonal (R4-6A2)
  • ELISA; mouse; loading ...; fig 5
Invitrogen Ifng antibody (ThermoFisher, R4-6A2) was used in ELISA on mouse samples (fig 5). Arthritis Res Ther (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2p
Invitrogen Ifng antibody (eBioscience, 17-7311-82) was used in flow cytometry on mouse samples (fig 2p). Antioxidants (Basel) (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2h
Invitrogen Ifng antibody (Thermofisher, XMG1.2) was used in flow cytometry on mouse samples (fig 2h). Protein Cell (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; fig s2-1a
Invitrogen Ifng antibody (Thermo Fisher Scientific, 11-7311-82) was used in flow cytometry on mouse samples at 1:100 (fig s2-1a). elife (2021) ncbi
rat monoclonal (XMG1.2)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1c
Invitrogen Ifng antibody (Thermo Scientific, MM700) was used in immunohistochemistry - frozen section on mouse samples (fig 1c). Front Physiol (2020) ncbi
rat monoclonal (XMG1.2)
  • ELISA; mouse; loading ...; fig 2c
Invitrogen Ifng antibody (eBiosciences, XMG1.2) was used in ELISA on mouse samples (fig 2c). Aging Cell (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; fig 4c
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples at 1:100 (fig 4c). Science (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 2a). Int J Biol Sci (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; loading ...; fig 3a
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples at 1:100 (fig 3a). elife (2020) ncbi
rat monoclonal (XMG1.2)
  • western blot; mouse; 1:500; loading ...; fig 5a
Invitrogen Ifng antibody (Thermo Fisher Scientific, MM700) was used in western blot on mouse samples at 1:500 (fig 5a). Brain Pathol (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; loading ...; fig 6
Invitrogen Ifng antibody (Thermo Fisher Scientific, XMG1.2) was used in flow cytometry on mouse samples at 1:100 (fig 6). elife (2020) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2p
Invitrogen Ifng antibody (eBioscience, 17-7311-82) was used in flow cytometry on mouse samples (fig 2p). Aging (Albany NY) (2020) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1g
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 1g). Sci Immunol (2020) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4b
Invitrogen Ifng antibody (eBioscience, 17-7311-82) was used in flow cytometry on mouse samples (fig 4b). Cell (2020) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4g
Invitrogen Ifng antibody (eBioscience/Thermo Fisher Scientific, XMG1.2) was used in flow cytometry on mouse samples (fig 4g). Sci Adv (2020) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 7b
Invitrogen Ifng antibody (ThermoFisher Scientific, 12-7311-81) was used in flow cytometry on mouse samples (fig 7b). elife (2020) ncbi
rat monoclonal (XMG1.2)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 7d
Invitrogen Ifng antibody (ThermoFisher, XMG1.2) was used in immunohistochemistry - paraffin section on mouse samples (fig 7d). Sci Rep (2020) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:1000; loading ...; fig 2e, 5f
Invitrogen Ifng antibody (Thermo Fisher Scientific, 53-7311-82) was used in flow cytometry on mouse samples at 1:1000 (fig 2e, 5f). elife (2020) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:300; loading ...; fig s7d
Invitrogen Ifng antibody (Invitrogen, 25-7311-82) was used in flow cytometry on mouse samples at 1:300 (fig s7d). Cell Res (2020) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5e
Invitrogen Ifng antibody (eBioscience, 11-7311-82) was used in flow cytometry on mouse samples (fig 5e). Aging (Albany NY) (2020) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4c
Invitrogen Ifng antibody (eBioscience, 25731182) was used in flow cytometry on mouse samples (fig 4c). Nat Commun (2020) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s1d
Invitrogen Ifng antibody (Thermo Fisher, 48-7311-82) was used in flow cytometry on mouse samples (fig s1d). Cell (2020) ncbi
rat monoclonal (AN-18)
  • flow cytometry; mouse; loading ...; fig 2f, 3c,
Invitrogen Ifng antibody (eBioscience, AN-18) was used in flow cytometry on mouse samples (fig 2f, 3c, ). JCI Insight (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 3h
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 3h). Nature (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; loading ...; fig 5
Invitrogen Ifng antibody (eBioscience, 25-7311) was used in flow cytometry on mouse samples at 1:100 (fig 5). JCI Insight (2020) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:400; loading ...; fig 5c
Invitrogen Ifng antibody (eBioscience, 17731181) was used in flow cytometry on mouse samples at 1:400 (fig 5c). Nat Commun (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4b
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 4b). Nature (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen Ifng antibody (eBioscience, 48-7311-82) was used in flow cytometry on mouse samples (fig 2a). Science (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2c, 6e
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 2c, 6e). Sci Adv (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; loading ...; fig 3d
Invitrogen Ifng antibody (Thermo Fisher, XMG1.2) was used in flow cytometry on mouse samples at 1:100 (fig 3d). Science (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 2a). BMC Complement Altern Med (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3d
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 3d). Nature (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; human; loading ...; fig 2b
Invitrogen Ifng antibody (eBioscience, XMG1.2.) was used in flow cytometry on human samples (fig 2b). Sci Adv (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5f
Invitrogen Ifng antibody (eBioscience, 12-7311-41) was used in flow cytometry on mouse samples (fig 5f). Cell (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 1a). Sci Rep (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 6c
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 6c). J Exp Med (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:200; loading ...; fig 3e
Invitrogen Ifng antibody (eBioscience, 11-7311-82) was used in flow cytometry on mouse samples at 1:200 (fig 3e). Nat Commun (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2d
Invitrogen Ifng antibody (eBiosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 2d). J Exp Med (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig ex1e
Invitrogen Ifng antibody (eBioscience, 17-7311-82) was used in flow cytometry on mouse samples (fig ex1e). Nature (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 1b). Oncoimmunology (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2e
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 2e). Immune Netw (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3c
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 3c). Front Immunol (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; loading ...; fig 6a
Invitrogen Ifng antibody (eBioscience, 48-7311-82) was used in flow cytometry on mouse samples at 1:100 (fig 6a). elife (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1b, 2c
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 1b, 2c). Nature (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3d
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 3d). J Exp Med (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5d
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 5d). Proc Natl Acad Sci U S A (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3d
Invitrogen Ifng antibody (eBioscience, 11-7311-82) was used in flow cytometry on mouse samples (fig 3d). Cell Mol Gastroenterol Hepatol (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s4d
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig s4d). Proc Natl Acad Sci U S A (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1g
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 1g). Cancer Res (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4f
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 4f). PLoS Pathog (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4b
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 4b). Nature (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 6d
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 6d). Front Microbiol (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 6b
Invitrogen Ifng antibody (eBioscience, 12-7311) was used in flow cytometry on mouse samples (fig 6b). J Neuroinflammation (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4b
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 4b). Front Immunol (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen Ifng antibody (Thermo Fisher Scientific, 25-7311-41) was used in flow cytometry on mouse samples (fig 2a). Immunity (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3c
Invitrogen Ifng antibody (eBiosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 3c). Science (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; human; 1:300; fig 3d
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on human samples at 1:300 (fig 3d). Nat Commun (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:500; loading ...; fig s4a
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples at 1:500 (fig s4a). Nat Commun (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4a
Invitrogen Ifng antibody (eBioscience, XMG 1.2) was used in flow cytometry on mouse samples (fig 4a). Front Immunol (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig e4b
Invitrogen Ifng antibody (eBiosciences, XMG1.2) was used in flow cytometry on mouse samples (fig e4b). Nature (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4b
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 4b). J Clin Invest (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3e
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 3e). J Exp Med (2018) ncbi
hamsters monoclonal (H22)
  • blocking or activating experiments; human; 10 ug/ml; loading ...; fig 1a
Invitrogen Ifng antibody (eBioscience, H22) was used in blocking or activating experiments on human samples at 10 ug/ml (fig 1a). Cancer Res (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4b
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 4b). J Virol (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4c
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 4c). Front Immunol (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s2a
Invitrogen Ifng antibody (eBioscience, 12-7311) was used in flow cytometry on mouse samples (fig s2a). Nat Med (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 1f
Invitrogen Ifng antibody (eBiosciences, 48-7311-82) was used in flow cytometry on mouse samples (fig 1f). Cell (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3c
Invitrogen Ifng antibody (eBioscience, 177311) was used in flow cytometry on mouse samples (fig 3c). Br J Pharmacol (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 3b
Invitrogen Ifng antibody (eBiosciences, 25-7311-41) was used in flow cytometry on mouse samples (fig 3b). Cell (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3a
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 3a). EMBO J (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 3b
Invitrogen Ifng antibody (Thermo Fisher Scientific, 25-7311-41) was used in flow cytometry on mouse samples (fig 3b). Cell (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; human; loading ...; fig 2c
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on human samples (fig 2c). J Immunol (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2a, 2d
  • ELISA; mouse; loading ...; fig 3a
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 2a, 2d) and in ELISA on mouse samples (fig 3a). Infect Immun (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s2b
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig s2b). Cancer Res (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 5a
Invitrogen Ifng antibody (Invitrogen, XMG1.2) was used in flow cytometry on mouse samples (fig 5a). J Immunol (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4a
In order to investigate the important of Ly49A ITIM signaling in NK-cell effector inhibition, licensing, and receptor repertoire development, Invitrogen Ifng antibody (eBiosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 4a). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1e
In order to investigate the effect of polymicrobial sepsis in skin immune response, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 1e). PLoS Pathog (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1g
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 1g). Eur J Immunol (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:1000; loading ...; fig s3d
Invitrogen Ifng antibody (ebioscience, XMG1.2) was used in flow cytometry on mouse samples at 1:1000 (fig s3d). Nat Commun (2017) ncbi
rat monoclonal (R4-6A2)
  • ELISA; mouse; loading ...; fig 3a
Invitrogen Ifng antibody (eBioscience, R4-6A2) was used in ELISA on mouse samples (fig 3a). J Immunol (2017) ncbi
rat monoclonal (AN-18)
  • ELISA; mouse; loading ...; fig 2e
In order to study the induction of CTL tolerance by neoantigens in Langerhans cells, Invitrogen Ifng antibody (eBiosciences, AN-18) was used in ELISA on mouse samples (fig 2e). J Immunol (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4e
In order to characterize the regulatory T cells expressing T-bet transcriptional factor, Invitrogen Ifng antibody (eBioscience, 48-7311-80) was used in flow cytometry on mouse samples (fig 4e). Nature (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4d
In order to study the regulatory mechanism for the sex-dependent stroke mortality, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 4d). Cell Immunol (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2b
  • flow cytometry; human; loading ...; fig 2b
In order to study the effect of human induced pluripotent stem cells-derived mesenchymal stem cells on T cell phenotype after xenotransplantation, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 2b) and in flow cytometry on human samples (fig 2b). Stem Cells (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2a
In order to investigate the role of Egr2 and 3 in adaptive immune responses and its mechanism, Invitrogen Ifng antibody (eBiosciences, 11-7311-81) was used in flow cytometry on mouse samples (fig 2a). J Exp Med (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s7d
In order to investigate the involvement of thymic antigen-presenting cells in the epigenetic imprinting of alloantigen-specific regulatory T cells, Invitrogen Ifng antibody (eBiosciences, XMG1.2) was used in flow cytometry on mouse samples (fig s7d). Oncotarget (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1c
In order to generate and characterize Treg-of-B cells, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 1c). Sci Rep (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 2a). J Leukoc Biol (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 8a
In order to explore how the different Fcgamma receptors expressed on dendritic cells affect the initiation of T cell responses, Invitrogen Ifng antibody (Thermo Fisher Scientific, XMG1.2) was used in flow cytometry on mouse samples (fig 8a). J Exp Med (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3b
Invitrogen Ifng antibody (eBioscience, XMG121) was used in flow cytometry on mouse samples (fig 3b). Eur J Immunol (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4a
In order to elucidate how schistosome-induced B cells protect against allergic airway inflammation, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 4a). Int J Parasitol (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig s2b
In order to study intestinal immune responses during acute graft-versus-host disease, Invitrogen Ifng antibody (eBiosciences, XMG1.2) was used in flow cytometry on mouse samples (fig s2b). J Clin Invest (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; loading ...; fig 6l
In order to test if oncolytic poxvirus treatment improves anti-PD-L1 immunotherapy, Invitrogen Ifng antibody (eBioscience, 17-7311-82) was used in flow cytometry on mouse samples at 1:100 (fig 6l). Nat Commun (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 5c
In order to find that TLR3, 7 and 9 deficiencies on host cells result in complete tumor regression and induction of anti-tumor immunity, Invitrogen Ifng antibody (eBiosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 5c). Nat Commun (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s3c
In order to study the role of moesin during the generation of TGF-beta-induced T regulatory cells, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig s3c). J Clin Invest (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:500; loading ...; fig s1d
In order to report a CD40-dependent mechanism capable of abrogating inducible T regulatory cell induction by dendritic cells, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples at 1:500 (fig s1d). Nat Commun (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s3e
In order to investigate the use of red blood cells expressing disease-associated autoantigenas a means of inducing antigen-specific tolerance, Invitrogen Ifng antibody (eBioscience, 12-7311-82) was used in flow cytometry on mouse samples (fig s3e). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:200; loading ...; fig 5j
In order to evaluate the use of a recombinant Newcastle disease virus expressing ICOS ligand to treat cancer, Invitrogen Ifng antibody (eBioscience, 12-7311) was used in flow cytometry on mouse samples at 1:200 (fig 5j). Nat Commun (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 5a
In order to find that Th40 cells drive a rapid, more severe experimental autoimmune encephalomyelitis disease course than conventional CD4 T cells, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 5a). PLoS ONE (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 4h
In order to determine the contribution of B cell to obesity-induced insulin resistance, Invitrogen Ifng antibody (eBiosciences, 25-7311-82) was used in flow cytometry on mouse samples (fig 4h). J Clin Invest (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5b
In order to define the functions of IL-10 during Staphylococcus aureus, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 5b). J Immunol (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2b
In order to test the effect of paeoniflorin in experimental autoimmune encephalomyelitis, an animal model for multiple sclerosis, Invitrogen Ifng antibody (eBioscience, 17-7311) was used in flow cytometry on mouse samples (fig 2b). Sci Rep (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2b
In order to elucidate the role of interferon regulatory factor 4 in dendritic cells, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 2b). J Cell Biol (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2g
In order to evaluate miR-29a in B cells as a potential therapeutic target in arthritis, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 2g). Cell Mol Life Sci (2017) ncbi
rat monoclonal (R4-6A2)
  • blocking or activating experiments; mouse; loading ...; fig 4a
In order to compare the antitumor effects of Spirulina LPS to E. coli LPS in an MH134 hepatoma model, Invitrogen Ifng antibody (Endogen, MM701) was used in blocking or activating experiments on mouse samples (fig 4a). Oncol Rep (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4g
In order to study the role of MYSM1 in T cell development, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 4g). Immunology (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1k
In order to explore the role of PKCalpha-DOCK8-Cdc42 signaling in T cell migration, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 1k). J Exp Med (2017) ncbi
rat monoclonal (R4-6A2)
  • ELISA; mouse; loading ...; fig s7a
Invitrogen Ifng antibody (eBiosciences, R4-6A2) was used in ELISA on mouse samples (fig s7a). Nat Commun (2016) ncbi
rat monoclonal (XMG1.2)
  • ELISA; mouse; loading ...; fig s7a
Invitrogen Ifng antibody (eBiosciences, XMG1.2) was used in ELISA on mouse samples (fig s7a). Nat Commun (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 5a
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 5a). Cell (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3f
Invitrogen Ifng antibody (eBiosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 3f). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1f
In order to find that Tritrichomonas muris contributes to T cell-driven colitis, Invitrogen Ifng antibody (eBiosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 1f). J Exp Med (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5e
In order to investigate strains of Listeria monocytogenes that activate necrosis, apoptosis, or pyroptosis and study the role of CD8 positive T cells in these processes, Invitrogen Ifng antibody (ebioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 5e). Infect Immun (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1a
In order to study the role of MCH I in natural killer cell tolerance and hyporesponsiveness, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 1a). J Immunol (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:400; loading ...; fig 3a
In order to test how inhibiting autophagy impacts antitumor immune responses in immune-competent mouse models of melanoma and mammary cancer, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples at 1:400 (fig 3a). J Clin Invest (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 1
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 1). Oncoimmunology (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5B
In order to examine the thymic microenvironment using a model of paracoccidioidomycosis, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 5B). PLoS ONE (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s5f
Invitrogen Ifng antibody (eBiosciences, 17-7311-81) was used in flow cytometry on mouse samples (fig s5f). Nat Immunol (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1a
In order to discuss how Th1-driven inflammation affects Treg homeostasis in atherosclerosis, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 1a). Circ Res (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 4
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 4). Sci Rep (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1f
In order to investigate the contribution of TGF-beta to the eomesodermin-driven CD4 T cell program during viral infection, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 1f). J Clin Invest (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4a
In order to determine the function of the SLAM family of proteins in natural killer cells, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 4a). J Exp Med (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig s2
In order to measure expression of major histocompatibility complex class one and paired immunoglobulin-like receptor B in the central and peripheral nervous system after sciatic nerve injury in mice, Invitrogen Ifng antibody (eBioscience, 12-7311) was used in flow cytometry on mouse samples (fig s2). PLoS ONE (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 6f
In order to determine the contribution of lymphatic drainage to tumor inflammation and immunity, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 6f). J Clin Invest (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:200; fig 4
Invitrogen Ifng antibody (eBiosciences, 11-7311-82) was used in flow cytometry on mouse samples at 1:200 (fig 4). Nat Commun (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2e
In order to demonstrate that Blimp-1 controls CD4 T cell exhaustion, Invitrogen Ifng antibody (Affymetrix eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 2e). J Exp Med (2016) ncbi
rat monoclonal (XMG1.2)
  • blocking or activating experiments; mouse; loading ...; fig 6b
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in blocking or activating experiments on mouse samples (fig 6b). J Immunol (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5B
In order to study the contribution of CXCR6/CXCL16 interactions in glycolipid-dependent invariant natural killer cell activation and tumor control, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 5B). Oncoimmunology (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; human; loading ...; fig 6d
In order to investigate the effect of Tasquinimod in bladder cancer, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on human samples (fig 6d). Oncoimmunology (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5e
In order to use knockout mice to determine the role of cereblon in T cells, Invitrogen Ifng antibody (eBiosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 5e). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; loading ...; fig s3
In order to study the impact of p21 signaling on monocyte reprogramming, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples at 1:100 (fig s3). J Clin Invest (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3h
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 3h). Immunity (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to investigate the role of general control non-derepressible 2 in resolving autoimmune neuroinflammation, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples . J Neuroimmunol (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4m
In order to assess the contribution of interferon-induced transmembrane protein 3 to West Nile virus infection, Invitrogen Ifng antibody (eBioscience, 51-73-1182) was used in flow cytometry on mouse samples (fig 4m). J Virol (2016) ncbi
rat monoclonal (R4-6A2)
  • western blot; mouse; fig 3
In order to analyze regulation of NLRP3 inflammasome in adipose tissue by phosphodiesterase 3B (PDE3B), Invitrogen Ifng antibody (Thermo Scientific, MM701) was used in western blot on mouse samples (fig 3). Sci Rep (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2
In order to report the effects of PD-L1 modulation of T cell function in graft-versus-host disease, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 2). J Clin Invest (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s4d
In order to examine the dynamics of anti-inflammatory T cells in the intestine, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig s4d). Science (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2e
Invitrogen Ifng antibody (eBiosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 2e). Sci Rep (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s11a
In order to show that ATG16L1 and NOD2 are required for Bacteroides fragilis-mediated protection from colitis, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig s11a). Science (2016) ncbi
rat monoclonal (AN-18)
  • flow cytometry; mouse; loading ...; fig 4d
Invitrogen Ifng antibody (eBiosciences, AN-18) was used in flow cytometry on mouse samples (fig 4d). Cancer Res (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 2
In order to analyze the induction of immune-mediated survival advantage in murine intracranial glioma by agonist anti-GITR monoclonal antibody and stereotactic radation, Invitrogen Ifng antibody (eBioscience, 25731141) was used in flow cytometry on mouse samples (fig 2). J Immunother Cancer (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3c
In order to investigate how dopamine receptor D3 signaling affects the balance of effector T cells, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 3c). J Immunol (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2a
In order to investigate the mechanism for adoptively transferred effector T-cell survival and memory formation, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 2a). Cell Biosci (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s2b
Invitrogen Ifng antibody (eBioscience, 25-7311-82) was used in flow cytometry on mouse samples (fig s2b). Biol Open (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4a
In order to identify a B cell-intrinsic mechanism by which IFN signaling promotes lupus pathogenesis, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 4a). J Exp Med (2016) ncbi
rat monoclonal (R4-6A2)
  • ELISA; mouse; fig 3D
Invitrogen Ifng antibody (eBiosciences, R4-6A2) was used in ELISA on mouse samples (fig 3D). PLoS ONE (2016) ncbi
rat monoclonal (AN-18)
  • ELISA; mouse; fig 3D
Invitrogen Ifng antibody (eBiosciences, AN-18) was used in ELISA on mouse samples (fig 3D). PLoS ONE (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 10 ug/ml; fig 2
Invitrogen Ifng antibody (eBioscience, 45-7311-82) was used in flow cytometry on mouse samples at 10 ug/ml (fig 2). Mucosal Immunol (2017) ncbi
rat monoclonal (XMG1.2)
  • blocking or activating experiments; mouse; fig 8
Invitrogen Ifng antibody (eBioscience, 16-7311-85) was used in blocking or activating experiments on mouse samples (fig 8). PLoS Negl Trop Dis (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:200; loading ...; fig 2a
In order to investigate the role of IL-1beta produced by a T helper 17 cell-intrinsic ASC-NLRP3-caspase-8 inflammasome in experimental autoimmune encephalomyelitis, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples at 1:200 (fig 2a). Nat Immunol (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 6
Invitrogen Ifng antibody (e-Bioscience, 25-7311) was used in flow cytometry on mouse samples (fig 6). Nat Commun (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4e
In order to test if administration of exogenous IL-19 reduces progression of preformed atherosclerotic plaque, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 4e). Am J Pathol (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 2
In order to determine the composition of Orai1 channels found at the endoplasmic reticulum-plasma membrane junction, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 2). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 2
In order to establish that autophagy is essential for maintenance of a balanced CD4 positive intestinal T cell response, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 2). elife (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 1
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 1). J Exp Med (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 4
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 4). Sci Rep (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5a
In order to demonstrate that control of acute infection with Trypanosoma cruzi is associated with development of systemic necrotizing vasculitis, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 5a). Infect Immun (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig s7
Invitrogen Ifng antibody (eBioscience, 25-7311-82) was used in flow cytometry on mouse samples (fig s7). Sci Rep (2016) ncbi
rat monoclonal (R4-6A2)
  • flow cytometry; mouse; 1:100; fig s6b
In order to suggest that locally synthesized C1q promotes tumor growth, Invitrogen Ifng antibody (eBioscience, R4-6A2) was used in flow cytometry on mouse samples at 1:100 (fig s6b). Nat Commun (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 6
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 6). Sci Rep (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to examine the contribution of Foxo1 to activated T cells, Invitrogen Ifng antibody (eBiocience, XMG1.2) was used in flow cytometry on mouse samples . Nature (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 1
Invitrogen Ifng antibody (eBioscience, XMG 1.2) was used in flow cytometry on mouse samples (fig 1). Nat Commun (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; tbl 1
In order to determine the role of G-CSF in a murine model of human uveitis-experimental autoimmune uveoretinitis, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (tbl 1). Am J Pathol (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 5, 6
In order to discover how macrophage burst ressponse mobilizes innate and adaptive immunity via in vivo imaging of inflammasome activation, Invitrogen Ifng antibody (ebioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 5, 6). Nat Med (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig s8
In order to research the connection between oligodendrocyte death and immune-mediated CNS demyelination, Invitrogen Ifng antibody (eBioscience, 11-7311) was used in flow cytometry on mouse samples (fig s8). Nat Neurosci (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 3
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 3). J Immunol (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 4
In order to study how DNAM-1 controls NK cell-mediated cytotoxicity and cytokine production, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 4). J Exp Med (2015) ncbi
rat monoclonal (R4-6A2)
  • blocking or activating experiments; mouse
In order to discuss methods to generate different T cell subsets in vitro, Invitrogen Ifng antibody (eBiosciences, R4-6A2) was used in blocking or activating experiments on mouse samples . Methods Mol Biol (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 2b
Invitrogen Ifng antibody (eBiosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 2b). Nat Med (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2a
In order to investigate the role of TIGIT in the immune response, Invitrogen Ifng antibody (eBioscience, XMG-1.2) was used in flow cytometry on mouse samples (fig 2a). J Clin Invest (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s3c
In order to test if 17-allylamino-demethoxygeldanamycin improves intestinal barrier function using two mouse graft versus host disease models, Invitrogen Ifng antibody (eBioscience, 11-7311-41) was used in flow cytometry on mouse samples (fig s3c). Oncogene (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 5
In order to use peptidoglycan mimics to vaccinate against Staphylococcus aureus, Invitrogen Ifng antibody (eBioscience, 12-7311) was used in flow cytometry on mouse samples (fig 5). PLoS ONE (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to study PI3Kdelta in CD8+ T cells during infection with Listeria monocytogenes, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 5
Invitrogen Ifng antibody (eBioscience, 14-8311-63) was used in flow cytometry on mouse samples (fig 5). J Immunol (2015) ncbi
rat monoclonal (R4-6A2)
Invitrogen Ifng antibody (EBioscience, R4-6A2) was used . Mucosal Immunol (2016) ncbi
rat monoclonal (XMG1.2)
Invitrogen Ifng antibody (EBioscience, XMG1.2) was used . Mucosal Immunol (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; bovine
Invitrogen Ifng antibody (Affymetrix eBioscience, 48-7311-80) was used in flow cytometry on bovine samples . Cell Tissue Res (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1g
In order to determine the contribution of IL-23/IL-23R and IL-7/IL-7R signaling in T helper 17 and T helper 1 cell dynamics during central nervous system autoimmunity, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 1g). J Immunol (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2g
In order to test if anti-retroviral natural killer cell functions are inhibited by T regulatory cells during an acute Friend retrovirus infection, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 2g). Retrovirology (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 2a). Cancer Res (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 6
In order to evaluate as a mucosal vaccine platform against influenza A virus, Invitrogen Ifng antibody (eBioscience, #17-7311-82) was used in flow cytometry on mouse samples (fig 6). Front Immunol (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 2
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 2). J Neuroinflammation (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; fig s5
Invitrogen Ifng antibody (eBioscience, 17-7311-82) was used in flow cytometry on mouse samples at 1:100 (fig s5). Nat Commun (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 1C
In order to optimize application routes for trifunctional bispecific antibodies against tumor-associated ganglioside GD2, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 1C). Mol Cancer Ther (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; human; fig 3
In order to describe the use of CCR9 expression to create primary gastrointestinal tumors in immunodeficient mice by tail-vein injection, Invitrogen Ifng antibody (ebiosciences, XMG1.2) was used in flow cytometry on human samples (fig 3). Nat Biotechnol (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 6e
In order to find that lymph node-like vasculature in melanoma and lung carcinoma murine models is both a consequence of and key contributor to anti-tumor immunity, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 6e). Nat Commun (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5e
In order to assess the capacity of dried microneedle array vaccination on effector/memory CD8 positive T cell subsets, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 5e). Vaccine (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig s9
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig s9). Nature (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig s1
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig s1). PLoS ONE (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig s4
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig s4). PLoS Pathog (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
Invitrogen Ifng antibody (Invitrogen, XMG1.2) was used in flow cytometry on mouse samples . PLoS ONE (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 4
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 4). Infect Immun (2015) ncbi
rat monoclonal (XMG1.2)
  • blocking or activating experiments; mouse
  • flow cytometry; mouse; 1:100; fig 4
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in blocking or activating experiments on mouse samples and in flow cytometry on mouse samples at 1:100 (fig 4). PLoS Pathog (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 6
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 6). PLoS Pathog (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 7
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 7). J Clin Invest (2015) ncbi
domestic goat polyclonal
In order to examine the mechanism of sensorimotor declines in a rat model of repetitive overuse injury, Invitrogen Ifng antibody (Thermo Scientific, PA1-24782) was used . J Cell Commun Signal (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 6
In order to report that GP96 is required for T regulatory cell maintenance and function, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 6). J Clin Invest (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 2
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 2). PLoS Pathog (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; human; fig 3
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on human samples (fig 3). Cell Res (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 2
In order to show that the PTEN-mTORC2 axis maintains T regulatory cell stability and coordinates their control of effector responses, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 2). Nat Immunol (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
  • immunocytochemistry; mouse
Invitrogen Ifng antibody (eBioscience or BioLegend, XMG1.2) was used in flow cytometry on mouse samples and in immunocytochemistry on mouse samples . Cell Mol Immunol (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 4
Invitrogen Ifng antibody (ebioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 4). J Invest Dermatol (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to examine the role of lymph node stromal cells in immune responses, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples . elife (2014) ncbi
rat monoclonal (R4-6A2)
  • ELISA; mouse; fig 3
In order to analyze induction of murine cardiac allograft survival and regulatory T cells from treadmill exercise, Invitrogen Ifng antibody (Caltag Laboratories, R4-6A2) was used in ELISA on mouse samples (fig 3). Transpl Int (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 1
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 1). J Leukoc Biol (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 2
Invitrogen Ifng antibody (eBiosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 2). Nat Immunol (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 3f
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 3f). Nat Immunol (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 5
Invitrogen Ifng antibody (eBiosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 5). Eur J Immunol (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3a
In order to investigate the role of DUSP6 in colonic CD4 positive T-cell function, differentiation, and inflammatory profile, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 3a). Mucosal Immunol (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:200
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples at 1:200. Nat Commun (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4c
In order to test the efficacy of combining different monoclonal antibodies to treat cancer, Invitrogen Ifng antibody (ebioscience, MM700) was used in flow cytometry on mouse samples (fig 4c). Clin Cancer Res (2015) ncbi
rat monoclonal (XMG1.2)
  • western blot; mouse
Invitrogen Ifng antibody (eBioscience, 85-12-7311-81) was used in western blot on mouse samples . J Mol Cell Cardiol (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 3
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 3). PLoS ONE (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 4
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 4). PLoS ONE (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples . J Exp Med (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples . J Virol (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to describe mechanisms of p38 activation that converge on NFATc1 and result in opposing effects on T cell immunity, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples . J Exp Med (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to investigate incomplete immunity against intracellular pathogens in neonates, Invitrogen Ifng antibody (Invitrogen, XMG1.2) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples . Immunol Cell Biol (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to investigate the role of thoracic thymus in T cell development and homeostasis, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples . Eur J Immunol (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to study the effect of FTY720 treatment on CD8 T-cells, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples . J Neuroimmunol (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples . J Invest Dermatol (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples . Mucosal Immunol (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 1
In order to determine optimal IL-17-inducing conditions using a vaccine and Mycobacterium tuberculosis challenge strategy, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 1). PLoS ONE (2013) ncbi
rat monoclonal (XMG1.2)
  • immunocytochemistry; mouse
In order to examine the contribution of PD-L1 or PD-L2 to limiting stroke severity, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in immunocytochemistry on mouse samples . J Neuroinflammation (2013) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 5
In order to assess the lethality of primary F. tularensis live vaccine strain pulmonary infection in mice defective for IgA production, Invitrogen Ifng antibody (Caltag, clone XMG1.2) was used in flow cytometry on mouse samples (fig 5). Infect Immun (2013) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to use poly(I:C)-injected dams to study the effects of inflammation on fetal development, Invitrogen Ifng antibody (Invitrogen, XMG1.2) was used in flow cytometry on mouse samples . Brain Behav Immun (2013) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 3
In order to determine the contribution of Arg1 to lung inflammation and pathophysiology, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 3). PLoS ONE (2013) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to study the impact of mesenchymal stem cells to experimental allergic encephalomyelitis, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples . Front Immunol (2013) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to examine IL-7R signaling in Tbx21 and Rag2 knockout mice, Invitrogen Ifng antibody (ebiosciences, XMG1.2) was used in flow cytometry on mouse samples . Immunity (2012) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 1
In order to investigate vaccine-induced CD8(+) T cell responses, Invitrogen Ifng antibody (Invitrogen, XMG1.2) was used in flow cytometry on mouse samples (fig 1). J Virol (2012) ncbi
rat monoclonal (R4-6A2)
  • ELISA; mouse; fig 3
In order to examine the effects of Inchingorei-san treatment on the alloimmune responses in a murine model of cardiac allograft transplantation, Invitrogen Ifng antibody (Caltag Laboratories, R4-6A2) was used in ELISA on mouse samples (fig 3). Evid Based Complement Alternat Med (2012) ncbi
rat monoclonal (XMG1.2)
  • ELISA; mouse; fig 3
In order to examine the effects of Inchingorei-san treatment on the alloimmune responses in a murine model of cardiac allograft transplantation, Invitrogen Ifng antibody (Caltag Laboratories, XMG1.2) was used in ELISA on mouse samples (fig 3). Evid Based Complement Alternat Med (2012) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to elucidate how TGF-beta signaling regulates the self-reactivity of peripheral T cells, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples . Nat Immunol (2012) ncbi
rat monoclonal (XMG1.2)
  • ELISA; mouse; fig 3
In order to assess the effect of sounds on alloimmune responses in a murine model of cardiac allograft transplantation, Invitrogen Ifng antibody (Caltag Laboratories, XMG1.2) was used in ELISA on mouse samples (fig 3). J Cardiothorac Surg (2012) ncbi
rat monoclonal (R4-6A2)
  • ELISA; mouse; fig 3
In order to assess the effect of sounds on alloimmune responses in a murine model of cardiac allograft transplantation, Invitrogen Ifng antibody (Caltag Laboratories, R4-6A2) was used in ELISA on mouse samples (fig 3). J Cardiothorac Surg (2012) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 5
In order to test the ability of different types of antigen presenting cells to induce a CD8(+) T cell response, Invitrogen Ifng antibody (Invitrogen, XMG1.2) was used in flow cytometry on mouse samples (fig 5). PLoS ONE (2012) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 2
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 2). PLoS Pathog (2011) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 6
Invitrogen Ifng antibody (eBiosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 6). PLoS ONE (2011) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 3
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 3). BMC Immunol (2011) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig s3
In order to determine the components of the host immune system that are sufficient to prevent morbidity/mortality in a murine model of smallpox, Invitrogen Ifng antibody (Invitrogen, XMG1.2) was used in flow cytometry on mouse samples (fig s3). PLoS ONE (2011) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 6, 7
In order to use the Friend retrovirus mouse model to elucidate the mode of action of poly(I:C) in antiretroviral immunotherapy, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 6, 7). J Immunol (2010) ncbi
rat monoclonal (XMG1.2)
  • ELISA; mouse; fig 7
In order to examine the T cell subset responses to Ca(2+) signals, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in ELISA on mouse samples (fig 7). J Immunol (2010) ncbi
rat monoclonal (R4-6A2)
  • ELISA; mouse; fig 7
In order to examine the T cell subset responses to Ca(2+) signals, Invitrogen Ifng antibody (eBioscience, R4-6A2) was used in ELISA on mouse samples (fig 7). J Immunol (2010) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig s2
In order to investigate the different immune responses when mice are infected with type I or type II strains of T. gondii, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig s2). J Immunol (2010) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 6
In order to investigate how bystander CD8 cells are impacted during viral infection, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 6). J Immunol (2010) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 4
In order to assess the efficacy of an immune stimulatory complex-based vaccine in a murine pancreatic carcinoma model, Invitrogen Ifng antibody (Caltag, XMG1.2) was used in flow cytometry on mouse samples (fig 4). Int J Cancer (2011) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 3
In order to study the role of liver NK cells in virus-induced severe viral hepatitis, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 3). J Immunol (2010) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
Invitrogen Ifng antibody (eBiosciences, XMG1.2) was used in flow cytometry on mouse samples . Nat Med (2009) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 5
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 5). J Immunol (2009) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 1
In order to assess the effects of early termination of infection on primary T cell expansion, subsequent memory cell development, and protective immunity, Invitrogen Ifng antibody (Caltag, XMG1.2) was used in flow cytometry on mouse samples (fig 1). J Immunol (2009) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 1c
In order to elucidate the role of IL-17 in influenza A infection, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 1c). J Immunol (2009) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 2c
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 2c). Proc Natl Acad Sci U S A (2009) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
  • flow cytometry; human
In order to test the requirement for IL-6-mediated STAT3 signaling in orchestrating the inflammatory infiltrate in monoarticular and systemic models of experimental arthritis, Invitrogen Ifng antibody (Caltag, XMG1.2) was used in flow cytometry on mouse samples and in flow cytometry on human samples . J Immunol (2009) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 2
In order to report that Ly49D engagement on T cells leads to T cell activation and TCR-independent effector functions of CD8 T cells, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 2). J Immunol (2009) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to ascertain the roles of Th17 cells and retinoic acid receptor-related organ receptor gamma in chronic intestinal inflammation, Invitrogen Ifng antibody (Caltag-Invitrogen, XMG1.2) was used in flow cytometry on mouse samples . Gastroenterology (2009) ncbi
rat monoclonal (R4-6A2)
  • blocking or activating experiments; mouse
Invitrogen Ifng antibody (eBioscience, R4-6A2) was used in blocking or activating experiments on mouse samples . Cell Res (2008) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to identify a role for V alpha14 iNKT cells in modulating conventional T-cell responses in the liver, Invitrogen Ifng antibody (eBiosciences, XMG1.2) was used in flow cytometry on mouse samples . Gastroenterology (2008) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to analyze protection against Plasmodium berghei by a single-dose simian adenovirus vector using a human cytomegalovirus promoter containing intron A, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples . J Virol (2008) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 2
In order to study how multifactorial adjuvants show reduced toxicity and enhanced efficacy compared to unitary adjuvants as cancer vaccines, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 2). Blood (2008) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 6
In order to investigate the distribution of CD62L on antigen-activated T cells and their ability to clear pathogen from peripheral sites, Invitrogen Ifng antibody (Caltag, XMG1.2) was used in flow cytometry on mouse samples (fig 6). J Immunol (2008) ncbi
rat monoclonal (XMG1.2)
  • ELISA; mouse; 10 ug/ml
In order to determine whether the programmed death-1-programmed death ligand-1 pathway precipitates type 1 diabetes in young NOD mice, Invitrogen Ifng antibody (Invitrogen Life Technologies, XMG1.2) was used in ELISA on mouse samples at 10 ug/ml. J Immunol (2007) ncbi
rat monoclonal (R4-6A2)
  • ELISA; mouse; 10 ug/ml
In order to determine whether the programmed death-1-programmed death ligand-1 pathway precipitates type 1 diabetes in young NOD mice, Invitrogen Ifng antibody (Invitrogen Life Technologies, R4-6A2) was used in ELISA on mouse samples at 10 ug/ml. J Immunol (2007) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to assess whether B cells and antibodies are involved in Leishmania amazonensis disease and pathogenesis in mice, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples . Int J Parasitol (2008) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to test the influences of IL-21 on cytokine receptor expression, Invitrogen Ifng antibody (Caltag, XMG1.2) was used in flow cytometry on mouse samples . Eur J Immunol (2007) ncbi
rat monoclonal (XMG1.2)
  • ELISA; mouse
In order to study the strength and duration of an antigenic signal at initial stimulation and the development and response of effectors and memory cells to secondary stimulation with the same antigen, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in ELISA on mouse samples . Immunology (2008) ncbi
rat monoclonal (R4-6A2)
  • ELISA; mouse
In order to study the strength and duration of an antigenic signal at initial stimulation and the development and response of effectors and memory cells to secondary stimulation with the same antigen, Invitrogen Ifng antibody (eBioscience, R4-6A2) was used in ELISA on mouse samples . Immunology (2008) ncbi
rat monoclonal (XMG1.2)
  • blocking or activating experiments; mouse; fig 3
In order to assess the role and mechanism of Bifidobacterium longum BB536 probiotic in suppressing antigen-induced Th2 immune response in vitro, Invitrogen Ifng antibody (Invitrogen, XMG1.2) was used in blocking or activating experiments on mouse samples (fig 3). Microbiol Immunol (2007) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 4
Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 4). J Immunol (2007) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to suggest that the influenza A virus affects the MHC class II antigen-processing pathway, Invitrogen Ifng antibody (eBiosciences, XMG1.2) was used in flow cytometry on mouse samples . Int Immunol (2007) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 1
In order to identify the cells that are producing gamma interferon during infection with Listeria monocytogenes, Invitrogen Ifng antibody (Caltag, XMG1.2) was used in flow cytometry on mouse samples (fig 1). Infect Immun (2007) ncbi
rat monoclonal (XMG1.2)
  • ELISA; mouse; fig 2
In order to elucidate how CD73 regulates T regulatory cells and primed precursor T helper cells, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in ELISA on mouse samples (fig 2). J Immunol (2006) ncbi
rat monoclonal (XMG1.2)
  • ELISA; mouse; fig 2
In order to study T cell responses in CD154-/- mice treated with radiation-attenuated S. mansoni larvae, Invitrogen Ifng antibody (Caltag, XMG1.2) was used in ELISA on mouse samples (fig 2). J Immunol (2006) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 3
In order to examine the lineage relationships of T cells using mice infected with Listeria monocytogenes, Invitrogen Ifng antibody (eBioscience, MG1.2) was used in flow cytometry on mouse samples (fig 3). Eur J Immunol (2006) ncbi
rat monoclonal (R4-6A2)
  • ELISA; mouse; fig 5
In order to explore the effectiveness of TLR-mediated innate immune responses in neonates, Invitrogen Ifng antibody (eBioscience, R4-6A2) was used in ELISA on mouse samples (fig 5). J Immunol (2006) ncbi
mouse monoclonal (DB-1 (DB1))
  • ELISA; rat; fig 5
In order to test if HLA-B27 expression on T cells is required for development of colitis, Invitrogen Ifng antibody (Biosource, DB-1) was used in ELISA on rat samples (fig 5). Clin Exp Immunol (2006) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 2
In order to examine the role of T-bet in Valpha14i natural killer T cell function, Invitrogen Ifng antibody (eBioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 2). Blood (2006) ncbi
mouse monoclonal (DB-1 (DB1))
  • ELISA; mouse; fig 4
In order to induce protective immunity against secondary hydatidosis and elucidate the mechanisms of protection, Invitrogen Ifng antibody (Biosource, DB1) was used in ELISA on mouse samples (fig 4). Parasitol Res (2005) ncbi
mouse monoclonal (DB-1 (DB1))
  • ELISA; rat; fig 5
In order to elucidate how prebiotics prevent colitis in specific pathogen-free HLA-B27 rats, Invitrogen Ifng antibody (Biosource, DB-1) was used in ELISA on rat samples (fig 5). Inflamm Bowel Dis (2005) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to evaluate the tuberculosis vaccine candidate Mtb72F, Invitrogen Ifng antibody (Caltag, XMG1.2) was used in flow cytometry on mouse samples . Infect Immun (2005) ncbi
mouse monoclonal (DB-1 (DB1))
  • ELISA; rat; 1 ug/ml
In order to isolate rat dendritic cells and compare them to human and mouse dendritic cells, Invitrogen Ifng antibody (Biosource, DB-1) was used in ELISA on rat samples at 1 ug/ml. Immunol Lett (2005) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 1
In order to investigate how antiviral T cells incorporate multiple signals from their local microenvironment to regulate cytokine production, Invitrogen Ifng antibody (CalTag, XMG1.2) was used in flow cytometry on mouse samples (fig 1). Blood (2005) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:50; fig 3
In order to study the interaction of human papillomavirus 16 L1/E7 chimeric virus-like particles with mouse bone marrow-derived dendritic cells activated with different immune adjuvants, Invitrogen Ifng antibody (Caltag, XMG1.2) was used in flow cytometry on mouse samples at 1:50 (fig 3). Antivir Ther (2004) ncbi
mouse monoclonal (DB-1 (DB1))
  • ELISA; mouse
In order to determine the fate of autoreactive CD4+T cells in HNT-TCR x GFAP-HA double transgenic mice, Invitrogen Ifng antibody (Biosource, DB-1) was used in ELISA on mouse samples . J Autoimmun (2004) ncbi
mouse monoclonal (DB-1 (DB1))
  • ELISA; rat; fig 3
In order to use transgenic rats to investigate host-dependent immune responses to commensal caecal bacteria, Invitrogen Ifng antibody (Biosource, DB-1) was used in ELISA on rat samples (fig 3). Clin Exp Immunol (2004) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 1
In order to test if higher numbers of hematopoietic stem cells correlate with the speed of immune reconstitution in a congenic transplantation mouse model, Invitrogen Ifng antibody (Caltag, XMG1.2) was used in flow cytometry on mouse samples (fig 1). Blood (2004) ncbi
rat monoclonal (XMG1.2)
  • ELISA; mouse; fig 4
In order to determine the roles of PD-1 and its ligands in the induction of regulatory cells by intratracheal delivery of alloantigen, Invitrogen Ifng antibody (Caltag, XMG1.2) was used in ELISA on mouse samples (fig 4). Transplantation (2004) ncbi
rat monoclonal (R4-6A2)
  • ELISA; mouse; fig 4
In order to determine the roles of PD-1 and its ligands in the induction of regulatory cells by intratracheal delivery of alloantigen, Invitrogen Ifng antibody (Caltag, R4-6A2) was used in ELISA on mouse samples (fig 4). Transplantation (2004) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 4
In order to investigate how IL-10 regulates IL-12 production in skin treated with radiation-attenuated schistosomes, Invitrogen Ifng antibody (Caltag, XMG1.2) was used in flow cytometry on mouse samples (fig 4). Int Immunol (2003) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to report that T cell-specific adaptor protein-deficient mice develop lupus-like autoimmune disease, Invitrogen Ifng antibody (Caltag Probes, XMG1.2) was used in flow cytometry on mouse samples . J Exp Med (2003) ncbi
rat monoclonal (XMG1.2)
  • blocking or activating experiments; mouse; 5 ug/ml
In order to elucidate the immunosuppressive mechanism that occurs during T. cruzi infection, Invitrogen Ifng antibody (Endogen, XMG1.2) was used in blocking or activating experiments on mouse samples at 5 ug/ml. Int Immunol (2002) ncbi
mouse monoclonal (DB-1 (DB1))
  • immunohistochemistry - frozen section; mouse
In order to study herpes simplex virus-induced retinitis, Invitrogen Ifng antibody (BioSource International, clone DB-1) was used in immunohistochemistry - frozen section on mouse samples . J Neuroimmunol (2002) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to elucidate the capacity of old mice to control an infection with Mycobacterium tuberculosis, Invitrogen Ifng antibody (Caltag, XMG1.2) was used in flow cytometry on mouse samples . Infect Immun (2002) ncbi
rat monoclonal (XMG1.2)
  • ELISA; mouse; fig 7
In order to assess the role of TNF in the formation and maintenance of granulomas, Invitrogen Ifng antibody (Endogen, XMG1.2) was used in ELISA on mouse samples (fig 7). J Immunol (2002) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to discuss PG490-88, Invitrogen Ifng antibody (Caltag, XMG1.2) was used in flow cytometry on mouse samples . Transplantation (2000) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to study the importance of CD8(+) cytotoxic T lymphocytes during influenza A viral persistence, Invitrogen Ifng antibody (Caltag, XMG1.2) was used in flow cytometry on mouse samples . J Exp Med (2000) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to report that the number of divisions taken by T cells after activation contributes to their differentiation, Invitrogen Ifng antibody (Caltag, XMG) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (1998) ncbi
rat monoclonal (XMG1.2)
  • ELISA; mouse; tbl 2
In order to assess the lymphokine synthesis patterns of a panel of T cell clones, Invitrogen Ifng antibody (noco, XMG1.2) was used in ELISA on mouse samples (tbl 2). J Exp Med (1987) ncbi
BioLegend
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 6e, 6f, 6g, 6h
BioLegend Ifng antibody (BioLegend, 505859) was used in flow cytometry on mouse samples (fig 6e, 6f, 6g, 6h). Allergy Asthma Immunol Res (2022) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend Ifng antibody (BioLegend, 505806) was used in flow cytometry on mouse samples (fig 4a). Front Immunol (2022) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 6d, s4a
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples (fig 6d, s4a). Front Cell Infect Microbiol (2022) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; human; 1:100; loading ...; fig 7i
BioLegend Ifng antibody (Biolegend, 505826) was used in flow cytometry on human samples at 1:100 (fig 7i). PLoS Biol (2022) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 6e
BioLegend Ifng antibody (BioLegend, 505826) was used in flow cytometry on mouse samples (fig 6e). Sci Adv (2022) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; loading ...; fig 3d
BioLegend Ifng antibody (BioLegend, 505809) was used in flow cytometry on mouse samples at 1:100 (fig 3d). Nat Commun (2022) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5c
BioLegend Ifng antibody (Biolegend, 505825) was used in flow cytometry on mouse samples (fig 5c). iScience (2022) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4d
BioLegend Ifng antibody (BioLegend, 505808) was used in flow cytometry on mouse samples (fig 4d). Sci Adv (2022) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples at 1:100. Nat Commun (2022) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5a
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples (fig 5a). Oncoimmunology (2022) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 7b, s1a
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples (fig 7b, s1a). Nat Commun (2022) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:50; loading ...; fig s7r
BioLegend Ifng antibody (Biolegend, 505806) was used in flow cytometry on mouse samples at 1:50 (fig s7r). Nat Commun (2022) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:200; loading ...; fig 5d
BioLegend Ifng antibody (BioLegend, 505801) was used in flow cytometry on mouse samples at 1:200 (fig 5d). J Immunother Cancer (2022) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2i, 6d, 6e
BioLegend Ifng antibody (BioLegend, 505808) was used in flow cytometry on mouse samples (fig 2i, 6d, 6e). Mol Ther Nucleic Acids (2022) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2f, 3c
BioLegend Ifng antibody (Biolegend, 505808) was used in flow cytometry on mouse samples (fig 2f, 3c). J Immunother Cancer (2022) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig s4d
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig s4d). Gut Microbes (2022) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 6h
BioLegend Ifng antibody (BioLegend, 505810) was used in flow cytometry on mouse samples (fig 6h). J Clin Invest (2022) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s3e
BioLegend Ifng antibody (Biolegend, 505829) was used in flow cytometry on mouse samples (fig s3e). Nat Commun (2022) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; loading ...
BioLegend Ifng antibody (Biolegend, 505841) was used in flow cytometry on mouse samples at 1:100. Nat Nanotechnol (2022) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 7f
BioLegend Ifng antibody (BioLegend, 505818) was used in flow cytometry on mouse samples (fig 7f). Sci Immunol (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig s8a
BioLegend Ifng antibody (Biolegend, 505808) was used in flow cytometry on mouse samples (fig s8a). PLoS Pathog (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; fig 1d
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples at 1:100 (fig 1d). J Immunother Cancer (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5a
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 5a). Commun Biol (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 2b
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 2b). Int J Mol Sci (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:500; loading ...; fig 2f
  • ELISA; mouse; fig 2n
BioLegend Ifng antibody (BioLegend, XMG1.2,) was used in flow cytometry on mouse samples at 1:500 (fig 2f) and in ELISA on mouse samples (fig 2n). Sci Adv (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s8d
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples (fig s8d). J Immunother Cancer (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2c
BioLegend Ifng antibody (Biolegend, 505807) was used in flow cytometry on mouse samples (fig 2c). Front Pharmacol (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:200; loading ...; fig s1i
BioLegend Ifng antibody (Biolegend, 505808) was used in flow cytometry on mouse samples at 1:200 (fig s1i). Nat Commun (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2h
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples (fig 2h). PLoS Pathog (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:200; loading ...; fig 4h
BioLegend Ifng antibody (Biolegend, 505826) was used in flow cytometry on mouse samples at 1:200 (fig 4h). Aging Cell (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s3b
BioLegend Ifng antibody (Biolegend, 505810) was used in flow cytometry on mouse samples (fig s3b). J Immunother Cancer (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; loading ...; fig 5c
BioLegend Ifng antibody (BioLegend, 505810) was used in flow cytometry on mouse samples at 1:100 (fig 5c). iScience (2021) ncbi
rat monoclonal (XMG1.2)
  • immunohistochemistry; mouse; 5 ug/ml
BioLegend Ifng antibody (BioLegend, 505801) was used in immunohistochemistry on mouse samples at 5 ug/ml. elife (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5f
BioLegend Ifng antibody (BioLegend, 505810) was used in flow cytometry on mouse samples (fig 5f). Am J Cancer Res (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4d
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 4d). J Clin Invest (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend Ifng antibody (BioLegend, 505835) was used in flow cytometry on mouse samples (fig 2a). Mucosal Immunol (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:200; loading ...
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples at 1:200. Nat Commun (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5f, 5g
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples (fig 5f, 5g). Transl Oncol (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4d
BioLegend Ifng antibody (Biolegend, 505810) was used in flow cytometry on mouse samples (fig 4d). Proc Natl Acad Sci U S A (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
BioLegend Ifng antibody (Biolegend, 505810) was used in flow cytometry on mouse samples . Cell Rep Med (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 4b
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 4b). JCI Insight (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:400; loading ...; fig 3d
BioLegend Ifng antibody (BioLegend, 505845) was used in flow cytometry on mouse samples at 1:400 (fig 3d). Proc Natl Acad Sci U S A (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:1000; loading ...; fig 2f
BioLegend Ifng antibody (Biolegend, 505850) was used in flow cytometry on mouse samples at 1:1000 (fig 2f). PLoS Biol (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 12e, 12f
BioLegend Ifng antibody (BioLegend, 505810) was used in flow cytometry on mouse samples (fig 12e, 12f). Cell Mol Gastroenterol Hepatol (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; loading ...; fig 5c
BioLegend Ifng antibody (Biolegend, 505825) was used in flow cytometry on mouse samples at 1:100 (fig 5c). Nat Commun (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples . J Autoimmun (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; fig 3e
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples at 1:100 (fig 3e). Nat Commun (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:200; loading ...
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples at 1:200. Nat Immunol (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:50; fig s16a
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples at 1:50 (fig s16a). Sci Transl Med (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s7b
BioLegend Ifng antibody (Biolegend, 505809) was used in flow cytometry on mouse samples (fig s7b). Sci Adv (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2d, 2f
BioLegend Ifng antibody (Biolegend, 505806) was used in flow cytometry on mouse samples (fig 2d, 2f). Nat Commun (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4c, 4d, s2
BioLegend Ifng antibody (Biolegend, 505806) was used in flow cytometry on mouse samples (fig 4c, 4d, s2). Diabetes (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4e, 4h
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples (fig 4e, 4h). Antioxidants (Basel) (2020) ncbi
rat monoclonal (XMG1.2)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 6a
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in immunohistochemistry on mouse samples at 1:200 (fig 6a). Hepatol Commun (2020) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:250; loading ...
  • immunohistochemistry; mouse; loading ...; fig 2a
BioLegend Ifng antibody (Biolegend, 505810) was used in flow cytometry on mouse samples at 1:250 and in immunohistochemistry on mouse samples (fig 2a). elife (2020) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3c
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples (fig 3c). J Immunother Cancer (2020) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s17
BioLegend Ifng antibody (BioLegend, 505815) was used in flow cytometry on mouse samples (fig s17). Nat Commun (2020) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5b
BioLegend Ifng antibody (BioLegend, 505810) was used in flow cytometry on mouse samples (fig 5b). Oncoimmunology (2020) ncbi
rat monoclonal (XMG1.2)
  • blocking or activating experiments; mouse; ; fig 2b
  • flow cytometry; mouse; loading ...; fig 2c
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in blocking or activating experiments on mouse samples at (fig 2b) and in flow cytometry on mouse samples (fig 2c). Sci Adv (2020) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1f
BioLegend Ifng antibody (BioLegend, XMG-1.2) was used in flow cytometry on mouse samples (fig 1f). elife (2020) ncbi
rat monoclonal (XMG1.2)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 4d
  • flow cytometry; mouse; loading ...; fig 4a, 4b
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in immunohistochemistry - frozen section on mouse samples (fig 4d) and in flow cytometry on mouse samples (fig 4a, 4b). BMC Immunol (2020) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1 ug/ml; loading ...; fig 2i
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples at 1 ug/ml (fig 2i). Science (2020) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2c
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples (fig 2c). elife (2020) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; loading ...; fig 3s4d
BioLegend Ifng antibody (Biolegend, 505810) was used in flow cytometry on mouse samples at 1:100 (fig 3s4d). elife (2020) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 6e
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 6e). Sci Adv (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:200; loading ...; fig 6s2
BioLegend Ifng antibody (BioLegend, 505810) was used in flow cytometry on mouse samples at 1:200 (fig 6s2). elife (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4
BioLegend Ifng antibody (Bio-Legend, XMG1.2) was used in flow cytometry on mouse samples (fig 4). BMC Infect Dis (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 2 ug/ml; loading ...; fig s2f
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples at 2 ug/ml (fig s2f). Science (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2f, 2g
  • flow cytometry; human; loading ...; fig 7e
BioLegend Ifng antibody (BioLegend, 505808) was used in flow cytometry on mouse samples (fig 2f, 2g) and in flow cytometry on human samples (fig 7e). J Exp Med (2020) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s5b
BioLegend Ifng antibody (Biolegend, 505826) was used in flow cytometry on mouse samples (fig s5b). Cell (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5g
BioLegend Ifng antibody (Biolegend, 505810) was used in flow cytometry on mouse samples (fig 5g). Cell (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3e, 3k
BioLegend Ifng antibody (Biolegend, 505825) was used in flow cytometry on mouse samples (fig 3e, 3k). Oncoimmunology (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend Ifng antibody (Biolegend, 505839) was used in flow cytometry on mouse samples (fig 3a). Cell (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:200; fig 5b
BioLegend Ifng antibody (Biolegend, 505808) was used in flow cytometry on mouse samples at 1:200 (fig 5b). Nat Commun (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; loading ...; fig 3f
BioLegend Ifng antibody (BioLegend, 505810) was used in flow cytometry on mouse samples at 1:100 (fig 3f). Nat Commun (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4e
BioLegend Ifng antibody (BioLegend, 505830) was used in flow cytometry on mouse samples (fig 4e). EMBO J (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1b
BioLegend Ifng antibody (BioLegend, 505810) was used in flow cytometry on mouse samples (fig 1b). Immunity (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 10 ug/ml; loading ...; fig 3c
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples at 10 ug/ml (fig 3c). JCI Insight (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:200; loading ...; fig 4a
BioLegend Ifng antibody (BioLegend, 505810) was used in flow cytometry on mouse samples at 1:200 (fig 4a). Nature (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1d
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 1d). Nature (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1b
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples (fig 1b). Cell Rep (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2c
BioLegend Ifng antibody (Biolegend, 505806) was used in flow cytometry on mouse samples (fig 2c). Cell Rep (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 1a
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 1a). Nat Med (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s1d
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig s1d). Nat Commun (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:50; loading ...; fig 1d
BioLegend Ifng antibody (Biolegend, 505810) was used in flow cytometry on mouse samples at 1:50 (fig 1d). elife (2019) ncbi
mouse monoclonal (DB-1)
  • flow cytometry; rat; loading ...; fig s4b
BioLegend Ifng antibody (Biolegend, DB-1) was used in flow cytometry on rat samples (fig s4b). Nature (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 6b
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 6b). J Immunol (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2c, 2g
BioLegend Ifng antibody (Biolegend, 505808) was used in flow cytometry on mouse samples (fig 2c, 2g). Cell Rep (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 1a). J Clin Invest (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3d
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 3d). JCI Insight (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; loading ...; fig s4c
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples at 1:100 (fig s4c). Nat Commun (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 6m
BioLegend Ifng antibody (Biolegend, 505810) was used in flow cytometry on mouse samples (fig 6m). Cell Rep (2018) ncbi
rat monoclonal (XMG1.2)
  • blocking or activating experiments; mouse; 1 ug/ml; loading ...; fig s9c
BioLegend Ifng antibody (BioLegend, 505802) was used in blocking or activating experiments on mouse samples at 1 ug/ml (fig s9c). Nat Commun (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 6a
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples (fig 6a). EMBO J (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 9g
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 9g). J Clin Invest (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend Ifng antibody (BioLegend, XMG-1.2) was used in flow cytometry on mouse samples (fig 2a). J Clin Invest (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:300; loading ...; fig 4a
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples at 1:300 (fig 4a). J Exp Med (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5e
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 5e). J Exp Med (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1d
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples (fig 1d). PLoS ONE (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:400; loading ...; fig 4a
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples at 1:400 (fig 4a). Proc Natl Acad Sci U S A (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2f
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 2f). J Exp Med (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 7c
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 7c). J Clin Invest (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3f
BioLegend Ifng antibody (Biolegend, 505808) was used in flow cytometry on mouse samples (fig 3f). J Clin Invest (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3d
BioLegend Ifng antibody (Biolegend, 505823) was used in flow cytometry on mouse samples (fig 3d). PLoS Biol (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3e
BioLegend Ifng antibody (BioLegend, 505813) was used in flow cytometry on mouse samples (fig 3e). Nat Commun (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 6a
BioLegend Ifng antibody (BioLegend, XM1.2) was used in flow cytometry on mouse samples (fig 6a). J Clin Invest (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s3a
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples (fig s3a). Front Immunol (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 4d
BioLegend Ifng antibody (BioLegend, 505806) was used in flow cytometry on mouse samples (fig 4d). Science (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1e
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples (fig 1e). Proc Natl Acad Sci U S A (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3o
BioLegend Ifng antibody (Biolegend, 505814) was used in flow cytometry on mouse samples (fig 3o). Science (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s4c
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig s4c). PLoS ONE (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1e
BioLegend Ifng antibody (BioLegend, HMG1.2) was used in flow cytometry on mouse samples (fig 1e). J Immunol (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5d
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples (fig 5d). J Immunol (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; human; 1:100; fig 5a
BioLegend Ifng antibody (BioLegend, 505810) was used in flow cytometry on human samples at 1:100 (fig 5a). Nat Commun (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 8d
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 8d). J Clin Invest (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 3a
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples (fig 3a). JCI Insight (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s10i
BioLegend Ifng antibody (BioLegend, 505808) was used in flow cytometry on mouse samples (fig s10i). Nature (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:400; loading ...; fig 2a
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples at 1:400 (fig 2a). Nat Commun (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig e1b
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples (fig e1b). Nature (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 3i
In order to study the involvement of RANKL in decidual M2 macrophage polarization, BioLegend Ifng antibody (Biolegend, 505810) was used in flow cytometry on mouse samples (fig 3i). Cell Death Dis (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1d
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples (fig 1d). Eur J Immunol (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4b
BioLegend Ifng antibody (BioLegend, 505806) was used in flow cytometry on mouse samples (fig 4b). J Clin Invest (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:200; loading ...; fig 8b
BioLegend Ifng antibody (Biolegend, 505829) was used in flow cytometry on mouse samples at 1:200 (fig 8b). Nat Cell Biol (2017) ncbi
rat monoclonal (XMG1.2)
  • blocking or activating experiments; mouse; fig 3a
BioLegend Ifng antibody (BioLegend, 505801) was used in blocking or activating experiments on mouse samples (fig 3a). Eur J Immunol (2017) ncbi
rat monoclonal (R4-6A2)
  • ELISA; mouse; loading ...; fig 2e
In order to study the induction of CTL tolerance by neoantigens in Langerhans cells, BioLegend Ifng antibody (BioLegend, R46A2) was used in ELISA on mouse samples (fig 2e). J Immunol (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...
In order to evaluate mouse models of hepacivirus infection, BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples . Science (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5e
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 5e). Cell Death Differ (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 6d
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples (fig 6d). Cancer Res (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 6e
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples (fig 6e). J Virol (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; loading ...; fig 2a
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples at 1:100 (fig 2a). Nat Commun (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 4d
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 4d). J Clin Invest (2017) ncbi
rat monoclonal (R4-6A2)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend Ifng antibody (BioLegend, 505702) was used in flow cytometry on mouse samples (fig 1c). J Immunol (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4f
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 4f). J Exp Med (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 3d
In order to study the involvement of endocannabinoid system in intestinal immune homeostasis, BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples (fig 3d). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1d
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 1d). J Exp Med (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3f
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples (fig 3f). Nat Med (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s2
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig s2). J Exp Med (2017) ncbi
hamsters monoclonal (H22)
  • immunohistochemistry; mouse; loading ...; fig 3e
In order to clarify the mechanisms by which miR-21 contributes to oncogenesis, BioLegend Ifng antibody (Biolegend, 513202) was used in immunohistochemistry on mouse samples (fig 3e). Oncogene (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4c
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 4c). Front Immunol (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples . J Exp Med (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s3e
In order to investigate the use of red blood cells expressing disease-associated autoantigenas a means of inducing antigen-specific tolerance, BioLegend Ifng antibody (BioLegend, 505806) was used in flow cytometry on mouse samples (fig s3e). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3f
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 3f). J Clin Invest (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5c
In order to explore the contribution of epithelial cells to systemic sclerosis pathogenesis, BioLegend Ifng antibody (BioLegend, 505805) was used in flow cytometry on mouse samples (fig 5c). J Exp Med (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s7
In order to characterize mitochondrial changes in T cells due to PD-1 blockade therapy, BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig s7). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (DB-1)
  • flow cytometry; rat; loading ...; fig 4c
BioLegend Ifng antibody (BioLegend, DB-1) was used in flow cytometry on rat samples (fig 4c). Eur J Immunol (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig s2a
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig s2a). Nat Immunol (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 6a
In order to elucidate how P2X7 regulates the contraction of intestinal CD4 positive effector T cells, BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 6a). Mucosal Immunol (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3a
In order to determine the effect of a high salt diet on intestinal immunity and the risk of inflammatory bowel disease, BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 3a). Oncotarget (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s5d
In order to show that parasite-specific CD8 positive T cell-induced fatal vascular breakdown and subsequent neuronal death in an animal model of cerebral malaria, BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig s5d). PLoS Pathog (2016) ncbi
rat monoclonal (R4-6A2)
  • blocking or activating experiments; mouse; loading ...; fig s4c
BioLegend Ifng antibody (BioLegend, R4-6A2) was used in blocking or activating experiments on mouse samples (fig s4c). Nat Commun (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 6b
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 6b). Sci Rep (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2a
In order to study the role of TMEM16F in limiting T cell responses in mice infected with virus, BioLegend Ifng antibody (BioLegend, 505826) was used in flow cytometry on mouse samples (fig 2a). J Exp Med (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 6b
In order to determine the impact of myeloperoxidase during malaria infection, BioLegend Ifng antibody (Biolegend, XMG 1.2) was used in flow cytometry on mouse samples (fig 6b). Infect Immun (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; loading ...; fig 4b
In order to find genes that alter invariant natural killer T cell development, migration, or function, BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples at 1:100 (fig 4b). Nat Commun (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s2a
In order to examine the contribution of T cells to the pathogenesis of age-related ocular surface disease, BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples (fig s2a). Mucosal Immunol (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3b
In order to study T cell migration in inflammatory demyelinating lesions confined to optic nerves and spinal cord, BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 3b). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3c
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 3c). J Exp Med (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig S1b
BioLegend Ifng antibody (BioLegend, 505809) was used in flow cytometry on mouse samples (fig S1b). J Exp Clin Cancer Res (2016) ncbi
rat monoclonal (XMG1.2)
  • blocking or activating experiments; mouse; 10 ug/ml; loading ...; fig 2b
In order to study changes in IL-23 and IL-22 after scratching, BioLegend Ifng antibody (BioLegend, XMG1.2) was used in blocking or activating experiments on mouse samples at 10 ug/ml (fig 2b). J Exp Med (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:333; loading ...; fig 7a
In order to investigate the contribution of neutrophils and macrophages during Rickettsia typhi infection, BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples at 1:333 (fig 7a). PLoS Negl Trop Dis (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s2c
In order to explore the role of exhausted CD8 positive CXCR5 positive T cells in mice chronically infected with lymphocytic choriomeningitis virus, BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples (fig s2c). Nature (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 9a
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 9a). J Exp Med (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s1a
In order to elucidate the molecular mechanisms that regulate doxorubicin-mediated cell death of myeloid-derived suppressor cells, BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig s1a). Oncogene (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3c
In order to investigate how dopamine receptor D3 signaling affects the balance of effector T cells, BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 3c). J Immunol (2016) ncbi
rat monoclonal (AN-18)
  • flow cytometry; mouse; loading ...; fig 3c
In order to investigate how dopamine receptor D3 signaling affects the balance of effector T cells, BioLegend Ifng antibody (BioLegend, AN-18) was used in flow cytometry on mouse samples (fig 3c). J Immunol (2016) ncbi
rat monoclonal (XMG1.2)
BioLegend Ifng antibody (Biolegend, 505804) was used . Sci Rep (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1e
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 1e). Eur J Immunol (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; fig s5
BioLegend Ifng antibody (BioLegend, 505810) was used in flow cytometry on mouse samples at 1:100 (fig s5). Nat Commun (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 2
In order to study the requisite for the function of regulatory T cells known as phosphatase PP2A, BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples (fig 2). Nat Immunol (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 4
BioLegend Ifng antibody (BioLegend, 505807) was used in flow cytometry on mouse samples (fig 4). PLoS ONE (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2d
In order to show that Bhlhe40 expression marks encephalitogenic T helper cells and that the PTX-IL-1-Bhlhe40 pathway is active in mice with experimental autoimmune encephalomyelitis, BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 2d). J Exp Med (2016) ncbi
rat monoclonal (XMG1.2)
  • ELISA; mouse; 1 ug/ml; fig 5
BioLegend Ifng antibody (Biolegend, 505804) was used in ELISA on mouse samples at 1 ug/ml (fig 5). Nat Commun (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 2
In order to examine the effect of 4-methylumbelliferone treatment on experimental autoimmune encephalomyelitis, BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples (fig 2). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5f
In order to study the effect of atypical protein kinase C i on asymmetric division and CD8(+) T Lymphocyte, BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples (fig 5f). Sci Rep (2016) ncbi
rat monoclonal (XMG1.2)
BioLegend Ifng antibody (Biolegend, 505808) was used . Sci Rep (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 4
In order to study apolipoprotein-1 during normocholesterolemic conditions, BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 4). J Immunol (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 1a). Mucosal Immunol (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:200; fig 1
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples at 1:200 (fig 1). Nat Commun (2015) ncbi
mouse monoclonal (DB-1)
  • western blot; rat
BioLegend Ifng antibody (Biolegend, 507802) was used in western blot on rat samples . Int J Clin Exp Pathol (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 8c
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 8c). J Leukoc Biol (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; human; fig 1
  • flow cytometry; mouse; fig 2
In order to study engineered anti-melanoma vaccines that modulate cytokine priming and silence PD-L1 simultaneously by use of ex vivo myeloid-derived suppressor cells as a readout of therapeutic efficacy, BioLegend Ifng antibody (BioLegend, 505815) was used in flow cytometry on human samples (fig 1) and in flow cytometry on mouse samples (fig 2). Oncoimmunology (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples . Eur J Immunol (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to elucidate the role of Treg during T. gondii infection, BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples . Microbes Infect (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to report that AMPK regulates protein phosphatase activity to control the of survival and function of CD8+ T cells, thus regulating immune surveillance of tumors, BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples . Oncotarget (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 5
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples (fig 5). J Immunol (2015) ncbi
rat monoclonal (XMG1.2)
  • ELISA; mouse; fig 4
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in ELISA on mouse samples (fig 4). Eur J Immunol (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples . Sci Rep (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 6b
In order to investigate the effect of IL-7 and anti-PD-1 treatment in sepsis model followed by Candida albicans infection, BioLegend Ifng antibody (BioLegend, 505808) was used in flow cytometry on mouse samples (fig 6b). Shock (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples . J Clin Invest (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to examine the role of GPR18 in intestinal intraepithelial lymphocytes, BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples . J Exp Med (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 5
In order to determine the role of interferon regulatory factor 7 in Plasmodium berghei ANKA infection, BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 5). Eur J Immunol (2015) ncbi
rat monoclonal (XMG1.2)
In order to examine the role of interleukin-4 in relation to eomesodermin within CD8+ T cells, BioLegend Ifng antibody (Biolegend, XMG1.2) was used . PLoS ONE (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:200
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples at 1:200. Cancer Res (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples . Eur J Immunol (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 6
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 6). Am J Pathol (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:50
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples at 1:50. Nat Commun (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples . J Exp Med (2014) ncbi
rat monoclonal (XMG1.2)
BioLegend Ifng antibody (BioLegend, XMG1.2) was used . Proc Natl Acad Sci U S A (2014) ncbi
rat monoclonal (XMG1.2)
  • blocking or activating experiments; mouse; loading ...; fig s2c
In order to study the role of TH9 cells in ulcerative colitis, BioLegend Ifng antibody (Biolegend, 505802) was used in blocking or activating experiments on mouse samples (fig s2c). Nat Immunol (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples . Infect Immun (2014) ncbi
rat monoclonal (XMG1.2)
  • blocking or activating experiments; mouse; 10 ug/ml
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in blocking or activating experiments on mouse samples at 10 ug/ml. J Clin Invest (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 4
BioLegend Ifng antibody (Biolegend, clone XMG1.2) was used in flow cytometry on mouse samples (fig 4). Vaccine (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 6b
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 6b). J Leukoc Biol (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in flow cytometry on mouse samples (fig 2). J Immunol (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
BioLegend Ifng antibody (Biolegend, XMG1.2) was used in flow cytometry on mouse samples . Eur J Immunol (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to elucidate the immunological pathways that lead to obesity-associated asthma, BioLegend Ifng antibody (BioLegend, 505826) was used in flow cytometry on mouse samples . Nat Med (2014) ncbi
rat monoclonal (XMG1.2)
  • blocking or activating experiments; mouse; 5 ug/ml
BioLegend Ifng antibody (BioLegend, XMG1.2) was used in blocking or activating experiments on mouse samples at 5 ug/ml. J Immunol (2014) ncbi
Bio X Cell
rat monoclonal (XMG1.2)
  • blocking or activating experiments; mouse; 10 ug/ml; loading ...; fig 5b
Bio X Cell Ifng antibody (Bio X Cell, XMG1.2) was used in blocking or activating experiments on mouse samples at 10 ug/ml (fig 5b). Sci Adv (2022) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5a
Bio X Cell Ifng antibody (Bio X Cell, XMG1.2) was used in flow cytometry on mouse samples (fig 5a). Hepatol Commun (2020) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...
Bio X Cell Ifng antibody (BioXcell, XMG1.2) was used in flow cytometry on mouse samples . Cell (2020) ncbi
rat monoclonal (XMG1.2)
  • blocking or activating experiments; mouse; fig 4c
Bio X Cell Ifng antibody (BioXCell, XMG1.2) was used in blocking or activating experiments on mouse samples (fig 4c). elife (2020) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3f
Bio X Cell Ifng antibody (Bio X cell, XMG1.2) was used in flow cytometry on mouse samples (fig 3f). Nature (2020) ncbi
rat monoclonal (R4-6A2)
  • flow cytometry; mouse; loading ...; fig 3f
Bio X Cell Ifng antibody (Bio X cell, R4-6A2) was used in flow cytometry on mouse samples (fig 3f). Nature (2020) ncbi
rat monoclonal (R4-6A2)
  • flow cytometry; mouse; loading ...; fig 1b, 2d, 3b
Bio X Cell Ifng antibody (Bio X Cell, BE0054-5MG) was used in flow cytometry on mouse samples (fig 1b, 2d, 3b). JCI Insight (2019) ncbi
rat monoclonal (XMG1.2)
  • other; mouse
Bio X Cell Ifng antibody (Bio X Cell, XMG1.2) was used in other on mouse samples . Infect Immun (2020) ncbi
rat monoclonal (XMG1.2)
  • blocking or activating experiments; mouse; 10 ug/ml; loading ...; fig s2
Bio X Cell Ifng antibody (Bio X Cell, XMG1.2) was used in blocking or activating experiments on mouse samples at 10 ug/ml (fig s2). Cancer Res (2018) ncbi
rat monoclonal (XMG1.2)
  • blocking or activating experiments; mouse; loading ...; fig 5a
In order to study the effects of IL-10R signaling during Plasmodium berghei ANKA-induced experimental cerebral malaria, Bio X Cell Ifng antibody (BioXCell, XMG1.2) was used in blocking or activating experiments on mouse samples (fig 5a). Infect Immun (2017) ncbi
rat monoclonal (XMG1.2)
  • blocking or activating experiments; mouse; loading ...; fig 3d
Bio X Cell Ifng antibody (BioXcell, XMG1.2) was used in blocking or activating experiments on mouse samples (fig 3d). J Immunol (2016) ncbi
rat monoclonal (R4-6A2)
  • blocking or activating experiments; mouse; loading ...; fig s7
In order to report that poly-N-acetylglucosamine production by Staphylococcus epidermidis biofilms exacerbates disease, Bio X Cell Ifng antibody (BioXcell, R4-6A2) was used in blocking or activating experiments on mouse samples (fig s7). Infect Immun (2016) ncbi
rat monoclonal (XMG1.2)
  • blocking or activating experiments; mouse; 20 ug/ml; fig s3e
  • flow cytometry; mouse
In order to elucidate the role of B cells in the initiation of central nervous system autoimmunity, Bio X Cell Ifng antibody (BioXcell, XMG1.2) was used in blocking or activating experiments on mouse samples at 20 ug/ml (fig s3e) and in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2016) ncbi
MABTECH
rat monoclonal (AN18)
  • other; mouse; loading ...; fig 3c
MABTECH Ifng antibody (MabTech, AN-18) was used in other on mouse samples (fig 3c). Vaccines (Basel) (2020) ncbi
rat monoclonal (R4-6A2)
  • other; mouse; loading ...; fig 3c
MABTECH Ifng antibody (MabTech, R4-6A2) was used in other on mouse samples (fig 3c). Vaccines (Basel) (2020) ncbi
rat monoclonal (AN18)
  • other; mouse; 10 ug/ml; loading ...; fig 5a
MABTECH Ifng antibody (Mabtech, AN-18) was used in other on mouse samples at 10 ug/ml (fig 5a). Nat Commun (2020) ncbi
rat monoclonal (R4-6A2)
  • other; mouse; 1 ug/ml; loading ...; fig 5a
MABTECH Ifng antibody (Mabtech, R4-6A2) was used in other on mouse samples at 1 ug/ml (fig 5a). Nat Commun (2020) ncbi
rat monoclonal (R4-6A2)
  • ELISA; human; 1 ug/ml; loading ...; fig 4b
MABTECH Ifng antibody (Mabtech, R4-6A2) was used in ELISA on human samples at 1 ug/ml (fig 4b). Nature (2016) ncbi
rat monoclonal (AN18)
  • ELISA; human; 10 ug/ml; loading ...; fig 4b
MABTECH Ifng antibody (Mabtech, AN18) was used in ELISA on human samples at 10 ug/ml (fig 4b). Nature (2016) ncbi
rat monoclonal (R4-6A2)
  • ELISA; mouse; 1 ug/ml; fig 2
MABTECH Ifng antibody (Mabtech, 3321-6-250) was used in ELISA on mouse samples at 1 ug/ml (fig 2). PLoS ONE (2016) ncbi
rat monoclonal (AN18)
  • ELISA; mouse; 10 ug/ml; fig 2
MABTECH Ifng antibody (Mabtech, 3321-3-1000) was used in ELISA on mouse samples at 10 ug/ml (fig 2). PLoS ONE (2016) ncbi
rat monoclonal (AN18)
In order to show that the rotaviral VP6 protein has an in vivo adjuvant effect on norovirus-specific antibody responses, MABTECH Ifng antibody (Mabtech AB, 3321-3) was used . Hum Vaccin Immunother (2016) ncbi
Abcam
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:400; loading ...; fig 2d
Abcam Ifng antibody (Abcam, ab9657) was used in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig 2d). J Am Heart Assoc (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; loading ...; fig 2f
Abcam Ifng antibody (Abcam, ab9657) was used in immunohistochemistry - paraffin section on human samples (fig 2f). Aging Cell (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; human; 1:100; loading ...; fig 8m
Abcam Ifng antibody (Abcam, ab25101) was used in immunohistochemistry on human samples at 1:100 (fig 8m). Nat Immunol (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:100; loading ...; fig 2h
Abcam Ifng antibody (Abcam, ab9657) was used in immunohistochemistry on mouse samples at 1:100 (fig 2h). Nat Commun (2018) ncbi
domestic rabbit monoclonal (EPR1108)
  • immunocytochemistry; mouse; 1:200; loading ...; fig 3e
In order to study the role of CUGBP1 in the profibrotic TGF-beta-dependent activation of hepatic stellate cells, Abcam Ifng antibody (Abcam, ab133566) was used in immunocytochemistry on mouse samples at 1:200 (fig 3e). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:300; fig 3
In order to assess regulation of angiogenesis in the full-term human placenta and the expression of factors involved that effect in vitro fertilization, Abcam Ifng antibody (Abcam, Ab9657) was used in western blot on human samples at 1:300 (fig 3). Reprod Biol (2016) ncbi
domestic rabbit polyclonal
  • blocking or activating experiments; human; fig s7
In order to elucidate enrichment of oxidized mitochondrial DNA in neutrophil extracellular traps contributes to lupus-like disease, Abcam Ifng antibody (Abcam, ab9657) was used in blocking or activating experiments on human samples (fig s7). Nat Med (2016) ncbi
Miltenyi Biotec
rat monoclonal (AN.18.17.24)
  • flow cytometry; mouse; loading ...; fig 5d
Miltenyi Biotec Ifng antibody (Miltenyi Biotec, AN.18.17.24) was used in flow cytometry on mouse samples (fig 5d). J Transl Med (2017) ncbi
Bio-Rad
domestic rabbit polyclonal
  • western blot; mouse; 1:500; fig 4a
In order to determine the contribution of lymphatic drainage to tumor inflammation and immunity, Bio-Rad Ifng antibody (AbD Serotec, AAM29) was used in western blot on mouse samples at 1:500 (fig 4a). J Clin Invest (2016) ncbi
Tonbo Biosciences
mouse monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; loading ...; fig s7a
Tonbo Biosciences Ifng antibody (Tonbo, XMG1.2) was used in flow cytometry on mouse samples at 1:100 (fig s7a). Science (2021) ncbi
mouse monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3e
Tonbo Biosciences Ifng antibody (TONBO Biosciences, 35-7311-U100) was used in flow cytometry on mouse samples (fig 3e). Cell Rep (2020) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3g
Tonbo Biosciences Ifng antibody (tonbo Biosciences, 20-7311) was used in flow cytometry on mouse samples (fig 3g). Cell Rep (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s7g
Tonbo Biosciences Ifng antibody (Tonbo, 50-7311) was used in flow cytometry on mouse samples (fig s7g). Gastroenterology (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s3e
In order to discuss how NLRC3 protects against colorectal cancer by modulating mTor signaling, Tonbo Biosciences Ifng antibody (Tonbo, 50-7311) was used in flow cytometry on mouse samples (fig s3e). Nature (2016) ncbi
BD Biosciences
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples . Front Immunol (2022) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 5b
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 5b). J Immunother Cancer (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...
BD Biosciences Ifng antibody (BD, XMG1.2) was used in flow cytometry on mouse samples . Front Immunol (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2a, 3b
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 2a, 3b). Front Immunol (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; loading ...; fig s7b
BD Biosciences Ifng antibody (BD, XMG1.2) was used in flow cytometry on mouse samples at 1:100 (fig s7b). Nat Commun (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 1c
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 1c). Mucosal Immunol (2021) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4b
BD Biosciences Ifng antibody (BD PharMingen, XMG1.2) was used in flow cytometry on mouse samples (fig 4b). Front Immunol (2020) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1m
BD Biosciences Ifng antibody (BD, XMG1.2) was used in flow cytometry on mouse samples (fig 1m). Nat Commun (2020) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s1c
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples (fig s1c). J Neuroinflammation (2020) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 3c
BD Biosciences Ifng antibody (BD Pharmingen, XMG1.2) was used in flow cytometry on mouse samples (fig 3c). Aging Cell (2020) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2d
BD Biosciences Ifng antibody (BD Biosciences, XMG-1.2) was used in flow cytometry on mouse samples (fig 2d). Science (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3a
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 3a). Proc Natl Acad Sci U S A (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4b
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 4b). Br J Pharmacol (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5d
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 5d). Proc Natl Acad Sci U S A (2019) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1e
BD Biosciences Ifng antibody (BD Pharmingen, XMG1.2) was used in flow cytometry on mouse samples (fig 1e). J Immunol Res (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:400; loading ...; fig s7a
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples at 1:400 (fig s7a). Nat Commun (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:200; loading ...; fig s3c
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples at 1:200 (fig s3c). J Clin Invest (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:1000; loading ...; fig s1b
BD Biosciences Ifng antibody (BD, 559065) was used in flow cytometry on mouse samples at 1:1000 (fig s1b). Nat Commun (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; human; loading ...; fig 1d
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on human samples (fig 1d). J Virol (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; human; loading ...; fig 1d
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on human samples (fig 1d). Nat Commun (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s3g
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples (fig s3g). Science (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5a
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 5a). EMBO J (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 7a
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 7a). J Virol (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2a
BD Biosciences Ifng antibody (BD Pharmingen, XMG1.2) was used in flow cytometry on mouse samples (fig 2a). Front Immunol (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5e
BD Biosciences Ifng antibody (BD Pharmingen, XMG1.2) was used in flow cytometry on mouse samples (fig 5e). Cell Immunol (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:50; loading ...; fig 7e
BD Biosciences Ifng antibody (BD Bioscience, XMG1.2) was used in flow cytometry on mouse samples at 1:50 (fig 7e). Nat Commun (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5b
BD Biosciences Ifng antibody (BD Pharmingen, XMG1.2) was used in flow cytometry on mouse samples (fig 5b). Nat Commun (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; loading ...; fig 2a
BD Biosciences Ifng antibody (BD, XMG1.2) was used in flow cytometry on mouse samples at 1:100 (fig 2a). Infect Immun (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1b
BD Biosciences Ifng antibody (BD PharMingen, XMG1.2) was used in flow cytometry on mouse samples (fig 1b). J Immunol (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1c
BD Biosciences Ifng antibody (BD Bioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 1c). J Virol (2018) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 6b
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 6b). Immunology (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; human; fig 7b
In order to show that QS-21 directly activated human monocyte-derived dendritic cells and promoted a pro-inflammatory transcriptional program, BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on human samples (fig 7b). Front Immunol (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 5e
In order to show that ABCA7 regulates natural killer T cell development in a cell-extrinsic manner, BD Biosciences Ifng antibody (BD Bioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 5e). Sci Rep (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s1c
In order to test if dermal gammadelta cells freely re-circulate out of skin, or behave like dermal resident memory T cells in mice, BD Biosciences Ifng antibody (BD PharMingen, XMG1.2) was used in flow cytometry on mouse samples (fig s1c). PLoS ONE (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; loading ...; fig 4A
In order to find that C-type lectin dendritic cell immunoreceptor is required to modulate lung inflammation and bacterial burden in tuberculosis, BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples at 1:100 (fig 4A). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s8b
In order to find microenvironmental regulators of metastatic colonization, BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples (fig s8b). Nature (2017) ncbi
rat monoclonal (XMG1.2)
  • blocking or activating experiments; mouse; loading ...
  • flow cytometry; mouse; loading ...
In order to assess the role of p38 signaling in limiting regulatory T cell induction, BD Biosciences Ifng antibody (BD, XMG1.2) was used in blocking or activating experiments on mouse samples and in flow cytometry on mouse samples . J Biol Chem (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:100; loading ...; fig s4a
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples at 1:100 (fig s4a). Nat Commun (2016) ncbi
rat monoclonal (XMG1.2)
In order to discuss the contribution of astrocytic IL-15 to postischemic brain damage, BD Biosciences Ifng antibody (BD, XMG1.2) was used . Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3e
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 3e). Cancer Res (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4d
In order to explore the role of NR4A3 in CD103+ migratory dendritic cells and CCR7-dependent cell migration, BD Biosciences Ifng antibody (BD Bioscience, XMG1.2) was used in flow cytometry on mouse samples (fig 4d). J Clin Invest (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s6
In order to explore the role of hippocampal T cell infiltration in tau-driven pathophysiology and cognitive impairments, BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples (fig s6). Brain (2017) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig s3
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples (fig s3). PLoS ONE (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig s2b
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples (fig s2b). J Immunol (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 1
BD Biosciences Ifng antibody (Pharmingen, XMG1.2) was used in flow cytometry on mouse samples (fig 1). PLoS Pathog (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 5
In order to study the functions of WASp knock out natural killer cells, BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 5). Sci Rep (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 5b
In order to examine the impact of emergency granulopoiesis on T and B cell function, BD Biosciences Ifng antibody (BD, XMG1.2) was used in flow cytometry on mouse samples (fig 5b). J Exp Med (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:50; loading ...; fig s5b
In order to find that coagulation factor XII modulates immune responses, BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples at 1:50 (fig s5b). Nat Commun (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 7
BD Biosciences Ifng antibody (BD Pharmingen, XMG1.2 BD) was used in flow cytometry on mouse samples (fig 7). Sci Rep (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 4b
In order to elucidate the role of AMP-activated protein kinase in regulating T cell survival and function, BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 4b). Oncotarget (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; 1:200; loading ...; fig 1c
In order to demonstrate that Ndfip1/Ndfip2 regulate cross talk between T-cell receptor and cytokine signaling pathways, BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples at 1:200 (fig 1c). Nat Commun (2016) ncbi
rat monoclonal (XMG1.2)
  • immunocytochemistry; mouse; 1:100; fig 6
BD Biosciences Ifng antibody (BD Biosciences, 559065) was used in immunocytochemistry on mouse samples at 1:100 (fig 6). J Immunol Res (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 4
In order to characterize promotion of an effective anti-tumor immune response by enhancing the production of type 1 interferons by 2'-5' oligoadenylate synthetase-like 1 (OASL1) deficiency in mice, BD Biosciences Ifng antibody (BD Pharmingen, XMG1.2) was used in flow cytometry on mouse samples (fig 4). Cancer Immunol Immunother (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2I
In order to compare the capacity of induced T regulatory and T helper 17 cells to develop in a T cell model of colitis, BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 2I). J Immunol (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2a
In order to report the contribution of dendritic cell-derived thrombospondin-1 on allergic eye disease, BD Biosciences Ifng antibody (BD PharMingen, XMG1.2) was used in flow cytometry on mouse samples (fig 2a). J Leukoc Biol (2016) ncbi
rat monoclonal (XMG1.2)
  • ELISA; mouse; fig 2
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in ELISA on mouse samples (fig 2). Sci Rep (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 3
BD Biosciences Ifng antibody (BD Pharmingen, XMG1.2) was used in flow cytometry on mouse samples (fig 3). PLoS Pathog (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 2
In order to study cessation of colorectal cancer colonization of the liver by acting on the hepatic microenvironment by IFN-alpha gene/cell therapy, BD Biosciences Ifng antibody (BD Pharmingen, XMG1.2) was used in flow cytometry on mouse samples (fig 2). EMBO Mol Med (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 4
In order to investigate the control of LAT recruitment to the immune synapse and T-cell activation in vivo by IFT20, BD Biosciences Ifng antibody (BD, XMG1.2) was used in flow cytometry on mouse samples (fig 4). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 1A; 2D
In order to determine that Th2 cell responses, alternative macrophage activation, and immunoglobulin class switching to IgG1, are enhanced in Batf3(-/-) mice responding to helminth parasites, BD Biosciences Ifng antibody (BD, XMG1.2) was used in flow cytometry on mouse samples (fig 1A; 2D). J Exp Med (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 5
In order to study murine nasal passages to identify and analyze natural killer cells, BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 5). PLoS ONE (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 5
In order to determine the promotion of the formation of conjugates between transformed T helper cells and B lymphoma cells by murid gammaherpesvirus latency-associated protein M2, BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 5). PLoS ONE (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 3
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 3). J Virol (2016) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 2a
In order to determine the mechanism by which BCR-ABL positive leukemia escapes immune surveillance, BD Biosciences Ifng antibody (BD Horizon, XMG1.2) was used in flow cytometry on mouse samples (fig 2a). J Immunol (2015) ncbi
rat monoclonal (XMG1.2)
  • ELISA; mouse; fig 5
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in ELISA on mouse samples (fig 5). J Immunol (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to investigate the induction and role of Tregs during the early pre-patent larval stage of infection with Schistosoma mansoni, BD Biosciences Ifng antibody (BD Bioscience, XMG1.2) was used in flow cytometry on mouse samples . Infect Immun (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; loading ...; fig 3a
BD Biosciences Ifng antibody (BD Biosciences, clone XMG1.2) was used in flow cytometry on mouse samples (fig 3a). Cell Host Microbe (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
  • ELISA; mouse; 1 ug/ml
In order to study the contribution of IL-10 to virus-induced demyelination, BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples and in ELISA on mouse samples at 1 ug/ml. Glia (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples . Front Immunol (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 2c
In order to assess a CD 4 T-cell population during tuberculosis that has memory-like properties maintained by Bcl6 and ICOS-dependent pathways, BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 2c). J Exp Med (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
BD Biosciences Ifng antibody (BD Pharmingen, XMG1.2) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples . PLoS ONE (2015) ncbi
rat monoclonal (XMG1.2)
  • western blot; mouse; 1:100; fig 5,6
BD Biosciences Ifng antibody (BD Bioscience, XMG1.2) was used in western blot on mouse samples at 1:100 (fig 5,6). Nat Commun (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples . J Leukoc Biol (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to identify DUBA as a suppressor of IL-17 production in T cells, BD Biosciences Ifng antibody (BD, XMG1.2) was used in flow cytometry on mouse samples . Nature (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to study CD4 and CD8 responses to L. monocytogenes using GZMB-Tom knock-in mice, BD Biosciences Ifng antibody (BD Pharmingen, XMG1.2) was used in flow cytometry on mouse samples . Immunology (2015) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 2
In order to show that MID1 regulates cytotoxic lymphocytes responses, BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 2). Eur J Immunol (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
In order to demonstrate that CTLA-4 promotes Tc17 differentiation and robust Tc17 responses, BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples . Eur J Immunol (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
BD Biosciences Ifng antibody (BD, XMG1.2) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
BD Biosciences Ifng antibody (PharMingen, XMG1.2) was used in flow cytometry on mouse samples . Vaccine (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
BD Biosciences Ifng antibody (BD, XMG1.2) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (XMG1.2)
  • ELISA; mouse; 2 ug/ml
In order to identify CD8 T cell epitopes in the L sequence of hRSV for immunization purposes, BD Biosciences Ifng antibody (BD Pharmingen, XMG 1.2) was used in ELISA on mouse samples at 2 ug/ml. Intervirology (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 4
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples (fig 4). Mucosal Immunol (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (XMG1.2)
  • blocking or activating experiments; mouse; 5 ug/ml
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in blocking or activating experiments on mouse samples at 5 ug/ml. Int Immunol (2014) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse
BD Biosciences Ifng antibody (BD Biosciences, XMG1.2) was used in flow cytometry on mouse samples . Infect Immun (2011) ncbi
rat monoclonal (XMG1.2)
  • flow cytometry; mouse; fig 6C
In order to characterize and compare T helper 1 and 17 cells, BD Biosciences Ifng antibody (BD PharMingen, XMG1.2) was used in flow cytometry on mouse samples (fig 6C). J Leukoc Biol (2007) ncbi
Articles Reviewed
  1. Feng K, Meng P, Zhang M, Zou X, Li S, Huang C, et al. IL-24 Contributes to Neutrophilic Asthma in an IL-17A-Dependent Manner and Is Suppressed by IL-37. Allergy Asthma Immunol Res. 2022;14:505-527 pubmed publisher
  2. Dagkonaki A, Papalambrou A, Avloniti M, Gkika A, Evangelidou M, Androutsou M, et al. Maturation of circulating Ly6ChiCCR2+ monocytes by mannan-MOG induces antigen-specific tolerance and reverses autoimmune encephalomyelitis. Front Immunol. 2022;13:972003 pubmed publisher
  3. Zhao F, Zhang C, Li G, Zheng H, Gu L, Zhou H, et al. A role for whey acidic protein four-disulfide-core 12 (WFDC12) in the pathogenesis and development of psoriasis disease. Front Immunol. 2022;13:873720 pubmed publisher
  4. Hou X, Shi Y, Kang X, Rousu Z, Li D, Wang M, et al. Echinococcus granulosus: The establishment of the metacestode in the liver is associated with control of the CD4+ T-cell-mediated immune response in patients with cystic echinococcosis and a mouse model. Front Cell Infect Microbiol. 2022;12:983119 pubmed publisher
  5. Smith K, Minns D, McHugh B, Holloway R, O CONNOR R, Williams A, et al. The antimicrobial peptide cathelicidin drives development of experimental autoimmune encephalomyelitis in mice by affecting Th17 differentiation. PLoS Biol. 2022;20:e3001554 pubmed publisher
  6. Que W, Ma K, Hu X, Guo W, Li X. Combinations of anti-GITR antibody and CD28 superagonist induce permanent allograft acceptance by generating type 1 regulatory T cells. Sci Adv. 2022;8:eabo4413 pubmed publisher
  7. Xie F, Zhou X, Su P, Li H, Tu Y, Du J, et al. Breast cancer cell-derived extracellular vesicles promote CD8+ T cell exhaustion via TGF-β type II receptor signaling. Nat Commun. 2022;13:4461 pubmed publisher
  8. Kasahara K, Sasaki N, Amin H, Tanaka T, Horibe S, Yamashita T, et al. Depletion of Foxp3+ regulatory T cells augments CD4+ T cell immune responses in atherosclerosis-prone hypercholesterolemic mice. Heliyon. 2022;8:e09981 pubmed publisher
  9. Yong L, Yu Y, Li B, Ge H, Zhen Q, Mao Y, et al. Calcium/calmodulin-dependent protein kinase IV promotes imiquimod-induced psoriatic inflammation via macrophages and keratinocytes in mice. Nat Commun. 2022;13:4255 pubmed publisher
  10. Zhao X, Hu S, Zeng L, Liu X, Song Y, Zhang Y, et al. Irradiation combined with PD-L1-/- and autophagy inhibition enhances the antitumor effect of lung cancer via cGAS-STING-mediated T cell activation. iScience. 2022;25:104690 pubmed publisher
  11. Chen P, Katsuyama E, Satyam A, Li H, Rubio J, Jung S, et al. CD38 reduces mitochondrial fitness and cytotoxic T cell response against viral infection in lupus patients by suppressing mitophagy. Sci Adv. 2022;8:eabo4271 pubmed publisher
  12. Garnier L, Pick R, Montorfani J, Sun M, Brighouse D, Liaudet N, et al. IFN-γ-dependent tumor-antigen cross-presentation by lymphatic endothelial cells promotes their killing by T cells and inhibits metastasis. Sci Adv. 2022;8:eabl5162 pubmed publisher
  13. Lu L, Li T, Feng X, Liu Z, Liu Y, Chao T, et al. Excessive immunosuppression by regulatory T cells antagonizes T cell response to schistosome infection in PD-1-deficient mice. PLoS Pathog. 2022;18:e1010596 pubmed publisher
  14. Wang Q, Bergholz J, Ding L, Lin Z, Kabraji S, Hughes M, et al. STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer. Nat Commun. 2022;13:3022 pubmed publisher
  15. Pan C, Wu Q, Wang S, Mei Z, Zhang L, Gao X, et al. Combination with Toll-like receptor 4 (TLR4) agonist reverses GITR agonism mediated M2 polarization of macrophage in Hepatocellular carcinoma. Oncoimmunology. 2022;11:2073010 pubmed publisher
  16. Benkhoucha M, Tran N, Breville G, Senoner I, Bradfield P, Papayannopoulou T, et al. CD4+c-Met+Itgα4+ T cell subset promotes murine neuroinflammation. J Neuroinflammation. 2022;19:103 pubmed publisher
  17. Piao W, Li L, Saxena V, Iyyathurai J, Lakhan R, Zhang Y, et al. PD-L1 signaling selectively regulates T cell lymphatic transendothelial migration. Nat Commun. 2022;13:2176 pubmed publisher
  18. Bartsch P, Kilian C, Hellmig M, Paust H, Borchers A, Sivayoganathan A, et al. Th17 cell plasticity towards a T-bet-dependent Th1 phenotype is required for bacterial control in Staphylococcus aureus infection. PLoS Pathog. 2022;18:e1010430 pubmed publisher
  19. Xiong W, Gao X, Zhang T, Jiang B, Hu M, Bu X, et al. USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy. Nat Commun. 2022;13:1700 pubmed publisher
  20. Zhang Y, Huo F, Cao Q, Jia R, Huang Q, Wang Z, et al. FimH confers mannose-targeting ability to Bacillus Calmette-Guerin for improved immunotherapy in bladder cancer. J Immunother Cancer. 2022;10: pubmed publisher
  21. Tu J, Han D, Fang Y, Jiang H, Tan X, Xu Z, et al. MicroRNA-10b promotes arthritis development by disrupting CD4+ T cell subtypes. Mol Ther Nucleic Acids. 2022;27:733-750 pubmed publisher
  22. van Vloten J, Matuszewska K, Minow M, Minott J, Santry L, Pereira M, et al. Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer. J Immunother Cancer. 2022;10: pubmed publisher
  23. Wang H, Wang Q, Yang C, Guo M, Cui X, Jing Z, et al. Bacteroides acidifaciens in the gut plays a protective role against CD95-mediated liver injury. Gut Microbes. 2022;14:2027853 pubmed publisher
  24. Yang K, Han J, Asada M, Gill J, Park J, Sathe M, et al. Cytoplasmic RNA quality control failure engages mTORC1-mediated autoinflammatory disease. J Clin Invest. 2022;132: pubmed publisher
  25. Du Y, Peng Q, Cheng D, Pan T, Sun W, Wang H, et al. Cancer cell-expressed BTNL2 facilitates tumour immune escape via engagement with IL-17A-producing γδ T cells. Nat Commun. 2022;13:231 pubmed publisher
  26. Liu Y, Wang L, Song Q, Ali M, Crowe W, Kucera G, et al. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion. Nat Nanotechnol. 2022;17:206-216 pubmed publisher
  27. Tatsumi N, Codrington A, El Fenej J, Phondge V, Kumamoto Y. Effective CD4 T cell priming requires repertoire scanning by CD301b+ migratory cDC2 cells upon lymph node entry. Sci Immunol. 2021;6:eabg0336 pubmed publisher
  28. Zhu Y, Elsheikha H, Wang J, Fang S, He J, Zhu X, et al. Synergy between Toxoplasma gondii type I ΔGRA17 immunotherapy and PD-L1 checkpoint inhibition triggers the regression of targeted and distal tumors. J Immunother Cancer. 2021;9: pubmed publisher
  29. Snyder L, Doherty C, Mercer H, Denkers E. Induction of IL-12p40 and type 1 immunity by Toxoplasma gondii in the absence of the TLR-MyD88 signaling cascade. PLoS Pathog. 2021;17:e1009970 pubmed publisher
  30. Liu H, Pedros C, Kong K, Canonigo Balancio A, Xue W, Altman A. Leveraging the Treg-intrinsic CTLA4-PKCη signaling pathway for cancer immunotherapy. J Immunother Cancer. 2021;9: pubmed publisher
  31. Susukida T, Kuwahara S, Song B, Kazaoka A, Aoki S, Ito K. Regulation of the immune tolerance system determines the susceptibility to HLA-mediated abacavir-induced skin toxicity. Commun Biol. 2021;4:1137 pubmed publisher
  32. Tanaka Y, Onozato M, Mikami T, Kohwi Shigematsu T, Fukushima T, Kondo M. Increased Indoleamine 2,3-Dioxygenase Levels at the Onset of Sjögren's Syndrome in SATB1-Conditional Knockout Mice. Int J Mol Sci. 2021;22: pubmed publisher
  33. Jiang Y, Yuan Y, Chen M, Li S, Bai J, Zhang Y, et al. PRMT5 disruption drives antitumor immunity in cervical cancer by reprogramming T cell-mediated response and regulating PD-L1 expression. Theranostics. 2021;11:9162-9176 pubmed publisher
  34. Rizvi Z, Dalal R, Sadhu S, Kumar Y, Kumar S, Gupta S, et al. High-salt diet mediates interplay between NK cells and gut microbiota to induce potent tumor immunity. Sci Adv. 2021;7:eabg5016 pubmed publisher
  35. Rajendran R, Rajendran V, Giraldo Velasquez M, Megalofonou F, Gurski F, Stadelmann C, et al. Oligodendrocyte-Specific Deletion of FGFR1 Reduces Cerebellar Inflammation and Neurodegeneration in MOG35-55-Induced EAE. Int J Mol Sci. 2021;22: pubmed publisher
  36. Wang Z, He L, Li W, Xu C, Zhang J, Wang D, et al. GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma. J Immunother Cancer. 2021;9: pubmed publisher
  37. Zhang X, Chang A, Zou Y, Xu H, Cui J, Chen Z, et al. Aspirin Attenuates Cardiac Allograft Rejection by Inhibiting the Maturation of Dendritic Cells via the NF-κB Signaling Pathway. Front Pharmacol. 2021;12:706748 pubmed publisher
  38. Moreira T, Mangani D, Cox L, Leibowitz J, Lobo E, Oliveira M, et al. PD-L1+ and XCR1+ dendritic cells are region-specific regulators of gut homeostasis. Nat Commun. 2021;12:4907 pubmed publisher
  39. Petley E, Koay H, Henderson M, Sek K, Todd K, Keam S, et al. MAIT cells regulate NK cell-mediated tumor immunity. Nat Commun. 2021;12:4746 pubmed publisher
  40. Forman R, Logunova L, Smith H, Wemyss K, Mair I, Boon L, et al. Trichuris muris infection drives cell-intrinsic IL4R alpha independent colonic RELMα+ macrophages. PLoS Pathog. 2021;17:e1009768 pubmed publisher
  41. Funk K, Arutyunov A, Desai P, White J, Soung A, Rosen S, et al. Decreased antiviral immune response within the central nervous system of aged mice is associated with increased lethality of West Nile virus encephalitis. Aging Cell. 2021;20:e13412 pubmed publisher
  42. Kim G, Kim W, Lim S, Lee H, Koo J, Nam K, et al. In Vivo Induction of Regulatory T Cells Via CTLA-4 Signaling Peptide to Control Autoimmune Encephalomyelitis and Prevent Disease Relapse. Adv Sci (Weinh). 2021;8:2004973 pubmed publisher
  43. Wutschka J, Kast B, Sator Schmitt M, Appak Baskoy S, Hess J, Sinn H, et al. JUNB suppresses distant metastasis by influencing the initial metastatic stage. Clin Exp Metastasis. 2021;38:411-423 pubmed publisher
  44. Lauret Marie Joseph E, Kirilovsky A, Lecoester B, El Sissy C, Boullerot L, Rangan L, et al. Chemoradiation triggers antitumor Th1 and tissue resident memory-polarized immune responses to improve immune checkpoint inhibitors therapy. J Immunother Cancer. 2021;9: pubmed publisher
  45. Hering L, Katkeviciute E, Schwarzfischer M, Niechcial A, Riggs J, Wawrzyniak M, et al. Macrophages Compensate for Loss of Protein Tyrosine Phosphatase N2 in Dendritic Cells to Protect from Elevated Colitis. Int J Mol Sci. 2021;22: pubmed publisher
  46. Souza C, Ketelut Carneiro N, Milanezi C, Faccioli L, Gardinassi L, Silva J. NLRC4 inhibits NLRP3 inflammasome and abrogates effective antifungal CD8+ T cell responses. iScience. 2021;24:102548 pubmed publisher
  47. Ramos M, Tian L, de Ruiter E, Song C, Paucarmayta A, Singh A, et al. Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction. elife. 2021;10: pubmed publisher
  48. Uehara H, Zhang X, Pereira F, Narendran S, Choi S, Bhuvanagiri S, et al. Start codon disruption with CRISPR/Cas9 prevents murine Fuchs' endothelial corneal dystrophy. elife. 2021;10: pubmed publisher
  49. Wang J, Zhang Y, Xiao Y, Yuan X, Li P, Wang X, et al. Boosting immune surveillance by low-dose PI3K inhibitor facilitates early intervention of breast cancer. Am J Cancer Res. 2021;11:2005-2024 pubmed
  50. Zheng J, MEYERHOLZ D, Wong L, Gelb M, Murakami M, Perlman S. Coronavirus-specific antibody production in middle-aged mice requires phospholipase A2G2D. J Clin Invest. 2021;131: pubmed publisher
  51. Borkner L, Curham L, Wilk M, Moran B, Mills K. IL-17 mediates protective immunity against nasal infection with Bordetella pertussis by mobilizing neutrophils, especially Siglec-F+ neutrophils. Mucosal Immunol. 2021;14:1183-1202 pubmed publisher
  52. Amoozgar Z, Kloepper J, Ren J, Tay R, Kazer S, Kiner E, et al. Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas. Nat Commun. 2021;12:2582 pubmed publisher
  53. Li J, Xu J, Li Z. Obatoclax, the pan-Bcl-2 inhibitor sensitizes hepatocellular carcinoma cells to promote the anti-tumor efficacy in combination with immune checkpoint blockade. Transl Oncol. 2021;14:101116 pubmed publisher
  54. Lin Q, Rong L, Jia X, Li R, Yu B, Hu J, et al. IFN-γ-dependent NK cell activation is essential to metastasis suppression by engineered Salmonella. Nat Commun. 2021;12:2537 pubmed publisher
  55. Lin X, Twelkmeyer T, Zhu D, Zhang L, Zhao Y, Zhang C, et al. Homeostatic regulation of T follicular helper and antibody response to particle antigens by IL-1Ra of medullary sinus macrophage origin. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  56. Yang C, Kwon D, Kim M, Im S, Lee Y. Commensal Microbiome Expands Tγδ17 Cells in the Lung and Promotes Particulate Matter-Induced Acute Neutrophilia. Front Immunol. 2021;12:645741 pubmed publisher
  57. Zheng W, Song H, Luo Z, Wu H, Chen L, Wang Y, et al. Acetylcholine ameliorates colitis by promoting IL-10 secretion of monocytic myeloid-derived suppressor cells through the nAChR/ERK pathway. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  58. Akgul A, Maddaloni M, Jun S, Nelson A, Odreman V, Hoffman C, et al. Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjögren's syndrome. Arthritis Res Ther. 2021;23:99 pubmed publisher
  59. Roux C, Mucciolo G, Kopecka J, Novelli F, Riganti C, Cappello P. IL17A Depletion Affects the Metabolism of Macrophages Treated with Gemcitabine. Antioxidants (Basel). 2021;10: pubmed publisher
  60. Horiuchi H, Parajuli B, Komiya H, Ogawa Y, Jin S, Takahashi K, et al. Interleukin-19 Abrogates Experimental Autoimmune Encephalomyelitis by Attenuating Antigen-Presenting Cell Activation. Front Immunol. 2021;12:615898 pubmed publisher
  61. Bonilla W, Kirchhammer N, Marx A, Kallert S, Krzyzaniak M, Lu M, et al. Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attack. Cell Rep Med. 2021;2:100209 pubmed publisher
  62. Petty A, Dai R, Lapalombella R, Baiocchi R, Benson D, Li Z, et al. Hedgehog-induced PD-L1 on tumor-associated macrophages is critical for suppression of tumor-infiltrating CD8+ T cell function. JCI Insight. 2021;6: pubmed publisher
  63. Lu M, Dravid P, Zhang Y, Trivedi S, Li A, Harder O, et al. A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  64. Sripada A, Sirohi K, Michalec L, Guo L, McKay J, Yadav S, et al. Sprouty2 positively regulates T cell function and airway inflammation through regulation of CSK and LCK kinases. PLoS Biol. 2021;19:e3001063 pubmed publisher
  65. Mao F, Lv Y, Hao C, Teng Y, Liu Y, Cheng P, et al. Helicobacter pylori-Induced Rev-erbα Fosters Gastric Bacteria Colonization by Impairing Host Innate and Adaptive Defense. Cell Mol Gastroenterol Hepatol. 2021;12:395-425 pubmed publisher
  66. Yin H, Zhang X, Yang P, Zhang X, Peng Y, Li D, et al. RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming. Nat Commun. 2021;12:1394 pubmed publisher
  67. Minns D, Smith K, Alessandrini V, Hardisty G, Melrose L, Jackson Jones L, et al. The neutrophil antimicrobial peptide cathelicidin promotes Th17 differentiation. Nat Commun. 2021;12:1285 pubmed publisher
  68. Hamminger P, Marchetti L, Preglej T, Platzer R, Zhu C, Kamnev A, et al. Histone deacetylase 1 controls CD4+ T cell trafficking in autoinflammatory diseases. J Autoimmun. 2021;119:102610 pubmed publisher
  69. Yuan J, Cai T, Zheng X, Ren Y, Qi J, Lu X, et al. Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling. Protein Cell. 2021;12:240-260 pubmed publisher
  70. Sun Z, Yao Y, You M, Liu J, Guo W, Qi Z, et al. The kinase PDK1 is critical for promoting T follicular helper cell differentiation. elife. 2021;10: pubmed publisher
  71. Page N, Lemeille S, Vincenti I, Klimek B, Mariotte A, Wagner I, et al. Persistence of self-reactive CD8+ T cells in the CNS requires TOX-dependent chromatin remodeling. Nat Commun. 2021;12:1009 pubmed publisher
  72. Yao C, Lou G, Sun H, Zhu Z, Sun Y, Chen Z, et al. BACH2 enforces the transcriptional and epigenetic programs of stem-like CD8+ T cells. Nat Immunol. 2021;22:370-380 pubmed publisher
  73. Li Y, Sun Y, Kulke M, Hechler T, Van der Jeught K, Dong T, et al. Targeted immunotherapy for HER2-low breast cancer with 17p loss. Sci Transl Med. 2021;13: pubmed publisher
  74. Yue R, Wei X, Zhao J, Zhou Z, Zhong W. Essential Role of IFN-γ in Regulating Gut Antimicrobial Peptides and Microbiota to Protect Against Alcohol-Induced Bacterial Translocation and Hepatic Inflammation in Mice. Front Physiol. 2020;11:629141 pubmed publisher
  75. Phan T, Schink L, Mann J, Merk V, Zwicky P, Mundt S, et al. Keratinocytes control skin immune homeostasis through de novo-synthesized glucocorticoids. Sci Adv. 2021;7: pubmed publisher
  76. Nian Y, Iske J, Maenosono R, Minami K, Heinbokel T, Quante M, et al. Targeting age-specific changes in CD4+ T cell metabolism ameliorates alloimmune responses and prolongs graft survival. Aging Cell. 2021;20:e13299 pubmed publisher
  77. Xu K, Yin N, Peng M, Stamatiades E, Shyu A, Li P, et al. Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity. Science. 2021;371:405-410 pubmed publisher
  78. Sharma N, Hans C. Interleukin 12p40 Deficiency Promotes Abdominal Aortic Aneurysm by Activating CCN2/MMP2 Pathways. J Am Heart Assoc. 2021;10:e017633 pubmed publisher
  79. Break T, Oikonomou V, Dutzan N, Desai J, Swidergall M, Freiwald T, et al. Aberrant type 1 immunity drives susceptibility to mucosal fungal infections. Science. 2021;371: pubmed publisher
  80. Khaw Y, Majid D, Oh S, Kang E, Inoue M. Early-life-trauma triggers interferon-β resistance and neurodegeneration in a multiple sclerosis model via downregulated β1-adrenergic signaling. Nat Commun. 2021;12:105 pubmed publisher
  81. Chen S, Zhang J, Yu W, Zhuang J, Xiao W, Wu Z, et al. Eomesodermin in CD4+T cells is essential for Ginkgolide K ameliorating disease progression in experimental autoimmune encephalomyelitis. Int J Biol Sci. 2021;17:50-61 pubmed publisher
  82. Antony A, Lian Z, Perrard X, Perrard J, Liu H, Cox A, et al. Deficiency of Stat1 in CD11c+ Cells Alters Adipose Tissue Inflammation and Improves Metabolic Dysfunctions in Mice Fed a High-Fat Diet. Diabetes. 2021;70:720-732 pubmed publisher
  83. Meryk A, Grasse M, Balasco L, Kapferer W, Grubeck Loebenstein B, Pangrazzi L. Antioxidants N-Acetylcysteine and Vitamin C Improve T Cell Commitment to Memory and Long-Term Maintenance of Immunological Memory in Old Mice. Antioxidants (Basel). 2020;9: pubmed publisher
  84. Jensen I, Jensen S, Sjaastad F, Gibson Corley K, Dileepan T, Griffith T, et al. Sepsis impedes EAE disease development and diminishes autoantigen-specific naive CD4 T cells. elife. 2020;9: pubmed publisher
  85. Gao L, Li B, Wang J, Shen D, Yang M, Sun R, et al. Activation of Liver X Receptor α Sensitizes Mice to T-Cell Mediated Hepatitis. Hepatol Commun. 2020;4:1664-1679 pubmed publisher
  86. Kamali S, Rajendran R, Stadelmann C, Karnati S, Rajendran V, Giraldo Velasquez M, et al. Oligodendrocyte-specific deletion of FGFR2 ameliorates MOG35-55 -induced EAE through ERK and Akt signalling. Brain Pathol. 2021;31:297-311 pubmed publisher
  87. Zhao L, Hu S, Davila M, Yang J, Lin Y, Albanese J, et al. Coordinated co-migration of CCR10+ antibody-producing B cells with helper T cells for colonic homeostatic regulation. Mucosal Immunol. 2021;14:420-430 pubmed publisher
  88. Moreno Valladares M, Moreno Cugnon L, Silva T, Garcés J, Sáenz Antoñanzas A, Álvarez Satta M, et al. CD8+ T cells are increased in the subventricular zone with physiological and pathological aging. Aging Cell. 2020;:e13198 pubmed publisher
  89. Piersma S, Poursine Laurent J, Yang L, Barber G, Parikh B, Yokoyama W. Virus infection is controlled by hematopoietic and stromal cell sensing of murine cytomegalovirus through STING. elife. 2020;9: pubmed publisher
  90. Wang J, Zhang J, Zhao X, Lu J, Weng Z, Ding Z, et al. Circular RNA DHX33 promotes malignant behavior in ccRCC by targeting miR-489-3p/MEK1 axis. Aging (Albany NY). 2020;12:14885-14896 pubmed publisher
  91. Pasciuto E, Burton O, Roca C, Lagou V, Rajan W, Theys T, et al. Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition. Cell. 2020;182:625-640.e24 pubmed publisher
  92. Bhaskar A, Kumar S, Khan M, Singh A, Dwivedi V, Nandicoori V. Host sirtuin 2 as an immunotherapeutic target against tuberculosis. elife. 2020;9: pubmed publisher
  93. Harbour S, DiToro D, Witte S, Zindl C, Gao M, Schoeb T, et al. TH17 cells require ongoing classic IL-6 receptor signaling to retain transcriptional and functional identity. Sci Immunol. 2020;5: pubmed publisher
  94. Sun J, Zhuang Z, Zheng J, Li K, Wong R, Liu D, et al. Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment. Cell. 2020;182:734-743.e5 pubmed publisher
  95. Svensson M, Zoccheddu M, Yang S, Nygaard G, Secchi C, Doody K, et al. Synoviocyte-targeted therapy synergizes with TNF inhibition in arthritis reversal. Sci Adv. 2020;6:eaba4353 pubmed publisher
  96. Robbins Y, Greene S, Friedman J, Clavijo P, Van Waes C, Fabian K, et al. Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells. elife. 2020;9: pubmed publisher
  97. Zhou T, Damsky W, Weizman O, McGeary M, Hartmann K, Rosen C, et al. IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy. Nature. 2020;583:609-614 pubmed publisher
  98. Ning Y, Ding J, Sun X, Xie Y, Su M, Ma C, et al. HDAC9 deficiency promotes tumor progression by decreasing the CD8+ dendritic cell infiltration of the tumor microenvironment. J Immunother Cancer. 2020;8: pubmed publisher
  99. Alexander R, Liou Y, Knudsen N, Starost K, Xu C, Hyde A, et al. Bmal1 integrates mitochondrial metabolism and macrophage activation. elife. 2020;9: pubmed publisher
  100. Chinnakannan S, Cargill T, Donnison T, Ansari M, Sebastian S, Lee L, et al. The Design and Development of a Multi-HBV Antigen Encoded in Chimpanzee Adenoviral and Modified Vaccinia Ankara Viral Vectors; A Novel Therapeutic Vaccine Strategy against HBV. Vaccines (Basel). 2020;8: pubmed publisher
  101. von Roemeling C, Wang Y, Qie Y, Yuan H, Zhao H, Liu X, et al. Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity. Nat Commun. 2020;11:1508 pubmed publisher
  102. Gibaldi D, Vilar Pereira G, Pereira I, Silva A, Barrios L, Ramos I, et al. CCL3/Macrophage Inflammatory Protein-1α Is Dually Involved in Parasite Persistence and Induction of a TNF- and IFNγ-Enriched Inflammatory Milieu in Trypanosoma cruzi-Induced Chronic Cardiomyopathy. Front Immunol. 2020;11:306 pubmed publisher
  103. Donaldson D, Bradford B, Else K, Mabbott N. Accelerated onset of CNS prion disease in mice co-infected with a gastrointestinal helminth pathogen during the preclinical phase. Sci Rep. 2020;10:4554 pubmed publisher
  104. Chaurasiya S, Yang A, Kang S, Lu J, Kim S, Park A, et al. Oncolytic poxvirus CF33-hNIS-ΔF14.5 favorably modulates tumor immune microenvironment and works synergistically with anti-PD-L1 antibody in a triple-negative breast cancer model. Oncoimmunology. 2020;9:1729300 pubmed publisher
  105. Fu Y, Ding Y, Wang Q, Zhu F, Tan Y, Lu X, et al. Blood-stage malaria parasites manipulate host innate immune responses through the induction of sFGL2. Sci Adv. 2020;6:eaay9269 pubmed publisher
  106. Kumar A, Chamoto K, Chowdhury P, Honjo T. Tumors attenuating the mitochondrial activity in T cells escape from PD-1 blockade therapy. elife. 2020;9: pubmed publisher
  107. Wei J, Mattapallil M, Horai R, Jittayasothorn Y, Modi A, Sen H, et al. A novel role for lipoxin A4 in driving a lymph node-eye axis that controls autoimmunity to the neuroretina. elife. 2020;9: pubmed publisher
  108. Luker A, Graham L, Smith T, Camarena C, Zellner M, Gilmer J, et al. The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer. BMC Immunol. 2020;21:8 pubmed publisher
  109. Hu X, Deng Q, Ma L, Li Q, Chen Y, Liao Y, et al. Meningeal lymphatic vessels regulate brain tumor drainage and immunity. Cell Res. 2020;30:229-243 pubmed publisher
  110. Wang J, Li P, Yu Y, Fu Y, Jiang H, Lu M, et al. Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity. Science. 2020;367: pubmed publisher
  111. Tizian C, Lahmann A, Hölsken O, Cosovanu C, Kofoed Branzk M, Heinrich F, et al. c-Maf restrains T-bet-driven programming of CCR6-negative group 3 innate lymphoid cells. elife. 2020;9: pubmed publisher
  112. Marchingo J, Sinclair L, Howden A, Cantrell D. Quantitative analysis of how Myc controls T cell proteomes and metabolic pathways during T cell activation. elife. 2020;9: pubmed publisher
  113. Mosaheb M, Dobrikova E, Brown M, Yang Y, Cable J, Okada H, et al. Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity. Nat Commun. 2020;11:524 pubmed publisher
  114. Liu Z, Wen J, Wu C, Hu C, Wang J, Bao Q, et al. MicroRNA-200a induces immunosuppression by promoting PTEN-mediated PD-L1 upregulation in osteosarcoma. Aging (Albany NY). 2020;12:1213-1236 pubmed publisher
  115. Choi S, Bae H, Jeong S, Park I, Cho H, Hong S, et al. YAP/TAZ direct commitment and maturation of lymph node fibroblastic reticular cells. Nat Commun. 2020;11:519 pubmed publisher
  116. Yu M, Guo G, Huang L, Deng L, Chang C, Achyut B, et al. CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint. Nat Commun. 2020;11:515 pubmed publisher
  117. Blagih J, Zani F, Chakravarty P, Hennequart M, Pilley S, Hobor S, et al. Cancer-Specific Loss of p53 Leads to a Modulation of Myeloid and T Cell Responses. Cell Rep. 2020;30:481-496.e6 pubmed publisher
  118. Thiele Née Schrewe L, Guse K, Tietz S, Remlinger J, Demir S, Pedreiturria X, et al. Functional relevance of the multi-drug transporter abcg2 on teriflunomide therapy in an animal model of multiple sclerosis. J Neuroinflammation. 2020;17:9 pubmed publisher
  119. Cheng M, Chen Y, Huang D, Chen W, Xu W, Chen Y, et al. Intrinsically altered lung-resident γδT cells control lung melanoma by producing interleukin-17A in the elderly. Aging Cell. 2020;19:e13099 pubmed publisher
  120. Lee J, Hall J, Kroehling L, Wu L, Najar T, Nguyen H, et al. Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease. Cell. 2020;180:79-91.e16 pubmed publisher
  121. Raphael I, Gomez Rivera F, Raphael R, Robinson R, Nalawade S, Forsthuber T. TNFR2 limits proinflammatory astrocyte functions during EAE induced by pathogenic DR2b-restricted T cells. JCI Insight. 2019;4: pubmed publisher
  122. Williford J, Ishihara J, Ishihara A, Mansurov A, Hosseinchi P, Marchell T, et al. Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy. Sci Adv. 2019;5:eaay1357 pubmed publisher
  123. Jimeno R, Lebrusant Fernandez M, Margreitter C, LUCAS B, Veerapen N, Kelly G, et al. Tissue-specific shaping of the TCR repertoire and antigen specificity of iNKT cells. elife. 2019;8: pubmed publisher
  124. Wei J, Long L, Zheng W, Dhungana Y, Lim S, Guy C, et al. Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy. Nature. 2019;576:471-476 pubmed publisher
  125. Ward L, Lee D, Sharma A, Wang A, Naouar I, Ma X, et al. Siponimod therapy implicates Th17 cells in a preclinical model of subpial cortical injury. JCI Insight. 2020;5: pubmed publisher
  126. Koprivsek J, He Y, Song C, Zhang N, Tumanov A, Zhong G. Evasion of Innate Lymphoid Cell-Regulated Gamma Interferon Responses by Chlamydia muridarum To Achieve Long-Lasting Colonization in Mouse Colon. Infect Immun. 2020;88: pubmed publisher
  127. Shi L, Wang J, Ding N, Zhang Y, Zhu Y, Dong S, et al. Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy. Nat Commun. 2019;10:5421 pubmed publisher
  128. Hang S, Paik D, Yao L, Kim E, Jamma T, Lu J, et al. Bile acid metabolites control TH17 and Treg cell differentiation. Nature. 2019;576:143-148 pubmed publisher
  129. Zhao Y, Yang Q, Jin C, Feng Y, Xie S, Xie H, et al. Changes of CD103-expressing pulmonary CD4+ and CD8+ T cells in S. japonicum infected C57BL/6 mice. BMC Infect Dis. 2019;19:999 pubmed publisher
  130. Gil Cruz C, Perez Shibayama C, De Martin A, Ronchi F, Van der Borght K, Niederer R, et al. Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy. Science. 2019;366:881-886 pubmed publisher
  131. Leone R, Zhao L, Englert J, Sun I, Oh M, Sun I, et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science. 2019;366:1013-1021 pubmed publisher
  132. Yan D, Wang J, Sun H, Zamani A, Zhang H, Chen W, et al. TIPE2 specifies the functional polarization of myeloid-derived suppressor cells during tumorigenesis. J Exp Med. 2020;217: pubmed publisher
  133. Constantinides M, Link V, Tamoutounour S, Wong A, Pérez Chaparro P, Han S, et al. MAIT cells are imprinted by the microbiota in early life and promote tissue repair. Science. 2019;366: pubmed publisher
  134. Lin F, Meng X, Guo Y, Cao W, Liu W, Xia Q, et al. Epigenetic initiation of the TH17 differentiation program is promoted by Cxxc finger protein 1. Sci Adv. 2019;5:eaax1608 pubmed publisher
  135. Wolf Y, Bartok O, Patkar S, Eli G, Cohen S, Litchfield K, et al. UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma. Cell. 2019;179:219-235.e21 pubmed publisher
  136. Dong M, Wang G, Chow R, Ye L, Zhu L, Dai X, et al. Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells. Cell. 2019;178:1189-1204.e23 pubmed publisher
  137. Findlay E, Currie A, Zhang A, Ovciarikova J, Young L, Stevens H, et al. Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy. Oncoimmunology. 2019;8:1608106 pubmed publisher
  138. Cohen J, Edwards T, Liu A, Hirai T, Jones M, Wu J, et al. Cutaneous TRPV1+ Neurons Trigger Protective Innate Type 17 Anticipatory Immunity. Cell. 2019;178:919-932.e14 pubmed publisher
  139. Leclerc M, Voilin E, Gros G, Corgnac S, de Montpreville V, Validire P, et al. Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1. Nat Commun. 2019;10:3345 pubmed publisher
  140. Niemann J, Woller N, Brooks J, Fleischmann Mundt B, Martin N, Kloos A, et al. Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy. Nat Commun. 2019;10:3236 pubmed publisher
  141. Clancy Thompson E, Chen G, LaMarche N, Ali L, Jeong H, Crowley S, et al. Transnuclear mice reveal Peyer's patch iNKT cells that regulate B-cell class switching to IgG1. EMBO J. 2019;38:e101260 pubmed publisher
  142. Ma L, Dichwalkar T, Chang J, Cossette B, Garafola D, Zhang A, et al. Enhanced CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor. Science. 2019;365:162-168 pubmed publisher
  143. Pan X, Ma B, You X, Chen S, Wu J, Wang T, et al. Synthesized natural peptides from amphibian skin secretions increase the efficacy of a therapeutic vaccine by recruiting more T cells to the tumour site. BMC Complement Altern Med. 2019;19:163 pubmed publisher
  144. Liu D, Yin X, Olyha S, Nascimento M, Chen P, White T, et al. IL-10-Dependent Crosstalk between Murine Marginal Zone B Cells, Macrophages, and CD8α+ Dendritic Cells Promotes Listeria monocytogenes Infection. Immunity. 2019;: pubmed publisher
  145. Kono M, Maeda K, Stocton Gavanescu I, Pan W, Umeda M, Katsuyama E, et al. Pyruvate kinase M2 is requisite for Th1 and Th17 differentiation. JCI Insight. 2019;4: pubmed publisher
  146. Khan O, Giles J, McDonald S, Manne S, Ngiow S, Patel K, et al. TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion. Nature. 2019;: pubmed publisher
  147. Oh J, Iijima N, Song E, Lu P, Klein J, Jiang R, et al. Migrant memory B cells secrete luminal antibody in the vagina. Nature. 2019;: pubmed publisher
  148. Di Pilato M, Kim E, Cadilha B, Prüßmann J, Nasrallah M, Seruggia D, et al. Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy. Nature. 2019;570:112-116 pubmed publisher
  149. Qiu J, Villa M, Sanin D, Buck M, O Sullivan D, Ching R, et al. Acetate Promotes T Cell Effector Function during Glucose Restriction. Cell Rep. 2019;27:2063-2074.e5 pubmed publisher
  150. Sharma N, Vacher J, Allison J. TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion. Proc Natl Acad Sci U S A. 2019;116:10453-10462 pubmed publisher
  151. Kawalkowska J, Ogbechi J, Venables P, Williams R. cIAP1/2 inhibition synergizes with TNF inhibition in autoimmunity by down-regulating IL-17A and inducing Tregs. Sci Adv. 2019;5:eaaw5422 pubmed publisher
  152. Miao Y, Yang H, Levorse J, Yuan S, Polak L, Sribour M, et al. Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells. Cell. 2019;177:1172-1186.e14 pubmed publisher
  153. Misumi I, Starmer J, Uchimura T, Beck M, Magnuson T, Whitmire J. Obesity Expands a Distinct Population of T Cells in Adipose Tissue and Increases Vulnerability to Infection. Cell Rep. 2019;27:514-524.e5 pubmed publisher
  154. Hammerich L, Marron T, Upadhyay R, Svensson Arvelund J, Dhainaut M, Hussein S, et al. Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination. Nat Med. 2019;25:814-824 pubmed publisher
  155. Li Y, Tinoco R, Elmén L, Segota I, Xian Y, Fujita Y, et al. Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5-/- mice. Nat Commun. 2019;10:1492 pubmed publisher
  156. Sinclair L, Howden A, Brenes A, Spinelli L, Hukelmann J, Macintyre A, et al. Antigen receptor control of methionine metabolism in T cells. elife. 2019;8: pubmed publisher
  157. Kumar P, Rajasekaran K, Nanbakhsh A, Gorski J, Thakar M, Malarkannan S. IL-27 promotes NK cell effector functions via Maf-Nrf2 pathway during influenza infection. Sci Rep. 2019;9:4984 pubmed publisher
  158. Qian L, Bajana S, Georgescu C, Peng V, Wang H, Adrianto I, et al. Suppression of ILC2 differentiation from committed T cell precursors by E protein transcription factors. J Exp Med. 2019;216:884-899 pubmed publisher
  159. Cao Y, Trillo Tinoco J, Sierra R, Anadon C, Dai W, Mohamed E, et al. ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression. Nat Commun. 2019;10:1280 pubmed publisher
  160. Xing S, Gai K, Li X, Shao P, Zeng Z, Zhao X, et al. Tcf1 and Lef1 are required for the immunosuppressive function of regulatory T cells. J Exp Med. 2019;: pubmed publisher
  161. Chen J, López Moyado I, Seo H, Lio C, Hempleman L, Sekiya T, et al. NR4A transcription factors limit CAR T cell function in solid tumours. Nature. 2019;567:530-534 pubmed publisher
  162. Lodygin D, Hermann M, Schweingruber N, Flügel Koch C, Watanabe T, Schlosser C, et al. β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration. Nature. 2019;566:503-508 pubmed publisher
  163. Wen Z, Jin K, Shen Y, Yang Z, Li Y, Wu B, et al. N-myristoyltransferase deficiency impairs activation of kinase AMPK and promotes synovial tissue inflammation. Nat Immunol. 2019;20:313-325 pubmed publisher
  164. Salerno F, Guislain A, Freen van Heeren J, Nicolet B, Young H, Wolkers M. Critical role of post-transcriptional regulation for IFN-γ in tumor-infiltrating T cells. Oncoimmunology. 2019;8:e1532762 pubmed publisher
  165. Mikolajczyk T, Nosalski R, Skiba D, Koziol J, Mazur M, Justo Junior A, et al. 1,2,3,4,6-Penta-O-galloyl-β-d-glucose modulates perivascular inflammation and prevents vascular dysfunction in angiotensin II-induced hypertension. Br J Pharmacol. 2019;176:1951-1965 pubmed publisher
  166. McLaren J, Clement M, Marsden M, Miners K, Llewellyn Lacey S, Grant E, et al. IL-33 Augments Virus-Specific Memory T Cell Inflation and Potentiates the Efficacy of an Attenuated Cytomegalovirus-Based Vaccine. J Immunol. 2019;202:943-955 pubmed publisher
  167. Lee Y, Ju J, Shon W, Oh S, Min C, Kang M, et al. Skewed Dendritic Cell Differentiation of MyD88-Deficient Donor Bone Marrow Cells, Instead of Massive Expansion as Myeloid-Derived Suppressor Cells, Aggravates GVHD. Immune Netw. 2018;18:e44 pubmed publisher
  168. Li J, He Y, Hao J, Ni L, Dong C. High Levels of Eomes Promote Exhaustion of Anti-tumor CD8+ T Cells. Front Immunol. 2018;9:2981 pubmed publisher
  169. Ha D, Tanaka A, Kibayashi T, Tanemura A, Sugiyama D, Wing J, et al. Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibody. Proc Natl Acad Sci U S A. 2019;116:609-618 pubmed publisher
  170. Wang X, Piersma S, Nelson C, Dai Y, Christensen T, Lazear E, et al. A herpesvirus encoded Qa-1 mimic inhibits natural killer cell cytotoxicity through CD94/NKG2A receptor engagement. elife. 2018;7: pubmed publisher
  171. Karmaus P, Chen X, Lim S, Herrada A, Nguyen T, Xu B, et al. Metabolic heterogeneity underlies reciprocal fates of TH17 cell stemness and plasticity. Nature. 2019;565:101-105 pubmed publisher
  172. Bern M, Parikh B, Yang L, Beckman D, Poursine Laurent J, Yokoyama W. Inducible down-regulation of MHC class I results in natural killer cell tolerance. J Exp Med. 2019;216:99-116 pubmed publisher
  173. Kaplanov I, Carmi Y, Kornetsky R, Shemesh A, Shurin G, Shurin M, et al. Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation. Proc Natl Acad Sci U S A. 2019;116:1361-1369 pubmed publisher
  174. Ding L, Kim H, Wang Q, Kearns M, Jiang T, Ohlson C, et al. PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer. Cell Rep. 2018;25:2972-2980.e5 pubmed publisher
  175. Poncette L, Chen X, Lorenz F, Blankenstein T. Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression. J Clin Invest. 2019;129:324-335 pubmed publisher
  176. Sato Y, Bolzenius J, Eteleeb A, Su X, Maher C, Sehn J, et al. CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade. JCI Insight. 2018;3: pubmed publisher
  177. Kiyohara H, Sujino T, Teratani T, Miyamoto K, Arai M, Nomura E, et al. Toll-Like Receptor 7 Agonist-Induced Dermatitis Causes Severe Dextran Sulfate Sodium Colitis by Altering the Gut Microbiome and Immune Cells. Cell Mol Gastroenterol Hepatol. 2019;7:135-156 pubmed publisher
  178. Atretkhany K, Mufazalov I, Dunst J, Kuchmiy A, Gogoleva V, Andruszewski D, et al. Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity. Proc Natl Acad Sci U S A. 2018;115:13051-13056 pubmed publisher
  179. He Z, Zhang J, Huang Z, Du Q, Li N, Zhang Q, et al. Sumoylation of RORγt regulates TH17 differentiation and thymocyte development. Nat Commun. 2018;9:4870 pubmed publisher
  180. Chinta K, Rahman M, Saini V, Glasgow J, Reddy V, Lever J, et al. Microanatomic Distribution of Myeloid Heme Oxygenase-1 Protects against Free Radical-Mediated Immunopathology in Human Tuberculosis. Cell Rep. 2018;25:1938-1952.e5 pubmed publisher
  181. Mastroianni J, Stickel N, Andrlova H, Hanke K, Melchinger W, Duquesne S, et al. miR-146a Controls Immune Response in the Melanoma Microenvironment. Cancer Res. 2019;79:183-195 pubmed publisher
  182. Jensen I, Winborn C, Fosdick M, Shao P, Tremblay M, Shan Q, et al. Polymicrobial sepsis influences NK-cell-mediated immunity by diminishing NK-cell-intrinsic receptor-mediated effector responses to viral ligands or infections. PLoS Pathog. 2018;14:e1007405 pubmed publisher
  183. Singh A, Khare P, Obaid A, Conlon K, Basrur V, Depinho R, et al. SUMOylation of ROR-γt inhibits IL-17 expression and inflammation via HDAC2. Nat Commun. 2018;9:4515 pubmed publisher
  184. Er J, Koean R, Ding J. Loss of T-bet confers survival advantage to influenza-bacterial superinfection. EMBO J. 2019;38: pubmed publisher
  185. Song M, Sandoval T, Chae C, Chopra S, Tan C, Rutkowski M, et al. IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity. Nature. 2018;562:423-428 pubmed publisher
  186. Vuckovic S, Minnie S, Smith D, Gartlan K, Watkins T, Markey K, et al. Bone marrow transplantation generates T cell-dependent control of myeloma in mice. J Clin Invest. 2019;129:106-121 pubmed publisher
  187. Brun P, Scarpa M, Marchiori C, Conti J, Kotsafti A, Porzionato A, et al. Herpes Simplex Virus Type 1 Engages Toll Like Receptor 2 to Recruit Macrophages During Infection of Enteric Neurons. Front Microbiol. 2018;9:2148 pubmed publisher
  188. Qu J, Li L, Xie H, Zhang X, Yang Q, Qiu H, et al. TLR3 Modulates the Response of NK Cells against Schistosoma japonicum. J Immunol Res. 2018;2018:7519856 pubmed publisher
  189. Han L, Wang L, Tang S, Yuan L, Wu S, Du X, et al. ITGB4 deficiency in bronchial epithelial cells directs airway inflammation and bipolar disorder-related behavior. J Neuroinflammation. 2018;15:246 pubmed publisher
  190. Wang H, D Souza C, Lim X, Kostenko L, Pediongco T, Eckle S, et al. MAIT cells protect against pulmonary Legionella longbeachae infection. Nat Commun. 2018;9:3350 pubmed publisher
  191. Geary C, Krishna C, Lau C, Adams N, Gearty S, Pritykin Y, et al. Non-redundant ISGF3 Components Promote NK Cell Survival in an Auto-regulatory Manner during Viral Infection. Cell Rep. 2018;24:1949-1957.e6 pubmed publisher
  192. Tilstra J, Avery L, Menk A, Gordon R, Smita S, Kane L, et al. Kidney-infiltrating T cells in murine lupus nephritis are metabolically and functionally exhausted. J Clin Invest. 2018;128:4884-4897 pubmed publisher
  193. Zhao D, Kim Y, Jeong S, Greenson J, Chaudhry M, Hoepting M, et al. Survival signal REG3α prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease. J Clin Invest. 2018;128:4970-4979 pubmed publisher
  194. Cheng Y, Zhu X, Wang X, Zhuang Q, Huyan X, Sun X, et al. Trichinella spiralis Infection Mitigates Collagen-Induced Arthritis via Programmed Death 1-Mediated Immunomodulation. Front Immunol. 2018;9:1566 pubmed publisher
  195. Deason K, Troutman T, Jain A, Challa D, Mandraju R, Brewer T, et al. BCAP links IL-1R to the PI3K-mTOR pathway and regulates pathogenic Th17 cell differentiation. J Exp Med. 2018;215:2413-2428 pubmed publisher
  196. Singh M, Ni M, Sullivan J, Hamerman J, Campbell D. B cell adaptor for PI3-kinase (BCAP) modulates CD8+ effector and memory T cell differentiation. J Exp Med. 2018;215:2429-2443 pubmed publisher
  197. Cummings M, Arumanayagam A, Zhao P, Kannanganat S, Stuve O, Karandikar N, et al. Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis. PLoS ONE. 2018;13:e0200752 pubmed publisher
  198. Oldstone M, Ware B, Horton L, Welch M, Aiolfi R, Zarpellon A, et al. Lymphocytic choriomeningitis virus Clone 13 infection causes either persistence or acute death dependent on IFN-1, cytotoxic T lymphocytes (CTLs), and host genetics. Proc Natl Acad Sci U S A. 2018;115:E7814-E7823 pubmed publisher
  199. Stathopoulou C, Gangaplara A, Mallett G, Flomerfelt F, Liniany L, Knight D, et al. PD-1 Inhibitory Receptor Downregulates Asparaginyl Endopeptidase and Maintains Foxp3 Transcription Factor Stability in Induced Regulatory T Cells. Immunity. 2018;49:247-263.e7 pubmed publisher
  200. Poffenberger M, Metcalfe Roach A, Aguilar E, Chen J, Hsu B, Wong A, et al. LKB1 deficiency in T cells promotes the development of gastrointestinal polyposis. Science. 2018;361:406-411 pubmed publisher
  201. Zhu L, Xie X, Zhang L, Wang H, Jie Z, Zhou X, et al. TBK-binding protein 1 regulates IL-15-induced autophagy and NKT cell survival. Nat Commun. 2018;9:2812 pubmed publisher
  202. Zhang C, Wang C, Jiang M, Gu C, Xiao J, Chen X, et al. Act1 is a negative regulator in T and B cells via direct inhibition of STAT3. Nat Commun. 2018;9:2745 pubmed publisher
  203. Arnold I, Artola Borán M, Tallón de Lara P, Kyburz A, Taube C, OTTEMANN K, et al. Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation. J Exp Med. 2018;215:2055-2072 pubmed publisher
  204. Vendetti F, Karukonda P, Clump D, Teo T, Lalonde R, Nugent K, et al. ATR kinase inhibitor AZD6738 potentiates CD8+ T cell-dependent antitumor activity following radiation. J Clin Invest. 2018;128:3926-3940 pubmed publisher
  205. Alissafi T, Hatzioannou A, Mintzas K, Barouni R, Banos A, Sormendi S, et al. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells. J Clin Invest. 2018;128:3840-3852 pubmed publisher
  206. Khan A, Srivastava R, Vahed H, Roy S, Walia S, Kim G, et al. Human Asymptomatic Epitope Peptide/CXCL10-Based Prime/Pull Vaccine Induces Herpes Simplex Virus-Specific Gamma Interferon-Positive CD107+ CD8+ T Cells That Infiltrate the Corneas and Trigeminal Ganglia of Humanized HLA Transgenic Rabbits and Protect . J Virol. 2018;92: pubmed publisher
  207. Ludtmann M, Angelova P, Horrocks M, Choi M, Rodrigues M, Baev A, et al. α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson's disease. Nat Commun. 2018;9:2293 pubmed publisher
  208. Jogdand G, Sengupta S, Bhattacharya G, Singh S, Barik P, Devadas S. Inducible Costimulator Expressing T Cells Promote Parasitic Growth During Blood Stage Plasmodium berghei ANKA Infection. Front Immunol. 2018;9:1041 pubmed publisher
  209. Du X, Wen J, Wang Y, Karmaus P, Khatamian A, Tan H, et al. Hippo/Mst signalling couples metabolic state and immune function of CD8α+ dendritic cells. Nature. 2018;558:141-145 pubmed publisher
  210. Ma C, Han M, Heinrich B, Fu Q, Zhang Q, Sandhu M, et al. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science. 2018;360: pubmed publisher
  211. Daenthanasanmak A, Wu Y, Iamsawat S, Nguyen H, Bastian D, Zhang M, et al. PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity. J Clin Invest. 2018;128:2787-2801 pubmed publisher
  212. García Nores G, Ly C, Cuzzone D, Kataru R, Hespe G, Torrisi J, et al. CD4+ T cells are activated in regional lymph nodes and migrate to skin to initiate lymphedema. Nat Commun. 2018;9:1970 pubmed publisher
  213. Yu F, Sharma S, Jankovic D, Gurram R, Su P, Hu G, et al. The transcription factor Bhlhe40 is a switch of inflammatory versus antiinflammatory Th1 cell fate determination. J Exp Med. 2018;215:1813-1821 pubmed publisher
  214. Hu X, Majchrzak K, Liu X, Wyatt M, Spooner C, Moisan J, et al. In Vitro Priming of Adoptively Transferred T Cells with a RORγ Agonist Confers Durable Memory and Stemness In Vivo. Cancer Res. 2018;78:3888-3898 pubmed publisher
  215. Drobek A, Moudra A, Mueller D, Huranová M, Horková V, Pribikova M, et al. Strong homeostatic TCR signals induce formation of self-tolerant virtual memory CD8 T cells. EMBO J. 2018;37: pubmed publisher
  216. Wang Y, Dong W, Zhang Y, Caligiuri M, Yu J. Dependence of innate lymphoid cell 1 development on NKp46. PLoS Biol. 2018;16:e2004867 pubmed publisher
  217. Anker J, Naseem A, Mok H, Schaeffer A, Abdulkadir S, Thumbikat P. Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy. Nat Commun. 2018;9:1591 pubmed publisher
  218. Dipiazza A, Laniewski N, Rattan A, Topham D, Miller J, Sant A. CD4 T Cell Epitope Specificity and Cytokine Potential Are Preserved as Cells Transition from the Lung Vasculature to Lung Tissue following Influenza Virus Infection. J Virol. 2018;92: pubmed publisher
  219. Varelias A, Bunting M, Ormerod K, Koyama M, Olver S, Straube J, et al. Recipient mucosal-associated invariant T cells control GVHD within the colon. J Clin Invest. 2018;128:1919-1936 pubmed publisher
  220. Prado C, Gaiazzi M, Gonzalez H, Ugalde V, Figueroa A, Osorio Barrios F, et al. Dopaminergic Stimulation of Myeloid Antigen-Presenting Cells Attenuates Signal Transducer and Activator of Transcription 3-Activation Favouring the Development of Experimental Autoimmune Encephalomyelitis. Front Immunol. 2018;9:571 pubmed publisher
  221. Kling J, Jordan M, Pitt L, Meiners J, Thanh Tran T, Tran L, et al. Temporal Regulation of Natural Killer T Cell Interferon Gamma Responses by β-Catenin-Dependent and -Independent Wnt Signaling. Front Immunol. 2018;9:483 pubmed publisher
  222. Kornberg M, Bhargava P, Kim P, Putluri V, Snowman A, Putluri N, et al. Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. Science. 2018;360:449-453 pubmed publisher
  223. Harker J, Wong K, Dallari S, Bao P, Dolgoter A, Jo Y, et al. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection. J Virol. 2018;92: pubmed publisher
  224. Xiao F, Ai G, Yan W, Wan X, Luo X, Ning Q. Intrahepatic recruitment of cytotoxic NK cells contributes to autoimmune hepatitis progression. Cell Immunol. 2018;327:13-20 pubmed publisher
  225. Mencarelli A, Khameneh H, Fric J, Vacca M, El Daker S, Janela B, et al. Calcineurin-mediated IL-2 production by CD11chighMHCII+ myeloid cells is crucial for intestinal immune homeostasis. Nat Commun. 2018;9:1102 pubmed publisher
  226. Stanko K, Iwert C, Appelt C, Vogt K, Schumann J, Strunk F, et al. CD96 expression determines the inflammatory potential of IL-9-producing Th9 cells. Proc Natl Acad Sci U S A. 2018;115:E2940-E2949 pubmed publisher
  227. Sockolosky J, Trotta E, Parisi G, Picton L, Su L, Le A, et al. Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes. Science. 2018;359:1037-1042 pubmed publisher
  228. Metghalchi S, Vandestienne M, Haddad Y, Esposito B, Dairou J, Tedgui A, et al. Indoleamine 2 3-dioxygenase knockout limits angiotensin II-induced aneurysm in low density lipoprotein receptor-deficient mice fed with high fat diet. PLoS ONE. 2018;13:e0193737 pubmed publisher
  229. Tinoco R, Carrette F, Henriquez M, Fujita Y, Bradley L. Fucosyltransferase Induction during Influenza Virus Infection Is Required for the Generation of Functional Memory CD4+ T Cells. J Immunol. 2018;200:2690-2702 pubmed publisher
  230. Nadafi R, Koning J, Veninga H, Stachtea X, Konijn T, Zwiers A, et al. Dendritic Cell Migration to Skin-Draining Lymph Nodes Is Controlled by Dermatan Sulfate and Determines Adaptive Immunity Magnitude. Front Immunol. 2018;9:206 pubmed publisher
  231. Westhorpe C, Norman M, Hall P, Snelgrove S, Finsterbusch M, Li A, et al. Effector CD4+ T cells recognize intravascular antigen presented by patrolling monocytes. Nat Commun. 2018;9:747 pubmed publisher
  232. Kotov D, Kotov J, Goldberg M, Jenkins M. Many Th Cell Subsets Have Fas Ligand-Dependent Cytotoxic Potential. J Immunol. 2018;200:2004-2012 pubmed publisher
  233. Mathew N, Baumgartner F, Braun L, O Sullivan D, Thomas S, Waterhouse M, et al. Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. Nat Med. 2018;24:282-291 pubmed publisher
  234. Hsieh W, Hsu T, Chang Y, Lai M. IL-6 receptor blockade corrects defects of XIAP-deficient regulatory T cells. Nat Commun. 2018;9:463 pubmed publisher
  235. Wheeler D, Sariol A, Meyerholz D, Perlman S. Microglia are required for protection against lethal coronavirus encephalitis in mice. J Clin Invest. 2018;128:931-943 pubmed publisher
  236. Linehan J, Harrison O, Han S, Byrd A, Vujkovic Cvijin I, Villarino A, et al. Non-classical Immunity Controls Microbiota Impact on Skin Immunity and Tissue Repair. Cell. 2018;172:784-796.e18 pubmed publisher
  237. Lu Y, Kim N, Jiang Y, Zhang H, Zheng D, Zhu F, et al. Cambogin suppresses dextran sulphate sodium-induced colitis by enhancing Treg cell stability and function. Br J Pharmacol. 2018;175:1085-1099 pubmed publisher
  238. Tavazoie M, Pollack I, Tanqueco R, Ostendorf B, Reis B, Gonsalves F, et al. LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer. Cell. 2018;172:825-840.e18 pubmed publisher
  239. Fontaine M, Vogel I, Van Eycke Y, Galuppo A, Ajouaou Y, Decaestecker C, et al. Regulatory T cells constrain the TCR repertoire of antigen-stimulated conventional CD4 T cells. EMBO J. 2018;37:398-412 pubmed publisher
  240. Guimarães G, Gomes M, Campos P, Marinho F, de Assis N, Silveira T, et al. Immunoproteasome Subunits Are Required for CD8+ T Cell Function and Host Resistance to Brucella abortus Infection in Mice. Infect Immun. 2018;86: pubmed publisher
  241. Gaya M, Barral P, Burbage M, Aggarwal S, Montaner B, Warren Navia A, et al. Initiation of Antiviral B Cell Immunity Relies on Innate Signals from Spatially Positioned NKT Cells. Cell. 2018;172:517-533.e20 pubmed publisher
  242. Maseda D, Johnson E, Nyhoff L, Baron B, Kojima F, Wilhelm A, et al. mPGES1-Dependent Prostaglandin E2 (PGE2) Controls Antigen-Specific Th17 and Th1 Responses by Regulating T Autocrine and Paracrine PGE2 Production. J Immunol. 2018;200:725-736 pubmed publisher
  243. Pedros C, Canonigo Balancio A, Kong K, Altman A. Requirement of Treg-intrinsic CTLA4/PKCη signaling pathway for suppressing tumor immunity. JCI Insight. 2017;2: pubmed publisher
  244. Ibrahim M, Scozzi D, Toth K, Ponti D, Kreisel D, Menna C, et al. Naive CD4+ T Cells Carrying a TLR2 Agonist Overcome TGF-β-Mediated Tumor Immune Evasion. J Immunol. 2018;200:847-856 pubmed publisher
  245. Sharma D, Malik A, Guy C, Karki R, Vogel P, Kanneganti T. Pyrin Inflammasome Regulates Tight Junction Integrity to Restrict Colitis and Tumorigenesis. Gastroenterology. 2018;154:948-964.e8 pubmed publisher
  246. Zhang J, Bu X, Wang H, Zhu Y, Geng Y, Nihira N, et al. Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance. Nature. 2018;553:91-95 pubmed publisher
  247. Johnson R, Yu H, Strank N, Karunakaran K, Zhu Y, Brunham R. B Cell Presentation of Chlamydia Antigen Selects Out Protective CD4?13 T Cells: Implications for Genital Tract Tissue-Resident Memory Lymphocyte Clusters. Infect Immun. 2018;86: pubmed publisher
  248. Whitney P, Makhlouf C, MacLeod B, Ma J, Gressier E, Greyer M, et al. Effective Priming of Herpes Simplex Virus-Specific CD8+ T Cells In Vivo Does Not Require Infected Dendritic Cells. J Virol. 2018;92: pubmed publisher
  249. Singh M, Vianden C, Cantwell M, Dai Z, Xiao Z, Sharma M, et al. Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain. Nat Commun. 2017;8:1447 pubmed publisher
  250. Kwak J, Laskowski J, Li H, McSharry M, Sippel T, Bullock B, et al. Complement Activation via a C3a Receptor Pathway Alters CD4+ T Lymphocytes and Mediates Lung Cancer Progression. Cancer Res. 2018;78:143-156 pubmed publisher
  251. Wasiuk A, Testa J, Weidlick J, Sisson C, Vitale L, Widger J, et al. CD27-Mediated Regulatory T Cell Depletion and Effector T Cell Costimulation Both Contribute to Antitumor Efficacy. J Immunol. 2017;199:4110-4123 pubmed publisher
  252. Zhang S, Takaku M, Zou L, Gu A, Chou W, Zhang G, et al. Reversing SKI-SMAD4-mediated suppression is essential for TH17 cell differentiation. Nature. 2017;551:105-109 pubmed publisher
  253. Meng Y, Zhou W, Jin L, Liu L, Chang K, Mei J, et al. RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization. Cell Death Dis. 2017;8:e3105 pubmed publisher
  254. Purvis H, Clarke F, Jordan C, Blanco C, Cornish G, Dai X, et al. Protein tyrosine phosphatase PTPN22 regulates IL-1β dependent Th17 responses by modulating dectin-1 signaling in mice. Eur J Immunol. 2018;48:306-315 pubmed publisher
  255. Bern M, Beckman D, Ebihara T, Taffner S, Poursine Laurent J, White J, et al. Immunoreceptor tyrosine-based inhibitory motif-dependent functions of an MHC class I-specific NK cell receptor. Proc Natl Acad Sci U S A. 2017;114:E8440-E8447 pubmed publisher
  256. Danahy D, Anthony S, Jensen I, Hartwig S, Shan Q, Xue H, et al. Polymicrobial sepsis impairs bystander recruitment of effector cells to infected skin despite optimal sensing and alarming function of skin resident memory CD8 T cells. PLoS Pathog. 2017;13:e1006569 pubmed publisher
  257. Zimmermann J, Durek P, Kuhl A, Schattenberg F, Maschmeyer P, Siracusa F, et al. The intestinal microbiota determines the colitis-inducing potential of T-bet-deficient Th cells in mice. Eur J Immunol. 2018;48:161-167 pubmed publisher
  258. Li B, Wang X, Choi I, Wang Y, Liu S, Pham A, et al. miR-146a modulates autoreactive Th17 cell differentiation and regulates organ-specific autoimmunity. J Clin Invest. 2017;127:3702-3716 pubmed publisher
  259. Giampazolias E, Zunino B, Dhayade S, Bock F, Cloix C, Cao K, et al. Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency. Nat Cell Biol. 2017;19:1116-1129 pubmed publisher
  260. Yi W, Gupta S, Ricker E, Manni M, Jessberger R, Chinenov Y, et al. The mTORC1-4E-BP-eIF4E axis controls de novo Bcl6 protein synthesis in T cells and systemic autoimmunity. Nat Commun. 2017;8:254 pubmed publisher
  261. Li L, Labuda J, Imai D, Griffey S, McSorley S. CCR7 Deficiency Allows Accelerated Clearance of Chlamydia from the Female Reproductive Tract. J Immunol. 2017;199:2547-2554 pubmed publisher
  262. Pirault J, Polyzos K, Petri M, Ketelhuth D, Bäck M, Hansson G. The inflammatory cytokine interferon-gamma inhibits sortilin-1 expression in hepatocytes via the JAK/STAT pathway. Eur J Immunol. 2017;47:1918-1924 pubmed publisher
  263. Strandt H, Pinheiro D, Kaplan D, Wirth D, GRATZ I, Hammerl P, et al. Neoantigen Expression in Steady-State Langerhans Cells Induces CTL Tolerance. J Immunol. 2017;199:1626-1634 pubmed publisher
  264. Billerbeck E, Wolfisberg R, Fahnøe U, Xiao J, Quirk C, Luna J, et al. Mouse models of acute and chronic hepacivirus infection. Science. 2017;357:204-208 pubmed publisher
  265. Lingel H, Wissing J, Arra A, Schanze D, Lienenklaus S, Klawonn F, et al. CTLA-4-mediated posttranslational modifications direct cytotoxic T-lymphocyte differentiation. Cell Death Differ. 2017;24:1739-1749 pubmed publisher
  266. Akiel M, Guo C, Li X, Rajasekaran D, Mendoza R, Robertson C, et al. IGFBP7 Deletion Promotes Hepatocellular Carcinoma. Cancer Res. 2017;77:4014-4025 pubmed publisher
  267. Lupfer C, Stokes K, Kuriakose T, Kanneganti T. Deficiency of the NOD-Like Receptor NLRC5 Results in Decreased CD8+ T Cell Function and Impaired Viral Clearance. J Virol. 2017;91: pubmed publisher
  268. Levine A, Mendoza A, Hemmers S, Moltedo B, Niec R, Schizas M, et al. Stability and function of regulatory T cells expressing the transcription factor T-bet. Nature. 2017;546:421-425 pubmed publisher
  269. Seifert H, Benedek G, Liang J, Nguyen H, Kent G, Vandenbark A, et al. Sex differences in regulatory cells in experimental stroke. Cell Immunol. 2017;318:49-54 pubmed publisher
  270. Hasan Z, Koizumi S, Sasaki D, Yamada H, Arakaki N, Fujihara Y, et al. JunB is essential for IL-23-dependent pathogenicity of Th17 cells. Nat Commun. 2017;8:15628 pubmed publisher
  271. Escribà Garcia L, Alvarez Fernández C, Tellez Gabriel M, Sierra J, Briones J. Dendritic cells combined with tumor cells and ?-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma. J Transl Med. 2017;15:115 pubmed publisher
  272. Li C, Leng Y, Zhao B, Gao C, Du F, Jin N, et al. Human iPSC-MSC-Derived Xenografts Modulate Immune Responses by Inhibiting the Cleavage of Caspases. Stem Cells. 2017;35:1719-1732 pubmed publisher
  273. Miao T, Symonds A, Singh R, Symonds J, Ogbe A, Omodho B, et al. Egr2 and 3 control adaptive immune responses by temporally uncoupling expansion from T cell differentiation. J Exp Med. 2017;214:1787-1808 pubmed publisher
  274. Bagchi S, He Y, Zhang H, Cao L, Van Rhijn I, Moody D, et al. CD1b-autoreactive T cells contribute to hyperlipidemia-induced skin inflammation in mice. J Clin Invest. 2017;127:2339-2352 pubmed publisher
  275. Singh R, Miao T, Symonds A, Omodho B, Li S, Wang P. Egr2 and 3 Inhibit T-bet-Mediated IFN-? Production in T Cells. J Immunol. 2017;198:4394-4402 pubmed publisher
  276. Daley D, Mani V, Mohan N, Akkad N, Pandian G, Savadkar S, et al. NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma. J Exp Med. 2017;214:1711-1724 pubmed publisher
  277. Acharya N, Penukonda S, Shcheglova T, Hagymasi A, Basu S, Srivastava P. Endocannabinoid system acts as a regulator of immune homeostasis in the gut. Proc Natl Acad Sci U S A. 2017;114:5005-5010 pubmed publisher
  278. Garg G, Nikolouli E, Hardtke Wolenski M, Toker A, Ohkura N, Beckstette M, et al. Unique properties of thymic antigen-presenting cells promote epigenetic imprinting of alloantigen-specific regulatory T cells. Oncotarget. 2017;8:35542-35557 pubmed publisher
  279. Chien C, Yu H, Chen S, Chiang B. Characterization of c-Maf+Foxp3- Regulatory T Cells Induced by Repeated Stimulation of Antigen-Presenting B Cells. Sci Rep. 2017;7:46348 pubmed publisher
  280. Fu G, Xu Q, Qiu Y, Jin X, Xu T, Dong S, et al. Suppression of Th17 cell differentiation by misshapen/NIK-related kinase MINK1. J Exp Med. 2017;214:1453-1469 pubmed publisher
  281. Claser C, de Souza J, Thorburn S, Grau G, Riley E, Renia L, et al. Host Resistance to Plasmodium-Induced Acute Immune Pathology Is Regulated by Interleukin-10 Receptor Signaling. Infect Immun. 2017;85: pubmed publisher
  282. Daley D, Mani V, Mohan N, Akkad N, Ochi A, Heindel D, et al. Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance. Nat Med. 2017;23:556-567 pubmed publisher
  283. Shrestha B, You D, Saravia J, Siefker D, Jaligama S, Lee G, et al. IL-4R? on dendritic cells in neonates and Th2 immunopathology in respiratory syncytial virus infection. J Leukoc Biol. 2017;102:153-161 pubmed publisher
  284. Lehmann C, Baranska A, Heidkamp G, Heger L, Neubert K, Lühr J, et al. DC subset-specific induction of T cell responses upon antigen uptake via Fc? receptors in vivo. J Exp Med. 2017;214:1509-1528 pubmed publisher
  285. Lino C, Barros Martins J, Oberdörfer L, Walzer T, Prinz I. Eomes expression reports the progressive differentiation of IFN-?-producing Th1-like ?? T cells. Eur J Immunol. 2017;47:970-981 pubmed publisher
  286. van der Vlugt L, Obieglo K, Ozir Fazalalikhan A, Sparwasser T, Haeberlein S, Smits H. Schistosome-induced pulmonary B cells inhibit allergic airway inflammation and display a reduced Th2-driving function. Int J Parasitol. 2017;47:545-554 pubmed publisher
  287. Bruce D, Stefanski H, Vincent B, Dant T, Reisdorf S, Bommiasamy H, et al. Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease. J Clin Invest. 2017;127:1813-1825 pubmed publisher
  288. Kitada S, Kayama H, Okuzaki D, Koga R, Kobayashi M, Arima Y, et al. BATF2 inhibits immunopathological Th17 responses by suppressing Il23a expression during Trypanosoma cruzi infection. J Exp Med. 2017;214:1313-1331 pubmed publisher
  289. He W, Wang C, Mu R, Liang P, Huang Z, Zhang J, et al. MiR-21 is required for anti-tumor immune response in mice: an implication for its bi-directional roles. Oncogene. 2017;36:4212-4223 pubmed publisher
  290. Liu Z, Ravindranathan R, Kalinski P, Guo Z, Bartlett D. Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy. Nat Commun. 2017;8:14754 pubmed publisher
  291. González Pérez G, Lamousé Smith E. Gastrointestinal Microbiome Dysbiosis in Infant Mice Alters Peripheral CD8+ T Cell Receptor Signaling. Front Immunol. 2017;8:265 pubmed publisher
  292. Wolf Y, Shemer A, Polonsky M, Gross M, Mildner A, Yona S, et al. Autonomous TNF is critical for in vivo monocyte survival in steady state and inflammation. J Exp Med. 2017;214:905-917 pubmed publisher
  293. Klein J, Moses K, Zelinskyy G, Sody S, Buer J, Lang S, et al. Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growth. Nat Commun. 2017;8:14600 pubmed publisher
  294. Bhattacharyya M, Penaloza MacMaster P. T regulatory cells are critical for the maintenance, anamnestic expansion and protection elicited by vaccine-induced CD8 T cells. Immunology. 2017;151:340-348 pubmed publisher
  295. Ansa Addo E, Zhang Y, Yang Y, Hussey G, Howley B, Salem M, et al. Membrane-organizing protein moesin controls Treg differentiation and antitumor immunity via TGF-β signaling. J Clin Invest. 2017;127:1321-1337 pubmed publisher
  296. Barthels C, Ogrinc A, Steyer V, Meier S, Simon F, Wimmer M, et al. CD40-signalling abrogates induction of RORγt+ Treg cells by intestinal CD103+ DCs and causes fatal colitis. Nat Commun. 2017;8:14715 pubmed publisher
  297. Pishesha N, Bilate A, Wibowo M, Huang N, Li Z, Deshycka R, et al. Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease. Proc Natl Acad Sci U S A. 2017;114:3157-3162 pubmed publisher
  298. Stacey M, Clare S, Clement M, Marsden M, Abdul Karim J, Kane L, et al. The antiviral restriction factor IFN-induced transmembrane protein 3 prevents cytokine-driven CMV pathogenesis. J Clin Invest. 2017;127:1463-1474 pubmed publisher
  299. Takahashi T, Asano Y, Sugawara K, Yamashita T, Nakamura K, Saigusa R, et al. Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in scleroderma. J Exp Med. 2017;214:1129-1151 pubmed publisher
  300. Zamarin D, Holmgaard R, Ricca J, Plitt T, Palese P, Sharma P, et al. Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity. Nat Commun. 2017;8:14340 pubmed publisher
  301. Vaitaitis G, Yussman M, Waid D, Wagner D. Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells. PLoS ONE. 2017;12:e0172037 pubmed publisher
  302. Ying W, Wollam J, Ofrecio J, Bandyopadhyay G, El Ouarrat D, Lee Y, et al. Adipose tissue B2 cells promote insulin resistance through leukotriene LTB4/LTB4R1 signaling. J Clin Invest. 2017;127:1019-1030 pubmed publisher
  303. Leech J, Lacey K, Mulcahy M, Medina E, McLoughlin R. IL-10 Plays Opposing Roles during Staphylococcus aureus Systemic and Localized Infections. J Immunol. 2017;198:2352-2365 pubmed publisher
  304. Zhang H, Qi Y, Yuan Y, Cai L, Xu H, Zhang L, et al. Paeoniflorin Ameliorates Experimental Autoimmune Encephalomyelitis via Inhibition of Dendritic Cell Function and Th17 Cell Differentiation. Sci Rep. 2017;7:41887 pubmed publisher
  305. Vander Lugt B, Riddell J, Khan A, Hackney J, Lesch J, DeVoss J, et al. Transcriptional determinants of tolerogenic and immunogenic states during dendritic cell maturation. J Cell Biol. 2017;216:779-792 pubmed publisher
  306. van Nieuwenhuijze A, Dooley J, Humblet Baron S, Sreenivasan J, Koenders M, Schlenner S, et al. Defective germinal center B-cell response and reduced arthritic pathology in microRNA-29a-deficient mice. Cell Mol Life Sci. 2017;74:2095-2106 pubmed publisher
  307. Welsby I, Detienne S, N kuli F, Thomas S, Wouters S, Bechtold V, et al. Lysosome-Dependent Activation of Human Dendritic Cells by the Vaccine Adjuvant QS-21. Front Immunol. 2016;7:663 pubmed publisher
  308. Chamoto K, Chowdhury P, Kumar A, Sonomura K, Matsuda F, Fagarasan S, et al. Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity. Proc Natl Acad Sci U S A. 2017;114:E761-E770 pubmed publisher
  309. Nowyhed H, Chandra S, Kiosses W, Marcovecchio P, Andary F, Zhao M, et al. ATP Binding Cassette Transporter ABCA7 Regulates NKT Cell Development and Function by Controlling CD1d Expression and Lipid Raft Content. Sci Rep. 2017;7:40273 pubmed publisher
  310. Jiang X, Park C, Geddes Sweeney J, Yoo M, Gaide O, Kupper T. Dermal ?? T Cells Do Not Freely Re-Circulate Out of Skin and Produce IL-17 to Promote Neutrophil Infiltration during Primary Contact Hypersensitivity. PLoS ONE. 2017;12:e0169397 pubmed publisher
  311. Okuyama H, Tominaga A, Fukuoka S, Taguchi T, Kusumoto Y, Ono S. Spirulina lipopolysaccharides inhibit tumor growth in a Toll-like receptor 4-dependent manner by altering the cytokine milieu from interleukin-17/interleukin-23 to interferon-?. Oncol Rep. 2017;37:684-694 pubmed publisher
  312. Troegeler A, Mercier I, Cougoule C, Pietretti D, Colom A, Duval C, et al. C-type lectin receptor DCIR modulates immunity to tuberculosis by sustaining type I interferon signaling in dendritic cells. Proc Natl Acad Sci U S A. 2017;114:E540-E549 pubmed publisher
  313. Förster M, Boora R, Petrov J, Fodil N, Albanese I, Kim J, et al. A role for the histone H2A deubiquitinase MYSM1 in maintenance of CD8+ T cells. Immunology. 2017;151:110-121 pubmed publisher
  314. van der Weyden L, Arends M, Campbell A, Bald T, Wardle Jones H, Griggs N, et al. Genome-wide in vivo screen identifies novel host regulators of metastatic colonization. Nature. 2017;541:233-236 pubmed publisher
  315. Xu X, Han L, Zhao G, Xue S, Gao Y, Xiao J, et al. LRCH1 interferes with DOCK8-Cdc42-induced T cell migration and ameliorates experimental autoimmune encephalomyelitis. J Exp Med. 2017;214:209-226 pubmed publisher
  316. Tuncel J, Haag S, Holmdahl R. MHC class II alleles associated with Th1 rather than Th17 type immunity drive the onset of early arthritis in a rat model of rheumatoid arthritis. Eur J Immunol. 2017;47:563-574 pubmed publisher
  317. Hayakawa M, Hayakawa H, Petrova T, Ritprajak P, Sutavani R, Jiménez Andrade G, et al. Loss of Functionally Redundant p38 Isoforms in T Cells Enhances Regulatory T Cell Induction. J Biol Chem. 2017;292:1762-1772 pubmed publisher
  318. Griffiths K, Ahmed M, Das S, Gopal R, Horne W, Connell T, et al. Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy. Nat Commun. 2016;7:13894 pubmed publisher
  319. Li M, Li Z, Yao Y, Jin W, Wood K, Liu Q, et al. Astrocyte-derived interleukin-15 exacerbates ischemic brain injury via propagation of cellular immunity. Proc Natl Acad Sci U S A. 2017;114:E396-E405 pubmed publisher
  320. Beyaz S, Kim J, Pinello L, Xifaras M, Hu Y, Huang J, et al. The histone demethylase UTX regulates the lineage-specific epigenetic program of invariant natural killer T cells. Nat Immunol. 2017;18:184-195 pubmed publisher
  321. Hashimoto Hill S, Friesen L, Kim M, Kim C. Contraction of intestinal effector T cells by retinoic acid-induced purinergic receptor P2X7. Mucosal Immunol. 2017;10:912-923 pubmed publisher
  322. Karki R, Man S, Malireddi R, Kesavardhana S, Zhu Q, Burton A, et al. NLRC3 is an inhibitory sensor of PI3K-mTOR pathways in cancer. Nature. 2016;540:583-587 pubmed publisher
  323. Wei Y, Lu C, Chen J, Cui G, Wang L, Yu T, et al. High salt diet stimulates gut Th17 response and exacerbates TNBS-induced colitis in mice. Oncotarget. 2017;8:70-82 pubmed publisher
  324. Moroishi T, Hayashi T, Pan W, Fujita Y, Holt M, Qin J, et al. The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity. Cell. 2016;167:1525-1539.e17 pubmed publisher
  325. Swanson P, Hart G, Russo M, Nayak D, Yazew T, Pena M, et al. CD8+ T Cells Induce Fatal Brainstem Pathology during Cerebral Malaria via Luminal Antigen-Specific Engagement of Brain Vasculature. PLoS Pathog. 2016;12:e1006022 pubmed publisher
  326. Angela M, Endo Y, Asou H, Yamamoto T, Tumes D, Tokuyama H, et al. Fatty acid metabolic reprogramming via mTOR-mediated inductions of PPAR? directs early activation of T cells. Nat Commun. 2016;7:13683 pubmed publisher
  327. Yokota Nakatsuma A, Ohoka Y, Takeuchi H, Song S, Iwata M. Beta 1-integrin ligation and TLR ligation enhance GM-CSF-induced ALDH1A2 expression in dendritic cells, but differentially regulate their anti-inflammatory properties. Sci Rep. 2016;6:37914 pubmed publisher
  328. Sektioglu I, Carretero R, Bulbuc N, Bald T, Tüting T, Rudensky A, et al. Basophils Promote Tumor Rejection via Chemotaxis and Infiltration of CD8+ T Cells. Cancer Res. 2017;77:291-302 pubmed publisher
  329. Hammer A, Yang G, Friedrich J, Kovacs A, Lee D, Grave K, et al. Role of the receptor Mas in macrophage-mediated inflammation in vivo. Proc Natl Acad Sci U S A. 2016;113:14109-14114 pubmed
  330. Wu X, Wu X, Ma Y, Shao F, Tan Y, Tan T, et al. CUG-binding protein 1 regulates HSC activation and liver fibrogenesis. Nat Commun. 2016;7:13498 pubmed publisher
  331. Escalante N, Lemire P, Cruz Tleugabulova M, Prescott D, Mortha A, Streutker C, et al. The common mouse protozoa Tritrichomonas muris alters mucosal T cell homeostasis and colitis susceptibility. J Exp Med. 2016;213:2841-2850 pubmed
  332. Theisen E, Sauer J. Listeria monocytogenes-Induced Cell Death Inhibits the Generation of Cell-Mediated Immunity. Infect Immun. 2017;85: pubmed publisher
  333. Park K, Mikulski Z, Seo G, Andreyev A, Marcovecchio P, Blatchley A, et al. The transcription factor NR4A3 controls CD103+ dendritic cell migration. J Clin Invest. 2016;126:4603-4615 pubmed publisher
  334. Laurent C, Dorothee G, Hunot S, Martin E, Monnet Y, Duchamp M, et al. Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy. Brain. 2017;140:184-200 pubmed publisher
  335. Hu Y, Kim J, He K, Wan Q, Kim J, Flach M, et al. Scramblase TMEM16F terminates T cell receptor signaling to restrict T cell exhaustion. J Exp Med. 2016;213:2759-2772 pubmed
  336. Shifrin N, Kissiov D, Ardolino M, Joncker N, Raulet D. Differential Role of Hematopoietic and Nonhematopoietic Cell Types in the Regulation of NK Cell Tolerance and Responsiveness. J Immunol. 2016;197:4127-4136 pubmed publisher
  337. Theeß W, Sellau J, Steeg C, Klinke A, Baldus S, Cramer J, et al. Myeloperoxidase Attenuates Pathogen Clearance during Plasmodium yoelii Nonlethal Infection. Infect Immun. 2017;85: pubmed publisher
  338. Starobinets H, Ye J, Broz M, Barry K, Goldsmith J, Marsh T, et al. Antitumor adaptive immunity remains intact following inhibition of autophagy and antimalarial treatment. J Clin Invest. 2016;126:4417-4429 pubmed publisher
  339. Wang L, Ma N, Okamoto S, Amaishi Y, Sato E, Seo N, et al. Efficient tumor regression by adoptively transferred CEA-specific CAR-T cells associated with symptoms of mild cytokine release syndrome. Oncoimmunology. 2016;5:e1211218 pubmed
  340. Alves da Costa T, Di Gangi R, Thomé R, Barreto Felisbino M, Pires Bonfanti A, Lumi Watanabe Ishikawa L, et al. Severe Changes in Thymic Microenvironment in a Chronic Experimental Model of Paracoccidioidomycosis. PLoS ONE. 2016;11:e0164745 pubmed publisher
  341. Georgiev H, Ravens I, Benarafa C, Forster R, Bernhardt G. Distinct gene expression patterns correlate with developmental and functional traits of iNKT subsets. Nat Commun. 2016;7:13116 pubmed publisher
  342. Coursey T, Bian F, Zaheer M, Pflugfelder S, Volpe E, de Paiva C. Age-related spontaneous lacrimal keratoconjunctivitis is accompanied by dysfunctional T regulatory cells. Mucosal Immunol. 2017;10:743-756 pubmed publisher
  343. Gerriets V, Kishton R, Johnson M, Cohen S, Siska P, Nichols A, et al. Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression. Nat Immunol. 2016;17:1459-1466 pubmed publisher
  344. Klotz L, Kuzmanov I, Hucke S, Gross C, Posevitz V, Dreykluft A, et al. B7-H1 shapes T-cell-mediated brain endothelial cell dysfunction and regional encephalitogenicity in spontaneous CNS autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6182-E6191 pubmed
  345. Kishi Y, Kondo T, Xiao S, Yosef N, Gaublomme J, Wu C, et al. Protein C receptor (PROCR) is a negative regulator of Th17 pathogenicity. J Exp Med. 2016;213:2489-2501 pubmed
  346. Hrdinka M, Sudan K, Just S, Drobek A, Stepanek O, Schluter D, et al. Normal Development and Function of T Cells in Proline Rich 7 (Prr7) Deficient Mice. PLoS ONE. 2016;11:e0162863 pubmed publisher
  347. Butcher M, Filipowicz A, Waseem T, McGary C, Crow K, Magilnick N, et al. Atherosclerosis-Driven Treg Plasticity Results in Formation of a Dysfunctional Subset of Plastic IFN?+ Th1/Tregs. Circ Res. 2016;119:1190-1203 pubmed publisher
  348. Huang M, Zhang W, Guo J, Wei X, Phiwpan K, Zhang J, et al. Improved Transgenic Mouse Model for Studying HLA Class I Antigen Presentation. Sci Rep. 2016;6:33612 pubmed publisher
  349. Takeda Y, Azuma M, Matsumoto M, Seya T. Tumoricidal efficacy coincides with CD11c up-regulation in antigen-specific CD8(+) T cells during vaccine immunotherapy. J Exp Clin Cancer Res. 2016;35:143 pubmed publisher
  350. Le Gars M, Haustant M, Klezovich Bénard M, Paget C, Trottein F, Goossens P, et al. Mechanisms of Invariant NKT Cell Activity in Restraining Bacillus anthracis Systemic Dissemination. J Immunol. 2016;197:3225-3232 pubmed
  351. Lewis G, Wehrens E, Labarta Bajo L, Streeck H, Zuniga E. TGF-? receptor maintains CD4 T helper cell identity during chronic viral infections. J Clin Invest. 2016;126:3799-3813 pubmed publisher
  352. Guo H, Cranert S, Lu Y, Zhong M, Zhang S, Chen J, et al. Deletion of Slam locus in mice reveals inhibitory role of SLAM family in NK cell responses regulated by cytokines and LFA-1. J Exp Med. 2016;213:2187-207 pubmed publisher
  353. Bombeiro A, Thomé R, Oliveira Nunes S, Monteiro Moreira B, Verinaud L, Oliveira A. MHC-I and PirB Upregulation in the Central and Peripheral Nervous System following Sciatic Nerve Injury. PLoS ONE. 2016;11:e0161463 pubmed publisher
  354. Yoon J, Leyva Castillo J, Wang G, Galand C, Oyoshi M, Kumar L, et al. IL-23 induced in keratinocytes by endogenous TLR4 ligands polarizes dendritic cells to drive IL-22 responses to skin immunization. J Exp Med. 2016;213:2147-66 pubmed publisher
  355. Papp S, Moderzynski K, Rauch J, Heine L, Kuehl S, Richardt U, et al. Liver Necrosis and Lethal Systemic Inflammation in a Murine Model of Rickettsia typhi Infection: Role of Neutrophils, Macrophages and NK Cells. PLoS Negl Trop Dis. 2016;10:e0004935 pubmed publisher
  356. Wang H, Li M, Hung C, Sinha M, Lee L, Wiesner D, et al. MyD88 Shapes Vaccine Immunity by Extrinsically Regulating Survival of CD4+ T Cells during the Contraction Phase. PLoS Pathog. 2016;12:e1005787 pubmed publisher
  357. Lund A, Wagner M, Fankhauser M, Steinskog E, Broggi M, Spranger S, et al. Lymphatic vessels regulate immune microenvironments in human and murine melanoma. J Clin Invest. 2016;126:3389-402 pubmed publisher
  358. He R, Hou S, Liu C, Zhang A, Bai Q, Han M, et al. Follicular CXCR5- expressing CD8(+) T cells curtail chronic viral infection. Nature. 2016;537:412-428 pubmed publisher
  359. Shi L, Fu T, Guan B, Chen J, Blando J, Allison J, et al. Interdependent IL-7 and IFN-? signalling in T-cell controls tumour eradication by combined ?-CTLA-4+?-PD-1 therapy. Nat Commun. 2016;7:12335 pubmed publisher
  360. Ferreirinha P, Pérez Cabezas B, Correia A, Miyazawa B, França A, Carvalhais V, et al. Poly-N-Acetylglucosamine Production by Staphylococcus epidermidis Cells Increases Their In Vivo Proinflammatory Effect. Infect Immun. 2016;84:2933-43 pubmed publisher
  361. Hwang S, Cobb D, Bhadra R, Youngblood B, Khan I. Blimp-1-mediated CD4 T cell exhaustion causes CD8 T cell dysfunction during chronic toxoplasmosis. J Exp Med. 2016;213:1799-818 pubmed publisher
  362. Liu W, Kang S, Huang Z, Wu C, Jin H, Maine C, et al. A miR-155-Peli1-c-Rel pathway controls the generation and function of T follicular helper cells. J Exp Med. 2016;213:1901-19 pubmed publisher
  363. Kritikou J, Dahlberg C, Baptista M, Wagner A, Banerjee P, Gwalani L, et al. IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo. Sci Rep. 2016;6:30636 pubmed publisher
  364. Chow K, Delconte R, Huntington N, Tarlinton D, Sutherland R, Zhan Y, et al. Innate Allorecognition Results in Rapid Accumulation of Monocyte-Derived Dendritic Cells. J Immunol. 2016;197:2000-8 pubmed publisher
  365. Veinotte L, Gebremeskel S, Johnston B. CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFN? production and tumor control. Oncoimmunology. 2016;5:e1160979 pubmed publisher
  366. Nakhlé J, Pierron V, Bauchet A, Plas P, Thiongane A, Meyer Losic F, et al. Tasquinimod modulates tumor-infiltrating myeloid cells and improves the antitumor immune response to PD-L1 blockade in bladder cancer. Oncoimmunology. 2016;5:e1145333 pubmed publisher
  367. Kang J, Park S, Jeong S, Han M, Lee C, Lee K, et al. Epigenetic regulation of Kcna3-encoding Kv1.3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation. Proc Natl Acad Sci U S A. 2016;113:8771-6 pubmed publisher
  368. Parsa R, Lund H, Georgoudaki A, Zhang X, Ortlieb Guerreiro Cacais A, Grommisch D, et al. BAFF-secreting neutrophils drive plasma cell responses during emergency granulopoiesis. J Exp Med. 2016;213:1537-53 pubmed publisher
  369. Rackov G, Hernandez Jimenez E, Shokri R, Carmona Rodríguez L, Manes S, Alvarez Mon M, et al. p21 mediates macrophage reprogramming through regulation of p50-p50 NF-?B and IFN-?. J Clin Invest. 2016;126:3089-103 pubmed publisher
  370. Wang S, Xia P, Chen Y, Huang G, Xiong Z, Liu J, et al. Natural Killer-like B Cells Prime Innate Lymphocytes against Microbial Infection. Immunity. 2016;45:131-44 pubmed publisher
  371. Keil M, Sonner J, Lanz T, Oezen I, Bunse T, Bittner S, et al. General control non-derepressible 2 (GCN2) in T cells controls disease progression of autoimmune neuroinflammation. J Neuroimmunol. 2016;297:117-26 pubmed publisher
  372. Gorman M, Poddar S, Farzan M, Diamond M. The Interferon-Stimulated Gene Ifitm3 Restricts West Nile Virus Infection and Pathogenesis. J Virol. 2016;90:8212-25 pubmed publisher
  373. Deng Z, Rong Y, Teng Y, Zhuang X, Samykutty A, Mu J, et al. Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis. Oncogene. 2017;36:639-651 pubmed publisher
  374. Ahmad F, Chung Y, Tang Y, Hockman S, Liu S, Khan Y, et al. Phosphodiesterase 3B (PDE3B) regulates NLRP3 inflammasome in adipose tissue. Sci Rep. 2016;6:28056 pubmed publisher
  375. Saha A, O Connor R, Thangavelu G, Lovitch S, Dandamudi D, Wilson C, et al. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. J Clin Invest. 2016;126:2642-60 pubmed publisher
  376. Li C, Zhang Y, Tang L, Zhao H, Gao C, Gao L, et al. Expression of factors involved in the regulation of angiogenesis in the full-term human placenta: Effects of in vitro fertilization. Reprod Biol. 2016;16:104-12 pubmed publisher
  377. Kranz L, Diken M, Haas H, Kreiter S, Loquai C, Reuter K, et al. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature. 2016;534:396-401 pubmed publisher
  378. Sujino T, London M, Hoytema van Konijnenburg D, Rendon T, Buch T, Silva H, et al. Tissue adaptation of regulatory and intraepithelial CD4? T cells controls gut inflammation. Science. 2016;352:1581-6 pubmed publisher
  379. Lim J, Im K, Lee E, Kim N, Nam Y, Jeon Y, et al. Enhanced immunoregulation of mesenchymal stem cells by IL-10-producing type 1 regulatory T cells in collagen-induced arthritis. Sci Rep. 2016;6:26851 pubmed publisher
  380. Chu H, Khosravi A, Kusumawardhani I, Kwon A, Vasconcelos A, Cunha L, et al. Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease. Science. 2016;352:1116-20 pubmed publisher
  381. Yang X, Lin Y, Shi Y, Li B, Liu W, Yin W, et al. FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling. Cancer Res. 2016;76:4124-35 pubmed publisher
  382. Martin S, Brown S, Wick D, Nielsen J, Kroeger D, Twumasi Boateng K, et al. Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines. PLoS ONE. 2016;11:e0155189 pubmed publisher
  383. Patel M, Kim J, Theodros D, Tam A, Velarde E, Kochel C, et al. Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma. J Immunother Cancer. 2016;4:28 pubmed publisher
  384. Göbel K, Pankratz S, Asaridou C, Herrmann A, Bittner S, Merker M, et al. Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells. Nat Commun. 2016;7:11626 pubmed publisher
  385. Brandstätter O, Schanz O, Vorac J, König J, Mori T, Maruyama T, et al. Balancing intestinal and systemic inflammation through cell type-specific expression of the aryl hydrocarbon receptor repressor. Sci Rep. 2016;6:26091 pubmed publisher
  386. Contreras F, Prado C, Gonzalez H, Franz D, Osorio Barrios F, Osorio F, et al. Dopamine Receptor D3 Signaling on CD4+ T Cells Favors Th1- and Th17-Mediated Immunity. J Immunol. 2016;196:4143-9 pubmed publisher
  387. Rao E, Zhang Y, Li Q, Hao J, Egilmez N, Suttles J, et al. AMPK-dependent and independent effects of AICAR and compound C on T-cell responses. Oncotarget. 2016;7:33783-95 pubmed publisher
  388. Cooley L, El Shikh M, Li W, Keim R, Zhang Z, Strauss J, et al. Impaired immunological synapse in sperm associated antigen 6 (SPAG6) deficient mice. Sci Rep. 2016;6:25840 pubmed publisher
  389. Xu A, Bhanumathy K, Wu J, Ye Z, Freywald A, Leary S, et al. IL-15 signaling promotes adoptive effector T-cell survival and memory formation in irradiation-induced lymphopenia. Cell Biosci. 2016;6:30 pubmed publisher
  390. Salao K, Jiang L, Li H, Tsai V, Husaini Y, Curmi P, et al. CLIC1 regulates dendritic cell antigen processing and presentation by modulating phagosome acidification and proteolysis. Biol Open. 2016;5:620-30 pubmed publisher
  391. O Leary C, Riling C, Spruce L, Ding H, Kumar S, Deng G, et al. Ndfip-mediated degradation of Jak1 tunes cytokine signalling to limit expansion of CD4+ effector T cells. Nat Commun. 2016;7:11226 pubmed publisher
  392. Jackson S, Jacobs H, Arkatkar T, Dam E, Scharping N, Kolhatkar N, et al. B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6. J Exp Med. 2016;213:733-50 pubmed publisher
  393. Ufimtseva E. Differences between Mycobacterium-Host Cell Relationships in Latent Tuberculous Infection of Mice Ex Vivo and Mycobacterial Infection of Mouse Cells In Vitro. J Immunol Res. 2016;2016:4325646 pubmed publisher
  394. Holmkvist P, Pool L, Hägerbrand K, Agace W, Rivollier A. IL-18R?-deficient CD4(+) T cells induce intestinal inflammation in the CD45RB(hi) transfer model of colitis despite impaired innate responsiveness. Eur J Immunol. 2016;46:1371-82 pubmed publisher
  395. Arellano B, Hussain R, Miller Little W, Herndon E, Lambracht Washington D, Eagar T, et al. A Single Amino Acid Substitution Prevents Recognition of a Dominant Human Aquaporin-4 Determinant in the Context of HLA-DRB1*03:01 by a Murine TCR. PLoS ONE. 2016;11:e0152720 pubmed publisher
  396. Du C, Duan Y, Wei W, Cai Y, Chai H, Lv J, et al. Kappa opioid receptor activation alleviates experimental autoimmune encephalomyelitis and promotes oligodendrocyte-mediated remyelination. Nat Commun. 2016;7:11120 pubmed publisher
  397. Sim C, Cho Y, Kim B, Baek I, Kim Y, Lee M. 2'-5' Oligoadenylate synthetase-like 1 (OASL1) deficiency in mice promotes an effective anti-tumor immune response by enhancing the production of type I interferons. Cancer Immunol Immunother. 2016;65:663-75 pubmed publisher
  398. Qi X, Gurung P, Malireddi R, Karmaus P, Sharma D, Vogel P, et al. Critical role of caspase-8-mediated IL-1 signaling in promoting Th2 responses during asthma pathogenesis. Mucosal Immunol. 2017;10:128-138 pubmed publisher
  399. Martínez Gómez J, Ong L, Lam J, Binte Aman S, Libau E, Lee P, et al. Maternal Antibody-Mediated Disease Enhancement in Type I Interferon-Deficient Mice Leads to Lethal Disease Associated with Liver Damage. PLoS Negl Trop Dis. 2016;10:e0004536 pubmed publisher
  400. Martin B, Wang C, Zhang C, Kang Z, Gulen M, Zepp J, et al. T cell-intrinsic ASC critically promotes T(H)17-mediated experimental autoimmune encephalomyelitis. Nat Immunol. 2016;17:583-92 pubmed publisher
  401. Apostolidis S, Rodríguez Rodríguez N, Suárez Fueyo A, Dioufa N, Ozcan E, Crispín J, et al. Phosphatase PP2A is requisite for the function of regulatory T cells. Nat Immunol. 2016;17:556-64 pubmed publisher
  402. Tosiek M, Fiette L, El Daker S, Eberl G, Freitas A. IL-15-dependent balance between Foxp3 and RORγt expression impacts inflammatory bowel disease. Nat Commun. 2016;7:10888 pubmed publisher
  403. Flach A, Litke T, Strauss J, Haberl M, Gómez C, Reindl M, et al. Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease. Proc Natl Acad Sci U S A. 2016;113:3323-8 pubmed publisher
  404. Gabunia K, Ellison S, Kelemen S, Kako F, Cornwell W, Rogers T, et al. IL-19 Halts Progression of Atherosclerotic Plaque, Polarizes, and Increases Cholesterol Uptake and Efflux in Macrophages. Am J Pathol. 2016;186:1361-74 pubmed publisher
  405. Woo J, Srikanth S, Nishi M, Ping P, Takeshima H, Gwack Y. Junctophilin-4, a component of the endoplasmic reticulum-plasma membrane junctions, regulates Ca2+ dynamics in T cells. Proc Natl Acad Sci U S A. 2016;113:2762-7 pubmed publisher
  406. Haribhai D, Ziegelbauer J, Jia S, Upchurch K, Yan K, Schmitt E, et al. Alternatively Activated Macrophages Boost Induced Regulatory T and Th17 Cell Responses during Immunotherapy for Colitis. J Immunol. 2016;196:3305-17 pubmed publisher
  407. Kabat A, Harrison O, Riffelmacher T, Moghaddam A, Pearson C, Laing A, et al. The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation. elife. 2016;5:e12444 pubmed publisher
  408. Hu H, Wang H, Xiao Y, Jin J, Chang J, Zou Q, et al. Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination. J Exp Med. 2016;213:399-414 pubmed publisher
  409. Yang L, Cai C, Feng Q, Shi Y, Zuo Q, Yang H, et al. Protective efficacy of the chimeric Staphylococcus aureus vaccine candidate IC in sepsis and pneumonia models. Sci Rep. 2016;6:20929 pubmed publisher
  410. Roffê E, Marino A, Weaver J, Wan W, de Araújo F, Hoffman V, et al. Trypanosoma cruzi Causes Paralyzing Systemic Necrotizing Vasculitis Driven by Pathogen-Specific Type I Immunity in Mice. Infect Immun. 2016;84:1123-1136 pubmed publisher
  411. Smith R, Reyes N, Khandelwal P, Schlereth S, Lee H, Masli S, et al. Secondary allergic T cell responses are regulated by dendritic cell-derived thrombospondin-1 in the setting of allergic eye disease. J Leukoc Biol. 2016;100:371-80 pubmed publisher
  412. Haque M, Song J, Fino K, Sandhu P, Song X, Lei F, et al. Stem cell-derived tissue-associated regulatory T cells ameliorate the development of autoimmunity. Sci Rep. 2016;6:20588 pubmed publisher
  413. Kim K, Kim N, Lee G. Transcription Factors Oct-1 and GATA-3 Cooperatively Regulate Th2 Cytokine Gene Expression via the RHS5 within the Th2 Locus Control Region. PLoS ONE. 2016;11:e0148576 pubmed publisher
  414. Lin C, Bradstreet T, Schwarzkopf E, Jarjour N, Chou C, Archambault A, et al. IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation. J Exp Med. 2016;213:251-71 pubmed publisher
  415. Ying W, Tseng A, Chang R, Wang H, Lin Y, Kanameni S, et al. miR-150 regulates obesity-associated insulin resistance by controlling B cell functions. Sci Rep. 2016;6:20176 pubmed publisher
  416. Bulla R, Tripodo C, Rami D, Ling G, Agostinis C, Guarnotta C, et al. C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation. Nat Commun. 2016;7:10346 pubmed publisher
  417. Polansky J, Bahri R, Divivier M, Duitman E, Vock C, Goyeneche Patino D, et al. High dose CD11c-driven IL15 is sufficient to drive NK cell maturation and anti-tumor activity in a trans-presentation independent manner. Sci Rep. 2016;6:19699 pubmed publisher
  418. Thornton T, Delgado P, Chen L, Salas B, Krementsov D, Fernández M, et al. Inactivation of nuclear GSK3β by Ser(389) phosphorylation promotes lymphocyte fitness during DNA double-strand break response. Nat Commun. 2016;7:10553 pubmed publisher
  419. Maelfait J, Roose K, Vereecke L, Mc Guire C, Sze M, Schuijs M, et al. A20 Deficiency in Lung Epithelial Cells Protects against Influenza A Virus Infection. PLoS Pathog. 2016;12:e1005410 pubmed publisher
  420. Luo C, Liao W, Dadi S, Toure A, Li M. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity. Nature. 2016;529:532-6 pubmed publisher
  421. Kuipers H, Rieck M, Gurevich I, Nagy N, Butte M, Negrin R, et al. Hyaluronan synthesis is necessary for autoreactive T-cell trafficking, activation, and Th1 polarization. Proc Natl Acad Sci U S A. 2016;113:1339-44 pubmed publisher
  422. Lood C, Blanco L, Purmalek M, Carmona Rivera C, De Ravin S, Smith C, et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat Med. 2016;22:146-53 pubmed publisher
  423. Catarinella M, Monestiroli A, Escobar G, Fiocchi A, Tran N, Aiolfi R, et al. IFNα gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment. EMBO Mol Med. 2016;8:155-70 pubmed publisher
  424. Metz P, Lopez J, Kim S, Akimoto K, Ohno S, Chang J. Regulation of Asymmetric Division by Atypical Protein Kinase C Influences Early Specification of CD8(+) T Lymphocyte Fates. Sci Rep. 2016;6:19182 pubmed publisher
  425. Schedel M, Jia Y, Michel S, Takeda K, Domenico J, Joetham A, et al. 1,25D3 prevents CD8(+)Tc2 skewing and asthma development through VDR binding changes to the Cyp11a1 promoter. Nat Commun. 2016;7:10213 pubmed publisher
  426. Goldberg G, Cornish A, Murphy J, Pang E, Lim L, Campbell I, et al. G-CSF and Neutrophils Are Nonredundant Mediators of Murine Experimental Autoimmune Uveoretinitis. Am J Pathol. 2016;186:172-84 pubmed publisher
  427. Vivar O, Masi G, Carpier J, Magalhaes J, Galgano D, Pazour G, et al. IFT20 controls LAT recruitment to the immune synapse and T-cell activation in vivo. Proc Natl Acad Sci U S A. 2016;113:386-91 pubmed publisher
  428. Everts B, Tussiwand R, Dreesen L, Fairfax K, Huang S, Smith A, et al. Migratory CD103+ dendritic cells suppress helminth-driven type 2 immunity through constitutive expression of IL-12. J Exp Med. 2016;213:35-51 pubmed publisher
  429. Sagoo P, Garcia Z, Breart B, Lemaître F, Michonneau D, Albert M, et al. In vivo imaging of inflammasome activation reveals a subcapsular macrophage burst response that mobilizes innate and adaptive immunity. Nat Med. 2016;22:64-71 pubmed publisher
  430. Ren Y, Wang N, Hu W, Zhang X, Xu J, Wan Y. Successive site translocating inoculation potentiates DNA/recombinant vaccinia vaccination. Sci Rep. 2015;5:18099 pubmed publisher
  431. Traka M, Podojil J, McCarthy D, Miller S, Popko B. Oligodendrocyte death results in immune-mediated CNS demyelination. Nat Neurosci. 2016;19:65-74 pubmed publisher
  432. Moretto M, Khan I. IL-21 Is Important for Induction of KLRG1+ Effector CD8 T Cells during Acute Intracellular Infection. J Immunol. 2016;196:375-84 pubmed publisher
  433. Okada K, Sato S, Sato A, Mandelboim O, Yamasoba T, Kiyono H. Identification and Analysis of Natural Killer Cells in Murine Nasal Passages. PLoS ONE. 2015;10:e0142920 pubmed publisher
  434. Zhang Z, Wu N, Lu Y, Davidson D, Colonna M, Veillette A. DNAM-1 controls NK cell activation via an ITT-like motif. J Exp Med. 2015;212:2165-82 pubmed publisher
  435. Fontinha D, Lopes F, Marques S, Alenquer M, Simas J. Murid Gammaherpesvirus Latency-Associated Protein M2 Promotes the Formation of Conjugates between Transformed B Lymphoma Cells and T Helper Cells. PLoS ONE. 2015;10:e0142540 pubmed publisher
  436. Sekiya T, Yoshimura A. In Vitro Th Differentiation Protocol. Methods Mol Biol. 2016;1344:183-91 pubmed publisher
  437. Verma S, Weiskopf D, Gupta A, McDonald B, Peters B, Sette A, et al. Cytomegalovirus-Specific CD4 T Cells Are Cytolytic and Mediate Vaccine Protection. J Virol. 2016;90:650-8 pubmed publisher
  438. Alam M, Gaida M, Bergmann F, Lasitschka F, Giese T, Giese N, et al. Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression. Nat Med. 2015;21:1337-43 pubmed publisher
  439. Blazevic V, Malm M, Arinobu D, Lappalainen S, Vesikari T. Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine. Hum Vaccin Immunother. 2016;12:740-8 pubmed publisher
  440. Black L, Srivastava R, Schoeb T, Moore R, Barnes S, KABAROWSKI J. Cholesterol-Independent Suppression of Lymphocyte Activation, Autoimmunity, and Glomerulonephritis by Apolipoprotein A-I in Normocholesterolemic Lupus-Prone Mice. J Immunol. 2015;195:4685-98 pubmed publisher
  441. Wu V, Smith A, You H, Nguyen T, Ferguson R, Taylor M, et al. Plasmacytoid dendritic cell-derived IFNα modulates Th17 differentiation during early Bordetella pertussis infection in mice. Mucosal Immunol. 2016;9:777-86 pubmed publisher
  442. Kurtulus S, Sakuishi K, Ngiow S, Joller N, Tan D, Teng M, et al. TIGIT predominantly regulates the immune response via regulatory T cells. J Clin Invest. 2015;125:4053-62 pubmed publisher
  443. Manlove L, Berquam Vrieze K, Pauken K, Williams R, Jenkins M, Farrar M. Adaptive Immunity to Leukemia Is Inhibited by Cross-Reactive Induced Regulatory T Cells. J Immunol. 2015;195:4028-37 pubmed publisher
  444. Xiao X, Shi X, Fan Y, Zhang X, Wu M, Lan P, et al. GITR subverts Foxp3(+) Tregs to boost Th9 immunity through regulation of histone acetylation. Nat Commun. 2015;6:8266 pubmed publisher
  445. Joly A, Deepti A, Seignez A, Goloudina A, Hebrard S, Schmitt E, et al. The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development. Oncogene. 2016;35:2842-51 pubmed publisher
  446. Poncini C, Ilarregui J, Batalla E, Engels S, Cerliani J, Cucher M, et al. Trypanosoma cruzi Infection Imparts a Regulatory Program in Dendritic Cells and T Cells via Galectin-1-Dependent Mechanisms. J Immunol. 2015;195:3311-24 pubmed publisher
  447. Wang X, Huang Z, Chen Y, Lu X, Zhu P, Wen K, et al. A Multiple Antigenic Peptide Mimicking Peptidoglycan Induced T Cell Responses to Protect Mice from Systemic Infection with Staphylococcus aureus. PLoS ONE. 2015;10:e0136888 pubmed publisher
  448. Pearce V, Bouabe H, MacQueen A, Carbonaro V, Okkenhaug K. PI3Kδ Regulates the Magnitude of CD8+ T Cell Responses after Challenge with Listeria monocytogenes. J Immunol. 2015;195:3206-17 pubmed publisher
  449. Rapovy S, Zhao J, Bricker R, Schmidt S, Setchell K, Qualls J. Differential Requirements for L-Citrulline and L-Arginine during Antimycobacterial Macrophage Activity. J Immunol. 2015;195:3293-300 pubmed publisher
  450. Smith K, Filbey K, Reynolds L, Hewitson J, Harcus Y, Boon L, et al. Low-level regulatory T-cell activity is essential for functional type-2 effector immunity to expel gastrointestinal helminths. Mucosal Immunol. 2016;9:428-43 pubmed publisher
  451. Ampem G, Azegrouz H, Bacsadi Ã, Balogh L, Schmidt S, Thuróczy J, et al. Adipose tissue macrophages in non-rodent mammals: a comparative study. Cell Tissue Res. 2016;363:461-78 pubmed publisher
  452. Arbelaez C, Glatigny S, Duhen R, Eberl G, Oukka M, Bettelli E. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis. J Immunol. 2015;195:1974-83 pubmed publisher
  453. Littwitz Salomon E, Akhmetzyanova I, Vallet C, Francois S, Dittmer U, Gibbert K. Activated regulatory T cells suppress effector NK cell responses by an IL-2-mediated mechanism during an acute retroviral infection. Retrovirology. 2015;12:66 pubmed publisher
  454. Ngiow S, Young A, Jacquelot N, Yamazaki T, Enot D, Zitvogel L, et al. A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1. Cancer Res. 2015;75:3800-11 pubmed publisher
  455. Redpath S, Van Der Werf N, MacDonald A, Maizels R, Taylor M. Schistosoma mansoni Larvae Do Not Expand or Activate Foxp3+ Regulatory T Cells during Their Migratory Phase. Infect Immun. 2015;83:3881-9 pubmed publisher
  456. Garcia P, Apolinário L, Böckelmann P, da Silva Nunes I, Duran N, Fávaro W. Alterations in ubiquitin ligase Siah-2 and its corepressor N-CoR after P-MAPA immunotherapy and anti-androgen therapy: new therapeutic opportunities for non-muscle invasive bladder cancer. Int J Clin Exp Pathol. 2015;8:4427-43 pubmed
  457. Vogel A, Brown D. Single-Dose CpG Immunization Protects Against a Heterosubtypic Challenge and Generates Antigen-Specific Memory T Cells. Front Immunol. 2015;6:327 pubmed publisher
  458. Abt M, Lewis B, Caballero S, Xiong H, Carter R, Sušac B, et al. Innate Immune Defenses Mediated by Two ILC Subsets Are Critical for Protection against Acute Clostridium difficile Infection. Cell Host Microbe. 2015;18:27-37 pubmed publisher
  459. Puntambekar S, Hinton D, Yin X, Savarin C, Bergmann C, Trapp B, et al. Interleukin-10 is a critical regulator of white matter lesion containment following viral induced demyelination. Glia. 2015;63:2106-2120 pubmed publisher
  460. McWilliams I, Rajbhandari R, Nozell S, BENVENISTE E, Harrington L. STAT4 controls GM-CSF production by both Th1 and Th17 cells during EAE. J Neuroinflammation. 2015;12:128 pubmed publisher
  461. Mikucki M, Fisher D, Matsuzaki J, Skitzki J, Gaulin N, Muhitch J, et al. Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints. Nat Commun. 2015;6:7458 pubmed publisher
  462. Ackerknecht M, Hauser M, Legler D, Stein J. In vivo TCR Signaling in CD4(+) T Cells Imprints a Cell-Intrinsic, Transient Low-Motility Pattern Independent of Chemokine Receptor Expression Levels, or Microtubular Network, Integrin, and Protein Kinase C Activity. Front Immunol. 2015;6:297 pubmed publisher
  463. Evonuk K, Baker B, Doyle R, Moseley C, Sestero C, Johnston B, et al. Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination. J Immunol. 2015;195:450-463 pubmed publisher
  464. Deppisch N, Ruf P, Eissler N, Neff F, Buhmann R, Lindhofer H, et al. Efficacy and Tolerability of a GD2-Directed Trifunctional Bispecific Antibody in a Preclinical Model: Subcutaneous Administration Is Superior to Intravenous Delivery. Mol Cancer Ther. 2015;14:1877-83 pubmed publisher
  465. Deberge M, Ely K, Wright P, Thorp E, Enelow R. Shedding of TNF receptor 2 by effector CD8⁺ T cells by ADAM17 is important for regulating TNF-α availability during influenza infection. J Leukoc Biol. 2015;98:423-34 pubmed publisher
  466. Chen H, Sun J, Huang Z, Hou H, Arcilla M, Rakhilin N, et al. Comprehensive models of human primary and metastatic colorectal tumors in immunodeficient and immunocompetent mice by chemokine targeting. Nat Biotechnol. 2015;33:656-60 pubmed publisher
  467. Peske J, Thompson E, Gemta L, Baylis R, Fu Y, Engelhard V. Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity. Nat Commun. 2015;6:7114 pubmed publisher
  468. Liechtenstein T, Perez Janices N, Blanco Luquin I, Goyvaerts C, Schwarze J, Dufait I, et al. Anti-melanoma vaccines engineered to simultaneously modulate cytokine priming and silence PD-L1 characterized using ex vivo myeloid-derived suppressor cells as a readout of therapeutic efficacy. Oncoimmunology. 2014;3:e945378 pubmed
  469. Vuillefroy de Silly R, Ducimetière L, Yacoub Maroun C, Dietrich P, Derouazi M, Walker P. Phenotypic switch of CD8(+) T cells reactivated under hypoxia toward IL-10 secreting, poorly proliferative effector cells. Eur J Immunol. 2015;45:2263-75 pubmed publisher
  470. Moguche A, Shafiani S, Clemons C, Larson R, Dinh C, Higdon L, et al. ICOS and Bcl6-dependent pathways maintain a CD4 T cell population with memory-like properties during tuberculosis. J Exp Med. 2015;212:715-28 pubmed publisher
  471. Becker P, Hervouet C, Mason G, KWON S, Klavinskis L. Skin vaccination with live virus vectored microneedle arrays induce long lived CD8(+) T cell memory. Vaccine. 2015;33:4691-8 pubmed publisher
  472. Dahlgren M, Gustafsson Hedberg T, Livingston M, Cucak H, Alsén S, Yrlid U, et al. T follicular helper, but not Th1, cell differentiation in the absence of conventional dendritic cells. J Immunol. 2015;194:5187-99 pubmed publisher
  473. Olguín J, Fernández J, Salinas N, Juárez I, Rodriguez Sosa M, Campuzano J, et al. Adoptive transfer of CD4(+)Foxp3(+) regulatory T cells to C57BL/6J mice during acute infection with Toxoplasma gondii down modulates the exacerbated Th1 immune response. Microbes Infect. 2015;17:586-95 pubmed publisher
  474. Najm F, Madhavan M, Zaremba A, Shick E, Karl R, Factor D, et al. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo. Nature. 2015;522:216-20 pubmed publisher
  475. Kim Y, Lim H, Jung H, Wetsel R, Chung Y. Regulation of autoimmune germinal center reactions in lupus-prone BXD2 mice by follicular helper T cells. PLoS ONE. 2015;10:e0120294 pubmed publisher
  476. Wiesner D, Specht C, Lee C, Smith K, Mukaremera L, Lee S, et al. Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection. PLoS Pathog. 2015;11:e1004701 pubmed publisher
  477. Rao E, Zhang Y, Zhu G, Hao J, Persson X, Egilmez N, et al. Deficiency of AMPK in CD8+ T cells suppresses their anti-tumor function by inducing protein phosphatase-mediated cell death. Oncotarget. 2015;6:7944-58 pubmed
  478. Sakala I, Chaudhri G, Eldi P, Buller R, Karupiah G. Deficiency in Th2 cytokine responses exacerbate orthopoxvirus infection. PLoS ONE. 2015;10:e0118685 pubmed publisher
  479. Hsiao H, Hsu T, Liu W, Hsieh W, Chou T, Wu Y, et al. Deltex1 antagonizes HIF-1α and sustains the stability of regulatory T cells in vivo. Nat Commun. 2015;6:6353 pubmed publisher
  480. Zhan R, Han Q, Zhang C, Tian Z, Zhang J. Toll-Like receptor 2 (TLR2) and TLR9 play opposing roles in host innate immunity against Salmonella enterica serovar Typhimurium infection. Infect Immun. 2015;83:1641-9 pubmed publisher
  481. Sell S, Dietz M, Schneider A, Holtappels R, Mach M, Winkler T. Control of murine cytomegalovirus infection by γδ T cells. PLoS Pathog. 2015;11:e1004481 pubmed publisher
  482. Stack G, Jones E, Marsden M, Stacey M, Snelgrove R, Lacaze P, et al. CD200 receptor restriction of myeloid cell responses antagonizes antiviral immunity and facilitates cytomegalovirus persistence within mucosal tissue. PLoS Pathog. 2015;11:e1004641 pubmed publisher
  483. Huang Y, Clarke F, Karimi M, Roy N, Williamson E, Okumura M, et al. CRK proteins selectively regulate T cell migration into inflamed tissues. J Clin Invest. 2015;125:1019-32 pubmed publisher
  484. Fisher P, Zhao Y, Rico M, Massicotte V, WADE C, Litvin J, et al. Increased CCN2, substance P and tissue fibrosis are associated with sensorimotor declines in a rat model of repetitive overuse injury. J Cell Commun Signal. 2015;9:37-54 pubmed publisher
  485. Zhang Y, Wu B, Metelli A, Thaxton J, Hong F, Rachidi S, et al. GP96 is a GARP chaperone and controls regulatory T cell functions. J Clin Invest. 2015;125:859-69 pubmed publisher
  486. Cabrera Perez J, Condotta S, James B, Kashem S, Brincks E, Rai D, et al. Alterations in antigen-specific naive CD4 T cell precursors after sepsis impairs their responsiveness to pathogen challenge. J Immunol. 2015;194:1609-20 pubmed publisher
  487. Li J, Liu D, Mou Z, Ihedioha O, Blanchard A, Jia P, et al. Deficiency of prolactin-inducible protein leads to impaired Th1 immune response and susceptibility to Leishmania major in mice. Eur J Immunol. 2015;45:1082-91 pubmed publisher
  488. Glatigny S, Duhen R, Arbelaez C, Kumari S, Bettelli E. Integrin alpha L controls the homing of regulatory T cells during CNS autoimmunity in the absence of integrin alpha 4. Sci Rep. 2015;5:7834 pubmed publisher
  489. Clouthier D, Zhou A, Wortzman M, Luft O, Levy G, Watts T. GITR intrinsically sustains early type 1 and late follicular helper CD4 T cell accumulation to control a chronic viral infection. PLoS Pathog. 2015;11:e1004517 pubmed publisher
  490. Spada R, Rojas J, Pérez Yagüe S, Mulens V, Cannata Ortiz P, Bragado R, et al. NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery. J Leukoc Biol. 2015;97:583-98 pubmed publisher
  491. Hannani D, Vétizou M, Enot D, Rusakiewicz S, Chaput N, Klatzmann D, et al. Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25. Cell Res. 2015;25:208-24 pubmed publisher
  492. Shindo Y, Unsinger J, Burnham C, Green J, Hotchkiss R. Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression. Shock. 2015;43:334-43 pubmed publisher
  493. Shrestha S, Yang K, Guy C, Vogel P, Neale G, Chi H. Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses. Nat Immunol. 2015;16:178-87 pubmed publisher
  494. Hu Z, Molloy M, Usherwood E. CD4(+) T-cell dependence of primary CD8(+) T-cell response against vaccinia virus depends upon route of infection and viral dose. Cell Mol Immunol. 2016;13:82-93 pubmed publisher
  495. Yuan X, Dee M, Altman N, Malek T. IL-2Rβ-dependent signaling and CD103 functionally cooperate to maintain tolerance in the gut mucosa. J Immunol. 2015;194:1334-46 pubmed publisher
  496. Ikeda T, Hirata S, Takamatsu K, Haruta M, Tsukamoto H, Ito T, et al. Suppression of Th1-mediated autoimmunity by embryonic stem cell-derived dendritic cells. PLoS ONE. 2014;9:e115198 pubmed publisher
  497. Agarwal P, Rashighi M, Essien K, Richmond J, Randall L, Pazoki Toroudi H, et al. Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo. J Invest Dermatol. 2015;135:1080-1088 pubmed publisher
  498. White C, Villarino N, Sloan S, Ganusov V, Schmidt N. Plasmodium suppresses expansion of T cell responses to heterologous infections. J Immunol. 2015;194:697-708 pubmed publisher
  499. Stoycheva D, Deiser K, Stärck L, Nishanth G, Schlüter D, Uckert W, et al. IFN-γ regulates CD8+ memory T cell differentiation and survival in response to weak, but not strong, TCR signals. J Immunol. 2015;194:553-9 pubmed publisher
  500. Rutz S, Kayagaki N, Phung Q, Eidenschenk C, Noubade R, Wang X, et al. Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells. Nature. 2015;518:417-21 pubmed publisher
  501. Peters A, Burkett P, Sobel R, Buckley C, Watson S, Bettelli E, et al. Podoplanin negatively regulates CD4+ effector T cell responses. J Clin Invest. 2015;125:129-40 pubmed publisher
  502. Baptista A, Roozendaal R, Reijmers R, Koning J, Unger W, Greuter M, et al. Lymph node stromal cells constrain immunity via MHC class II self-antigen presentation. elife. 2014;3: pubmed publisher
  503. Uchiyama M, Jin X, Yin E, Shimokawa T, Niimi M. Treadmill exercise induces murine cardiac allograft survival and generates regulatory T cell. Transpl Int. 2015;28:352-62 pubmed publisher
  504. Mehta P, Nuotio Antar A, Smith C. γδ T cells promote inflammation and insulin resistance during high fat diet-induced obesity in mice. J Leukoc Biol. 2015;97:121-34 pubmed publisher
  505. Mouchacca P, Chasson L, Frick M, Foray C, Schmitt Verhulst A, Boyer C. Visualization of granzyme B-expressing CD8 T cells during primary and secondary immune responses to Listeria monocytogenes. Immunology. 2015;145:24-33 pubmed publisher
  506. Simpson L, Patel S, Bhakta N, Choy D, Brightbill H, Ren X, et al. A microRNA upregulated in asthma airway T cells promotes TH2 cytokine production. Nat Immunol. 2014;15:1162-70 pubmed publisher
  507. Wang X, Sumida H, Cyster J. GPR18 is required for a normal CD8αα intestinal intraepithelial lymphocyte compartment. J Exp Med. 2014;211:2351-9 pubmed publisher
  508. Backer R, Helbig C, Gentek R, Kent A, Laidlaw B, Dominguez C, et al. A central role for Notch in effector CD8(+) T cell differentiation. Nat Immunol. 2014;15:1143-51 pubmed publisher
  509. Edwards C, Best S, Gun S, Claser C, James K, de Oca M, et al. Spatiotemporal requirements for IRF7 in mediating type I IFN-dependent susceptibility to blood-stage Plasmodium infection. Eur J Immunol. 2015;45:130-41 pubmed publisher
  510. McDonnell A, Lesterhuis W, Khong A, Nowak A, Lake R, Currie A, et al. Tumor-infiltrating dendritic cells exhibit defective cross-presentation of tumor antigens, but is reversed by chemotherapy. Eur J Immunol. 2015;45:49-59 pubmed publisher
  511. Tassi I, Claudio E, Wang H, Tang W, Ha H, Saret S, et al. The NF-κB regulator Bcl-3 governs dendritic cell antigen presentation functions in adaptive immunity. J Immunol. 2014;193:4303-11 pubmed publisher
  512. Bertin S, Lozano Ruiz B, Bachiller V, García Martínez I, Herdman S, Zapater P, et al. Dual-specificity phosphatase 6 regulates CD4+ T-cell functions and restrains spontaneous colitis in IL-10-deficient mice. Mucosal Immunol. 2015;8:505-15 pubmed publisher
  513. Carty S, Koretzky G, Jordan M. Interleukin-4 regulates eomesodermin in CD8+ T cell development and differentiation. PLoS ONE. 2014;9:e106659 pubmed publisher
  514. Chatterjee S, Thyagarajan K, Kesarwani P, Song J, Soloshchenko M, Fu J, et al. Reducing CD73 expression by IL1?-Programmed Th17 cells improves immunotherapeutic control of tumors. Cancer Res. 2014;74:6048-59 pubmed publisher
  515. Wei H, Nash W, Makrigiannis A, Brown M. Impaired NK-cell education diminishes resistance to murine CMV infection. Eur J Immunol. 2014;44:3273-82 pubmed publisher
  516. Burton B, Britton G, Fang H, Verhagen J, Smithers B, Sabatos Peyton C, et al. Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy. Nat Commun. 2014;5:4741 pubmed publisher
  517. Kobayashi T, Hamaguchi Y, Hasegawa M, Fujimoto M, Takehara K, Matsushita T. B cells promote tumor immunity against B16F10 melanoma. Am J Pathol. 2014;184:3120-9 pubmed publisher
  518. Dai M, Yip Y, Hellstrom I, Hellstrom K. Curing mice with large tumors by locally delivering combinations of immunomodulatory antibodies. Clin Cancer Res. 2015;21:1127-38 pubmed publisher
  519. Wu C, He S, Peng Y, Kushwaha K, Lin J, Dong J, et al. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice. J Mol Cell Cardiol. 2014;76:33-45 pubmed publisher
  520. Ishihara M, Seo N, Mitsui J, Muraoka D, Tanaka M, Mineno J, et al. Systemic CD8+ T cell-mediated tumoricidal effects by intratumoral treatment of oncolytic herpes simplex virus with the agonistic monoclonal antibody for murine glucocorticoid-induced tumor necrosis factor receptor. PLoS ONE. 2014;9:e104669 pubmed publisher
  521. Chuang H, Sheu W, Lin Y, Tsai C, Yang C, Cheng Y, et al. HGK/MAP4K4 deficiency induces TRAF2 stabilization and Th17 differentiation leading to insulin resistance. Nat Commun. 2014;5:4602 pubmed publisher
  522. Berod L, Stüve P, Varela F, Behrends J, Swallow M, Kruse F, et al. Rapid rebound of the Treg compartment in DEREG mice limits the impact of Treg depletion on mycobacterial burden, but prevents autoimmunity. PLoS ONE. 2014;9:e102804 pubmed publisher
  523. Boding L, Hansen A, Meroni G, Johansen B, Braunstein T, Bonefeld C, et al. Midline 1 directs lytic granule exocytosis and cytotoxicity of mouse killer T cells. Eur J Immunol. 2014;44:3109-18 pubmed publisher
  524. Longman R, Diehl G, Victorio D, Huh J, Galan C, Miraldi E, et al. CX?CR1? mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J Exp Med. 2014;211:1571-83 pubmed publisher
  525. Hosking M, Flynn C, Whitton J. Antigen-specific naive CD8+ T cells produce a single pulse of IFN-γ in vivo within hours of infection, but without antiviral effect. J Immunol. 2014;193:1873-85 pubmed publisher
  526. Boyoglu Barnum S, Chirkova T, Todd S, Barnum T, Gaston K, Jorquera P, et al. Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice. J Virol. 2014;88:10569-83 pubmed publisher
  527. Madireddi S, Eun S, Lee S, Nemčovičová I, Mehta A, Zajonc D, et al. Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies. J Exp Med. 2014;211:1433-48 pubmed publisher
  528. Friedman R, Lindsay R, Lilly J, Nguyen V, Sorensen C, Jacobelli J, et al. An evolving autoimmune microenvironment regulates the quality of effector T cell restimulation and function. Proc Natl Acad Sci U S A. 2014;111:9223-8 pubmed publisher
  529. Gerlach K, Hwang Y, Nikolaev A, Atreya R, Dornhoff H, Steiner S, et al. TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells. Nat Immunol. 2014;15:676-86 pubmed publisher
  530. Geem D, Medina Contreras O, McBride M, Newberry R, Koni P, Denning T. Specific microbiota-induced intestinal Th17 differentiation requires MHC class II but not GALT and mesenteric lymph nodes. J Immunol. 2014;193:431-8 pubmed publisher
  531. Alam M, Gaida M, Ogawa Y, Kolios A, Lasitschka F, Ashwell J. Counter-regulation of T cell effector function by differentially activated p38. J Exp Med. 2014;211:1257-70 pubmed publisher
  532. Smith N, Wissink E, Wang J, Pinello J, Davenport M, Grimson A, et al. Rapid proliferation and differentiation impairs the development of memory CD8+ T cells in early life. J Immunol. 2014;193:177-84 pubmed publisher
  533. Bedke T, Iannitti R, De Luca A, Giovannini G, Fallarino F, Berges C, et al. Distinct and complementary roles for Aspergillus fumigatus-specific Tr1 and Foxp3+ regulatory T cells in humans and mice. Immunol Cell Biol. 2014;92:659-70 pubmed publisher
  534. Zhang Y, Mena P, Romanov G, Bliska J. Effector CD8+ T cells are generated in response to an immunodominant epitope in type III effector YopE during primary Yersinia pseudotuberculosis infection. Infect Immun. 2014;82:3033-44 pubmed publisher
  535. Smolarchuk C, Zhu L, Chan W, Anderson C. T cells generated in the absence of a thoracic thymus fail to establish homeostasis. Eur J Immunol. 2014;44:2263-73 pubmed publisher
  536. Pick J, Arra A, Lingel H, Hegel J, Huber M, Nishanth G, et al. CTLA-4 (CD152) enhances the Tc17 differentiation program. Eur J Immunol. 2014;44:2139-52 pubmed publisher
  537. Cochain C, Chaudhari S, Koch M, Wiendl H, Eckstein H, Zernecke A. Programmed cell death-1 deficiency exacerbates T cell activation and atherogenesis despite expansion of regulatory T cells in atherosclerosis-prone mice. PLoS ONE. 2014;9:e93280 pubmed publisher
  538. Ntranos A, Hall O, Robinson D, Grishkan I, Schott J, Tosi D, et al. FTY720 impairs CD8 T-cell function independently of the sphingosine-1-phosphate pathway. J Neuroimmunol. 2014;270:13-21 pubmed publisher
  539. Koga T, Hedrich C, Mizui M, Yoshida N, Otomo K, Lieberman L, et al. CaMK4-dependent activation of AKT/mTOR and CREM-? underlies autoimmunity-associated Th17 imbalance. J Clin Invest. 2014;124:2234-45 pubmed publisher
  540. Takei S, Omoto C, Kitagawa K, Morishita N, Katayama T, Shigemura K, et al. Oral administration of genetically modified Bifidobacterium displaying HCV-NS3 multi-epitope fusion protein could induce an HCV-NS3-specific systemic immune response in mice. Vaccine. 2014;32:3066-74 pubmed publisher
  541. Samuelson E, Laird R, Papillion A, Tatum A, Princiotta M, Hayes S. Reduced B lymphoid kinase (Blk) expression enhances proinflammatory cytokine production and induces nephrosis in C57BL/6-lpr/lpr mice. PLoS ONE. 2014;9:e92054 pubmed publisher
  542. Yan J, Villarreal D, Racine T, Chu J, Walters J, Morrow M, et al. Protective immunity to H7N9 influenza viruses elicited by synthetic DNA vaccine. Vaccine. 2014;32:2833-42 pubmed publisher
  543. Martins K, Steffens J, Van Tongeren S, Wells J, Bergeron A, Dickson S, et al. Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation. PLoS ONE. 2014;9:e89735 pubmed publisher
  544. Lee J, Walsh M, Hoehn K, James D, Wherry E, Choi Y. Regulator of fatty acid metabolism, acetyl coenzyme a carboxylase 1, controls T cell immunity. J Immunol. 2014;192:3190-9 pubmed publisher
  545. Medina Armenteros Y, Farinha Arcieri L, Braga C, Carromeu C, Tamura R, Ventura A. Mapping of CD8 T cell epitopes in human respiratory syncytial virus L protein. Intervirology. 2014;57:55-64 pubmed publisher
  546. Jayaraman A, Jackson D, Message S, Pearson R, Aniscenko J, Caramori G, et al. IL-15 complexes induce NK- and T-cell responses independent of type I IFN signaling during rhinovirus infection. Mucosal Immunol. 2014;7:1151-64 pubmed publisher
  547. Misumi I, Whitmire J. B cell depletion curtails CD4+ T cell memory and reduces protection against disseminating virus infection. J Immunol. 2014;192:1597-608 pubmed publisher
  548. Xia S, Wei J, Wang J, Sun H, Zheng W, Li Y, et al. A requirement of dendritic cell-derived interleukin-27 for the tumor infiltration of regulatory T cells. J Leukoc Biol. 2014;95:733-742 pubmed
  549. Brenndörfer E, Brass A, Karthe J, Ahlen G, Bode J, Sallberg M. Cleavage of the T cell protein tyrosine phosphatase by the hepatitis C virus nonstructural 3/4A protease induces a Th1 to Th2 shift reversible by ribavirin therapy. J Immunol. 2014;192:1671-80 pubmed publisher
  550. Kim E, Gasper D, Lee S, Plisch E, Svaren J, Suresh M. Bach2 regulates homeostasis of Foxp3+ regulatory T cells and protects against fatal lung disease in mice. J Immunol. 2014;192:985-95 pubmed publisher
  551. Chatterjee S, Eby J, Al Khami A, Soloshchenko M, Kang H, Kaur N, et al. A quantitative increase in regulatory T cells controls development of vitiligo. J Invest Dermatol. 2014;134:1285-1294 pubmed publisher
  552. McGuire D, Rowse A, Li H, Peng B, Sestero C, Cashman K, et al. CD5 enhances Th17-cell differentiation by regulating IFN-? response and ROR?t localization. Eur J Immunol. 2014;44:1137-42 pubmed publisher
  553. Kim H, Lee H, Chang Y, Pichavant M, Shore S, Fitzgerald K, et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med. 2014;20:54-61 pubmed publisher
  554. Chan I, Jain R, Tessmer M, Gorman D, Mangadu R, Sathe M, et al. Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells. Mucosal Immunol. 2014;7:842-56 pubmed publisher
  555. Lee P, Puppi M, Schluns K, Yu Lee L, Dong C, Lacorazza H. The transcription factor E74-like factor 4 suppresses differentiation of proliferating CD4+ T cells to the Th17 lineage. J Immunol. 2014;192:178-88 pubmed publisher
  556. Griffiths K, Stylianou E, Poyntz H, Betts G, Fletcher H, McShane H. Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice. PLoS ONE. 2013;8:e78312 pubmed publisher
  557. Iwata A, Kawashima S, Kobayashi M, Okubo A, Kawashima H, Suto A, et al. Th2-type inflammation instructs inflammatory dendritic cells to induce airway hyperreactivity. Int Immunol. 2014;26:103-14 pubmed publisher
  558. Bodhankar S, Chen Y, Vandenbark A, Murphy S, Offner H. PD-L1 enhances CNS inflammation and infarct volume following experimental stroke in mice in opposition to PD-1. J Neuroinflammation. 2013;10:111 pubmed publisher
  559. Furuya Y, Kirimanjeswara G, Roberts S, Metzger D. Increased susceptibility of IgA-deficient mice to pulmonary Francisella tularensis live vaccine strain infection. Infect Immun. 2013;81:3434-41 pubmed publisher
  560. Mandal M, Donnelly R, Elkabes S, Zhang P, Davini D, David B, et al. Maternal immune stimulation during pregnancy shapes the immunological phenotype of offspring. Brain Behav Immun. 2013;33:33-45 pubmed publisher
  561. Barron L, Smith A, El Kasmi K, Qualls J, Huang X, Cheever A, et al. Role of arginase 1 from myeloid cells in th2-dominated lung inflammation. PLoS ONE. 2013;8:e61961 pubmed publisher
  562. Koning J, Kooij G, de Vries H, Nolte M, Mebius R. Mesenchymal stem cells are mobilized from the bone marrow during inflammation. Front Immunol. 2013;4:49 pubmed publisher
  563. Powell N, Walker A, Stolarczyk E, Canavan J, Gökmen M, Marks E, et al. The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells. Immunity. 2012;37:674-84 pubmed publisher
  564. Walker J, Raué H, Slifka M. Characterization of CD8+ T cell function and immunodominance generated with an H2O2-inactivated whole-virus vaccine. J Virol. 2012;86:13735-44 pubmed publisher
  565. Jin X, Uchiyama M, Zhang Q, Hirai T, Niimi M. Inchingorei-san (TJ-117) and Artemisiae Capillaris Herba Induced Prolonged Survival of Fully Mismatched Cardiac Allografts and Generated Regulatory Cells in Mice. Evid Based Complement Alternat Med. 2012;2012:689810 pubmed publisher
  566. Zhang N, Bevan M. TGF-? signaling to T cells inhibits autoimmunity during lymphopenia-driven proliferation. Nat Immunol. 2012;13:667-73 pubmed publisher
  567. Uchiyama M, Jin X, Zhang Q, Hirai T, Amano A, Bashuda H, et al. Auditory stimulation of opera music induced prolongation of murine cardiac allograft survival and maintained generation of regulatory CD4+CD25+ cells. J Cardiothorac Surg. 2012;7:26 pubmed publisher
  568. Mathieu M, Cotta Grand N, Daudelin J, Boulet S, Lapointe R, Labrecque N. CD40-activated B cells can efficiently prime antigen-specific naïve CD8+ T cells to generate effector but not memory T cells. PLoS ONE. 2012;7:e30139 pubmed publisher
  569. Pinto A, Daffis S, Brien J, Gainey M, Yokoyama W, Sheehan K, et al. A temporal role of type I interferon signaling in CD8+ T cell maturation during acute West Nile virus infection. PLoS Pathog. 2011;7:e1002407 pubmed publisher
  570. Tousif S, Singh Y, Prasad D, Sharma P, Van Kaer L, Das G. T cells from Programmed Death-1 deficient mice respond poorly to Mycobacterium tuberculosis infection. PLoS ONE. 2011;6:e19864 pubmed publisher
  571. Werner J, Busl E, Farkas S, Schlitt H, Geissler E, Hornung M. DX5+NKT cells display phenotypical and functional differences between spleen and liver as well as NK1.1-Balb/c and NK1.1+ C57Bl/6 mice. BMC Immunol. 2011;12:26 pubmed publisher
  572. Mota B, Gallardo Romero N, Trindade G, Keckler M, Karem K, Carroll D, et al. Adverse events post smallpox-vaccination: insights from tail scarification infection in mice with Vaccinia virus. PLoS ONE. 2011;6:e18924 pubmed publisher
  573. Murapa P, Ward M, Gandhapudi S, Woodward J, D Orazio S. Heat shock factor 1 protects mice from rapid death during Listeria monocytogenes infection by regulating expression of tumor necrosis factor alpha during fever. Infect Immun. 2011;79:177-84 pubmed publisher
  574. Gibbert K, Dietze K, Zelinskyy G, Lang K, Barchet W, Kirschning C, et al. Polyinosinic-polycytidylic acid treatment of Friend retrovirus-infected mice improves functional properties of virus-specific T cells and prevents virus-induced disease. J Immunol. 2010;185:6179-89 pubmed publisher
  575. Weber K, Hildner K, Murphy K, Allen P. Trpm4 differentially regulates Th1 and Th2 function by altering calcium signaling and NFAT localization. J Immunol. 2010;185:2836-46 pubmed publisher
  576. Tait E, Jordan K, Dupont C, Harris T, Gregg B, Wilson E, et al. Virulence of Toxoplasma gondii is associated with distinct dendritic cell responses and reduced numbers of activated CD8+ T cells. J Immunol. 2010;185:1502-12 pubmed publisher
  577. Marshall H, Prince A, Berg L, Welsh R. IFN-alpha beta and self-MHC divert CD8 T cells into a distinct differentiation pathway characterized by rapid acquisition of effector functions. J Immunol. 2010;185:1419-28 pubmed publisher
  578. Jacobs C, Duewell P, Heckelsmiller K, Wei J, Bauernfeind F, Ellermeier J, et al. An ISCOM vaccine combined with a TLR9 agonist breaks immune evasion mediated by regulatory T cells in an orthotopic model of pancreatic carcinoma. Int J Cancer. 2011;128:897-907 pubmed publisher
  579. Zou Y, Chen T, Han M, Wang H, Yan W, Song G, et al. Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure. J Immunol. 2010;184:466-75 pubmed publisher
  580. Wu S, Rhee K, Albesiano E, RABIZADEH S, Wu X, Yen H, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med. 2009;15:1016-22 pubmed publisher
  581. Ellestad K, Tsutsui S, Noorbakhsh F, Warren K, Yong V, Pittman Q, et al. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells. J Immunol. 2009;183:298-309 pubmed publisher
  582. Tseng K, Chung C, H ng W, Wang S. Early infection termination affects number of CD8+ memory T cells and protective capacities in listeria monocytogenes-infected mice upon rechallenge. J Immunol. 2009;182:4590-600 pubmed publisher
  583. Hamada H, Garcia Hernandez M, Reome J, Misra S, Strutt T, McKinstry K, et al. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol. 2009;182:3469-81 pubmed publisher
  584. Cooper M, Elliott J, Keyel P, Yang L, Carrero J, Yokoyama W. Cytokine-induced memory-like natural killer cells. Proc Natl Acad Sci U S A. 2009;106:1915-9 pubmed publisher
  585. Nowell M, Williams A, Carty S, Scheller J, Hayes A, Jones G, et al. Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis. J Immunol. 2009;182:613-22 pubmed
  586. Merck E, Voyle R, MacDonald H. Ly49D engagement on T lymphocytes induces TCR-independent activation and CD8 effector functions that control tumor growth. J Immunol. 2009;182:183-92 pubmed
  587. Leppkes M, Becker C, Ivanov I, Hirth S, Wirtz S, Neufert C, et al. RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. Gastroenterology. 2009;136:257-67 pubmed publisher
  588. Sheng H, Wang Y, Jin Y, Zhang Q, Zhang Y, Wang L, et al. A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1. Cell Res. 2008;18:846-57 pubmed publisher
  589. Sprengers D, Sillé F, Derkow K, Besra G, Janssen H, Schott E, et al. Critical role for CD1d-restricted invariant NKT cells in stimulating intrahepatic CD8 T-cell responses to liver antigen. Gastroenterology. 2008;134:2132-43 pubmed publisher
  590. Sridhar S, Reyes Sandoval A, Draper S, Moore A, Gilbert S, Gao G, et al. Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A. J Virol. 2008;82:3822-33 pubmed publisher
  591. Ahonen C, Wasiuk A, Fuse S, Turk M, Ernstoff M, Suriawinata A, et al. Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared with unitary adjuvants as cancer vaccines. Blood. 2008;111:3116-25 pubmed publisher
  592. Richards H, Longhi M, Wright K, Gallimore A, Ager A. CD62L (L-selectin) down-regulation does not affect memory T cell distribution but failure to shed compromises anti-viral immunity. J Immunol. 2008;180:198-206 pubmed
  593. Tian C, Ansari M, Paez Cortez J, Bagley J, Godwin J, Donnarumma M, et al. Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy. J Immunol. 2007;179:6762-9 pubmed
  594. Wanasen N, Xin L, Soong L. Pathogenic role of B cells and antibodies in murine Leishmania amazonensis infection. Int J Parasitol. 2008;38:417-29 pubmed
  595. Allard E, Hardy M, Leignadier J, Marquis M, Rooney J, Lehoux D, et al. Overexpression of IL-21 promotes massive CD8+ memory T cell accumulation. Eur J Immunol. 2007;37:3069-77 pubmed
  596. Park S, Han Y, Aleyas A, George J, Yoon H, Lee J, et al. Low-dose antigen-experienced CD4+ T cells display reduced clonal expansion but facilitate an effective memory pool in response to secondary exposure. Immunology. 2008;123:426-37 pubmed
  597. Iwabuchi N, Takahashi N, Xiao J, Miyaji K, Iwatsuki K. In vitro Th1 cytokine-independent Th2 suppressive effects of bifidobacteria. Microbiol Immunol. 2007;51:649-60 pubmed
  598. Badovinac V, Harty J. Manipulating the rate of memory CD8+ T cell generation after acute infection. J Immunol. 2007;179:53-63 pubmed
  599. Burster T, Giffon T, Dahl M, Björck P, Bogyo M, Weber E, et al. Influenza A virus elevates active cathepsin B in primary murine DC. Int Immunol. 2007;19:645-55 pubmed
  600. Nakae S, Iwakura Y, Suto H, Galli S. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukoc Biol. 2007;81:1258-68 pubmed
  601. Chang S, Wang K, Lu Y, Yang L, Chen W, Lin Y, et al. Characterization of early gamma interferon (IFN-gamma) expression during murine listeriosis: identification of NK1.1+ CD11c+ cells as the primary IFN-gamma-expressing cells. Infect Immun. 2007;75:1167-76 pubmed
  602. Kobie J, Shah P, Yang L, Rebhahn J, Fowell D, Mosmann T. T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5'-adenosine monophosphate to adenosine. J Immunol. 2006;177:6780-6 pubmed
  603. Hewitson J, Jenkins G, Hamblin P, Mountford A. CD40/CD154 interactions are required for the optimal maturation of skin-derived APCs and the induction of helminth-specific IFN-gamma but not IL-4. J Immunol. 2006;177:3209-17 pubmed
  604. Huster K, Koffler M, Stemberger C, Schiemann M, Wagner H, Busch D. Unidirectional development of CD8+ central memory T cells into protective Listeria-specific effector memory T cells. Eur J Immunol. 2006;36:1453-64 pubmed
  605. Pedras Vasconcelos J, Goucher D, Puig M, Tonelli L, Wang V, Ito S, et al. CpG oligodeoxynucleotides protect newborn mice from a lethal challenge with the neurotropic Tacaribe arenavirus. J Immunol. 2006;176:4940-9 pubmed
  606. Hoentjen F, Tonkonogy S, Liu B, Sartor R, Taurog J, Dieleman L. Adoptive transfer of nontransgenic mesenteric lymph node cells induces colitis in athymic HLA-B27 transgenic nude rats. Clin Exp Immunol. 2006;143:474-83 pubmed
  607. Matsuda J, Zhang Q, Ndonye R, Richardson S, Howell A, Gapin L. T-bet concomitantly controls migration, survival, and effector functions during the development of Valpha14i NKT cells. Blood. 2006;107:2797-805 pubmed
  608. Al Qaoud K, Abdel Hafez S. Humoral and cytokine response during protection of mice against secondary hydatidosis caused by Echinococcus granulosus. Parasitol Res. 2005;98:54-60 pubmed
  609. Hoentjen F, Welling G, Harmsen H, Zhang X, Snart J, Tannock G, et al. Reduction of colitis by prebiotics in HLA-B27 transgenic rats is associated with microflora changes and immunomodulation. Inflamm Bowel Dis. 2005;11:977-85 pubmed
  610. Irwin S, Izzo A, Dow S, Skeiky Y, Reed S, Alderson M, et al. Tracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the Mtb72F polyprotein. Infect Immun. 2005;73:5809-16 pubmed
  611. Janelidze S, Enell K, Visse E, Darabi A, Salford L, Siesjo P. Activation of purified allogeneic CD4(+) T cells by rat bone marrow-derived dendritic cells induces concurrent secretion of IFN-gamma, IL-4, and IL-10. Immunol Lett. 2005;101:193-201 pubmed
  612. Beadling C, Slifka M. Differential regulation of virus-specific T-cell effector functions following activation by peptide or innate cytokines. Blood. 2005;105:1179-86 pubmed
  613. Freyschmidt E, Alonso A, Hartmann G, Gissmann L. Activation of dendritic cells and induction of T cell responses by HPV 16 L1/E7 chimeric virus-like particles are enhanced by CpG ODN or sorbitol. Antivir Ther. 2004;9:479-89 pubmed
  614. Cabarrocas J, Piaggio E, Zappulla J, Desbois S, Mars L, Lassmann H, et al. A transgenic mouse model for T-cell ignorance of a glial autoantigen. J Autoimmun. 2004;22:179-89 pubmed
  615. Dieleman L, Hoentjen F, Qian B, Sprengers D, Tjwa E, Torres M, et al. Reduced ratio of protective versus proinflammatory cytokine responses to commensal bacteria in HLA-B27 transgenic rats. Clin Exp Immunol. 2004;136:30-9 pubmed
  616. Chen B, Cui X, Sempowski G, Domen J, Chao N. Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation. Blood. 2004;103:4344-52 pubmed
  617. Aramaki O, Shirasugi N, Takayama T, Shimazu M, Kitajima M, Ikeda Y, et al. Programmed death-1-programmed death-L1 interaction is essential for induction of regulatory cells by intratracheal delivery of alloantigen. Transplantation. 2004;77:6-12 pubmed
  618. Hogg K, Kumkate S, Mountford A. IL-10 regulates early IL-12-mediated immune responses induced by the radiation-attenuated schistosome vaccine. Int Immunol. 2003;15:1451-9 pubmed
  619. Drappa J, Kamen L, Chan E, Georgiev M, Ashany D, Marti F, et al. Impaired T cell death and lupus-like autoimmunity in T cell-specific adapter protein-deficient mice. J Exp Med. 2003;198:809-21 pubmed
  620. Goñi O, Alcaide P, Fresno M. Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1(+))CD11b(+ )immature myeloid suppressor cells. Int Immunol. 2002;14:1125-34 pubmed
  621. Archin N, Atherton S. Infiltration of T-lymphocytes in the brain after anterior chamber inoculation of a neurovirulent and neuroinvasive strain of HSV-1. J Neuroimmunol. 2002;130:117-27 pubmed
  622. Turner J, Frank A, Orme I. Old mice express a transient early resistance to pulmonary tuberculosis that is mediated by CD8 T cells. Infect Immun. 2002;70:4628-37 pubmed
  623. Roach D, Bean A, Demangel C, France M, Briscoe H, Britton W. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol. 2002;168:4620-7 pubmed
  624. Chen B, Liu C, Cui X, Fidler J, Chao N. Prevention of graft-versus-host disease by a novel immunosuppressant, PG490-88, through inhibition of alloreactive T cell expansion. Transplantation. 2000;70:1442-7 pubmed
  625. Price G, Ou R, Jiang H, Huang L, Moskophidis D. Viral escape by selection of cytotoxic T cell-resistant variants in influenza A virus pneumonia. J Exp Med. 2000;191:1853-67 pubmed
  626. Gett A, Hodgkin P. Cell division regulates the T cell cytokine repertoire, revealing a mechanism underlying immune class regulation. Proc Natl Acad Sci U S A. 1998;95:9488-93 pubmed
  627. Cherwinski H, Schumacher J, Brown K, Mosmann T. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J Exp Med. 1987;166:1229-44 pubmed